{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Procter and Gamble, in 2022 Q1, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  |  |  |  | \nx | True | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  |  |  |  | \no | False | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)\u00a0OF THE SECURITIES EXCHANGE ACT OF 1934  |  | \n  |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOhio | OH | 1-434 |  | 31-0411980\n(State of Incorporation) |  | (Commission File Number) |  | (I.R.S. Employer Identification Number)\nOne Procter & Gamble Plaza |  | Cincinnati | OH | \nOne Procter & Gamble Plaza, Cincinnati, Ohio | 45202\n(Address of principal executive offices) | (Zip Code)  |  | \n  |  |  |  |  |  |  |  | \nTitle of each class | Trading Symbol | Name of each exchange on which registered\nCommon Stock, without Par Value | PG | NYSE\n2.000% Notes due 2022 | PG22B | NYSE\n1.125% Notes due 2023 | PG23A | NYSE\n0.500% Notes due 2024 | PG24A | NYSE\n0.625% Notes due 2024 | PG24B | NYSE\n1.375% Notes due 2025 | PG25 | NYSE\n0.110% Notes due 2026 | PG26D | NYSE\n4.875% EUR notes due May 2027 | PG27A | NYSE\n1.200% Notes due 2028 | PG28 | NYSE\n1.250% Notes due 2029 | PG29B | NYSE\n1.800% Notes due 2029 | PG29A | NYSE\n6.250% GBP notes due January 2030 | PG30 | NYSE\n0.350% Notes due 2030 | PG30C | NYSE\n0.230% Notes due 2031 | PG31A | NYSE\n5.250% GBP notes due January 2033 | PG33 | NYSE\n1.875% Notes due 2038 | PG38 | NYSE\n0.900% Notes due 2041 | PG41 | NYSE  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Large accelerated filer | \u00fe |  |  | Accelerated filer | \u00a8 | \n | Non-accelerated filer | \u00a8 |  |  | Smaller reporting company | \u00a8 | False\n |  |  |  |  | Emerging growth company | \u00a8 | False  |  |  |  |  | \nItem 1. | Financial Statements  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31 |  | Nine Months Ended March 31\nAmounts in millions except per share amounts | 2022 |  | 2021 |  | 2022 |  | 2021\nNET SALES | $ | 19,381 |  |  | $ | 18,109 |  |  | $ | 60,672 |  |  | $ | 57,172 | \nCost of products sold | 10,326 |  |  | 8,922 |  |  | 31,355 |  |  | 27,317 | \nSelling, general and administrative expense | 5,031 |  |  | 5,402 |  |  | 15,102 |  |  | 15,409 | \nOPERATING INCOME | 4,024 |  |  | 3,785 |  |  | 14,215 |  |  | 14,446 | \nInterest expense | (109) |  |  | (106) |  |  | (324) |  |  | (385) | \nInterest income | 9 |  |  | 11 |  |  | 30 |  |  | 30 | \nOther non-operating income/(expense), net | 147 |  |  | 187 |  |  | 424 |  |  | (40) | \nEARNINGS BEFORE INCOME TAXES | 4,071 |  |  | 3,877 |  |  | 14,345 |  |  | 14,051 | \nIncome taxes | 704 |  |  | 628 |  |  | 2,610 |  |  | 2,607 | \nNET EARNINGS | 3,367 |  |  | 3,249 |  |  | 11,735 |  |  | 11,444 | \nLess:  Net earnings/(loss) attributable to noncontrolling interests | 12 |  |  | (20) |  |  | 45 |  |  | 44 | \nNET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE | $ | 3,355 |  |  | $ | 3,269 |  |  | $ | 11,690 |  |  | $ | 11,400 | \n |  |  |  |  |  |  | \nNET EARNINGS PER SHARE(1) |  |  |  |  |  |  | \nBasic | $ | 1.37 |  |  | $ | 1.30 |  |  | $ | 4.76 |  |  | $ | 4.53 | \nDiluted | $ | 1.33 |  |  | $ | 1.26 |  |  | $ | 4.59 |  |  | $ | 4.37 | \n |  |  |  |  |  |  | \nDILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING | 2,530.2 |  |  | 2,590.3 |  |  | 2,544.4 |  |  | 2,610.4 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31 |  | Nine Months Ended March 31\nAmounts in millions | 2022 |  | 2021 |  | 2022 |  | 2021\nNET EARNINGS | $ | 3,367 |  |  | $ | 3,249 |  |  | $ | 11,735 |  |  | $ | 11,444 | \nOTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX |  |  |  |  |  |  | \nForeign currency translation | 23 |  |  | (598) |  |  | (683) |  |  | 639 | \nUnrealized gains on investment securities | \u2014 |  |  | 5 |  |  | 7 |  |  | 19 | \nUnrealized gains on defined benefit retirement plans | 89 |  |  | 194 |  |  | 968 |  |  | 24 | \nTOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX | 112 |  |  | (399) |  |  | 292 |  |  | 682 | \nTOTAL COMPREHENSIVE INCOME | 3,479 |  |  | 2,850 |  |  | 12,027 |  |  | 12,126 | \nLess:  Total comprehensive income/(loss) attributable to noncontrolling interests | 8 |  |  | (21) |  |  | 41 |  |  | 50 | \nTOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE | $ | 3,471 |  |  | $ | 2,871 |  |  | $ | 11,986 |  |  | $ | 12,076 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAmounts in millions |  |  |  |  | March 31, 2022 |  | June 30, 2021\nAssets |  |  |  |  |  |  | \nCURRENT ASSETS |  |  |  |  |  |  | \nCash and cash equivalents |  |  |  |  | $ | 8,526 |  |  | $ | 10,288 | \nAccounts receivable |  |  |  |  | 5,513 |  |  | 4,725 | \nINVENTORIES |  |  |  |  |  |  | \nMaterials and supplies |  |  |  |  | 2,146 |  |  | 1,645 | \nWork in process |  |  |  |  | 837 |  |  | 719 | \nFinished goods |  |  |  |  | 4,118 |  |  | 3,619 | \nTotal inventories |  |  |  |  | 7,101 |  |  | 5,983 | \nPrepaid expenses and other current assets |  |  |  |  | 2,276 |  |  | 2,095 | \nTOTAL CURRENT ASSETS |  |  |  |  | 23,416 |  |  | 23,091 | \nPROPERTY, PLANT AND EQUIPMENT, NET |  |  |  |  | 21,323 |  |  | 21,686 | \nGOODWILL |  |  |  |  | 40,710 |  |  | 40,924 | \nTRADEMARKS AND OTHER INTANGIBLE ASSETS, NET |  |  |  | 23,913 |  |  | 23,642 | \nOTHER NONCURRENT ASSETS |  |  |  |  | 10,855 |  |  | 9,964 | \nTOTAL ASSETS |  |  |  |  | $ | 120,217 |  |  | $ | 119,307 | \n |  |  |  |  |  |  | \nLiabilities and Shareholders' Equity |  |  |  |  |  |  | \nCURRENT LIABILITIES |  |  |  |  |  |  | \nAccounts payable |  |  |  |  | $ | 14,175 |  |  | $ | 13,720 | \nAccrued and other liabilities |  |  |  |  | 10,324 |  |  | 10,523 | \nDebt due within one year |  |  |  |  | 9,902 |  |  | 8,889 | \nTOTAL CURRENT LIABILITIES |  |  |  |  | 34,401 |  |  | 33,132 | \nLONG-TERM DEBT |  |  |  |  | 23,767 |  |  | 23,099 | \nDEFERRED INCOME TAXES |  |  |  |  | 6,543 |  |  | 6,153 | \nOTHER NONCURRENT LIABILITIES |  |  |  |  | 9,760 |  |  | 10,269 | \nTOTAL LIABILITIES |  |  |  |  | 74,471 |  |  | 72,653 | \nSHAREHOLDERS\u2019 EQUITY |  |  |  |  |  |  | \nPreferred stock |  |  |  |  | 846 |  |  | 870 | \nCommon stock \u2013 shares issued \u2013 | March 2022 |  | 4,009.2 |  |  |  |  | \n | June 2021 |  | 4,009.2 |  |  | 4,009 |  |  | 4,009 | \nAdditional paid-in capital |  |  |  |  | 65,614 |  |  | 64,848 | \nReserve for ESOP debt retirement |  |  |  |  | (916) |  |  | (1,006) | \nAccumulated other comprehensive loss |  |  |  |  | (13,448) |  |  | (13,744) | \nTreasury stock |  |  |  |  | (122,272) |  |  | (114,973) | \nRetained earnings |  |  |  |  | 111,645 |  |  | 106,374 | \nNoncontrolling interest |  |  |  |  | 268 |  |  | 276 | \nTOTAL SHAREHOLDERS\u2019 EQUITY |  |  |  |  | 45,746 |  |  | 46,654 | \nTOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY |  |  |  | $ | 120,217 |  |  | $ | 119,307 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2022\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Add-itional Paid-In Capital | Reserve for ESOP Debt Retirement | AccumulatedOtherComp-rehensiveIncome/(Loss) | Treasury Stock | Retained Earnings | Non-controlling Interest | Total Share-holders' Equity\nShares | Amount\nBALANCE DECEMBER 31, 2021 | 2,397,066 |  | $4,009 |  | $856 |  | $65,432 |  | ($965) |  | ($13,564) |  | ($121,543) |  | $110,393 |  | $275 |  | $44,893 | \nNet earnings |  |  |  |  |  |  |  | 3,355 |  | 12 |  | 3,367 | \nOther comprehensive income/(loss) |  |  |  |  |  | 116 |  |  |  | (4) |  | 112 | \nDividends and dividend equivalents($0.8698per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (2,092) |  |  | (2,092) | \nPreferred |  |  |  |  |  |  |  | (68) |  |  | (68) | \nTreasury stock purchases | (7,909) |  |  |  |  |  |  | (1,249) |  |  |  | (1,249) | \nEmployee stock plans | 9,108 |  |  |  | 180 |  |  |  | 512 |  |  |  | 692 | \nPreferred stock conversions | 1,032 |  |  | (10) |  | 2 |  |  |  | 8 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 49 |  |  |  | 57 |  |  | 106 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (15) |  | (15) | \nBALANCE MARCH 31, 2022 | 2,399,297 |  | $4,009 |  | $846 |  | $65,614 |  | ($916) |  | ($13,448) |  | ($122,272) |  | $111,645 |  | $268 |  | $45,746 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended March 31, 2022\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Add-itional Paid-In Capital | Reserve for ESOP Debt Retirement | AccumulatedOtherComp-rehensiveIncome/(Loss) | Treasury Stock | Retained Earnings | Non-controlling Interest | Total Share-holders' Equity\nShares | Amount\nBALANCEJUNE 30, 2021 | 2,429,706 |  | $4,009 |  | $870 |  | $64,848 |  | ($1,006) |  | ($13,744) |  | ($114,973) |  | $106,374 |  | $276 |  | $46,654 | \nNet earnings |  |  |  |  |  |  |  | 11,690 |  | 45 |  | 11,735 | \nOther comprehensive income/(loss) |  |  |  |  |  | 296 |  |  |  | (4) |  | 292 | \nDividends and dividend equivalents($2.6094per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (6,318) |  |  | (6,318) | \nPreferred |  |  |  |  |  |  |  | (208) |  |  | (208) | \nTreasury stock purchases | (58,695) |  |  |  |  |  |  | (8,753) |  |  |  | (8,753) | \nEmployee stock plans | 25,531 |  |  |  | 764 |  |  |  | 1,434 |  |  |  | 2,198 | \nPreferred stock conversions | 2,755 |  |  | (24) |  | 4 |  |  |  | 20 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 90 |  |  |  | 107 |  |  | 197 | \nNoncontrolling interest, net |  |  |  | (2) |  |  |  |  |  | (49) |  | (51) | \nBALANCE MARCH 31, 2022 | 2,399,297 |  | $4,009 |  | $846 |  | $65,614 |  | ($916) |  | ($13,448) |  | ($122,272) |  | $111,645 |  | $268 |  | $45,746 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2021\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Add-itional Paid-In Capital | Reserve for ESOP Debt Retirement | AccumulatedOtherComp-rehensiveIncome/(Loss) | Treasury Stock | Retained Earnings | Non-controlling Interest | Total Share-holders' Equity\nShares | Amount\nBALANCE DECEMBER 31, 2020 | 2,462,476 |  | $4,009 |  | $885 |  | $64,672 |  | ($1,072) |  | ($15,091) |  | ($109,583) |  | $104,361 |  | $359 |  | $48,540 | \nNet earnings |  |  |  |  |  |  |  | 3,269 |  | (20) |  | 3,249 | \nOther comprehensive income/(loss) |  |  |  |  |  | (398) |  |  |  | (1) |  | (399) | \nDividends and dividend equivalents($0.7907per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (1,952) |  |  | (1,952) | \nPreferred |  |  |  |  |  |  |  | (65) |  |  | (65) | \nTreasury stock purchases | (23,085) |  |  |  |  |  |  | (3,001) |  |  |  | (3,001) | \nEmployee stock plans | 7,605 |  |  |  | 8 |  |  |  | 427 |  |  |  | 435 | \nPreferred stock conversions | 1,237 |  |  | (12) |  | 2 |  |  |  | 10 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 66 |  |  |  | 61 |  |  | 127 | \nNoncontrolling interest, net |  |  |  |  |  |  |  |  | (15) |  | (15) | \nBALANCE MARCH 31, 2021 | 2,448,233 |  | $4,009 |  | $873 |  | $64,682 |  | ($1,006) |  | ($15,489) |  | ($112,147) |  | $105,674 |  | $323 |  | $46,919 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended March 31, 2021\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Add-itional Paid-In Capital | Reserve for ESOP Debt Retirement | AccumulatedOtherComp-rehensiveIncome/(Loss) | Treasury Stock | Retained Earnings | Non-controlling Interest | Total Share-holders' Equity\nShares | Amount\nBALANCEJUNE 30, 2020 | 2,479,746 |  | $4,009 |  | $897 |  | $64,194 |  | ($1,080) |  | ($16,165) |  | ($105,573) |  | $100,239 |  | $357 |  | $46,878 | \nNet earnings |  |  |  |  |  |  |  | 11,400 |  | 44 |  | 11,444 | \nOther comprehensive income/(loss) |  |  |  |  |  | 676 |  |  |  | 6 |  | 682 | \nDividends and dividend equivalents( $2.3721per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (5,887) |  |  | (5,887) | \nPreferred |  |  |  |  |  |  |  | (197) |  |  | (197) | \nTreasury stock purchases | (59,212) |  |  |  |  |  |  | (8,009) |  |  |  | (8,009) | \nEmployee stock plans | 24,945 |  |  |  | 484 |  |  |  | 1,415 |  |  |  | 1,899 | \nPreferred stock conversions | 2,754 |  |  | (24) |  | 4 |  |  |  | 20 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 74 |  |  |  | 119 |  |  | 193 | \nNoncontrolling interest, net |  |  |  |  |  |  |  |  | (84) |  | (84) | \nBALANCE MARCH 31, 2021 | 2,448,233 |  | $4,009 |  | $873 |  | $64,682 |  | ($1,006) |  | ($15,489) |  | ($112,147) |  | $105,674 |  | $323 |  | $46,919 |   |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended March 31\nAmounts in millions | 2022 |  | 2021\nCASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD | $ | 10,288 |  |  | $ | 16,181 | \nOPERATING ACTIVITIES |  |  | \nNet earnings | 11,735 |  |  | 11,444 | \nDepreciation and amortization | 2,085 |  |  | 2,025 | \nLoss on early extinguishment of debt | \u2014 |  |  | 512 | \nShare-based compensation expense | 398 |  |  | 398 | \nDeferred income taxes | (259) |  |  | (167) | \nGain on sale of assets | (84) |  |  | (15) | \nChanges in: |  |  | \nAccounts receivable | (916) |  |  | (604) | \nInventories | (1,252) |  |  | (399) | \nAccounts payable, accrued and other liabilities | 1,347 |  |  | 1,049 | \nOther operating assets and liabilities | (131) |  |  | (92) | \nOther | 87 |  |  | 99 | \nTOTAL OPERATING ACTIVITIES | 13,010 |  |  | 14,250 | \nINVESTING ACTIVITIES |  |  | \nCapital expenditures | (2,464) |  |  | (2,073) | \nProceeds from asset sales | 99 |  |  | 40 | \nAcquisitions, net of cash acquired | (1,381) |  |  | \u2014 | \nChange in other investments | 4 |  |  | (10) | \nTOTAL INVESTING ACTIVITIES | (3,742) |  |  | (2,043) | \nFINANCING ACTIVITIES |  |  | \nDividends to shareholders | (6,508) |  |  | (6,066) | \nAdditions to short-term debt with original maturities of more than three months | 10,146 |  |  | 6,238 | \nReductions in short-term debt with original maturities of more than three months | (8,163) |  |  | (3,805) | \nReductions in other short-term debt | (849) |  |  | (5,814) | \nAdditions to long-term debt | 4,385 |  |  | 2,429 | \nReductions to long-term debt(1) | (2,776) |  |  | (4,889) | \nTreasury stock purchases | (8,753) |  |  | (8,009) | \nImpact of stock options and other | 1,800 |  |  | 1,470 | \nTOTAL FINANCING ACTIVITIES | (10,718) |  |  | (18,446) | \nEFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (312) |  |  | 65 | \nCHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (1,762) |  |  | (6,174) | \nCASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD | $ | 8,526 |  |  | $ | 10,007 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | % of Net sales by operating segment(1)\n | Three Months Ended March 31 |  | Nine Months Ended March 31\n | 2022 |  | 2021 |  | 2022 |  | 2021\nFabric Care | 23% |  | 23% |  | 23% |  | 22%\nHome Care | 12% |  | 12% |  | 11% |  | 12%\nBaby Care | 11% |  | 11% |  | 10% |  | 10%\nSkin and Personal Care | 9% |  | 9% |  | 10% |  | 10%\nFamily Care | 9% |  | 9% |  | 9% |  | 9%\nHair Care | 8% |  | 9% |  | 9% |  | 9%\nOral Care | 8% |  | 8% |  | 8% |  | 8%\nShave Care | 7% |  | 7% |  | 6% |  | 7%\nFeminine Care | 6% |  | 6% |  | 6% |  | 6%\nPersonal Health Care | 6% |  | 5% |  | 6% |  | 5%\nOther | 1% |  | 1% |  | 2% |  | 2%\nTotal | 100% |  | 100% |  | 100% |  | 100%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended March 31 |  | Nine Months Ended March 31\n |  | Net Sales |  | Earnings/(Loss) Before Income Taxes |  | Net Earnings |  | Net Sales |  | Earnings/(Loss) Before Income Taxes |  | Net Earnings\nBeauty | 2022 | $ | 3,389 |  |  | $ | 792 |  |  | $ | 644 |  |  | $ | 11,279 |  |  | $ | 3,213 |  |  | $ | 2,582 | \n | 2021 | 3,316 |  |  | 721 |  |  | 577 |  |  | 10,907 |  |  | 3,145 |  |  | 2,508 | \nGrooming | 2022 | 1,481 |  |  | 353 |  |  | 290 |  |  | 4,979 |  |  | 1,447 |  |  | 1,183 | \n | 2021 | 1,438 |  |  | 314 |  |  | 256 |  |  | 4,774 |  |  | 1,277 |  |  | 1,063 | \nHealth Care | 2022 | 2,662 |  |  | 625 |  |  | 485 |  |  | 8,314 |  |  | 2,225 |  |  | 1,715 | \n | 2021 | 2,356 |  |  | 484 |  |  | 377 |  |  | 7,573 |  |  | 1,993 |  |  | 1,557 | \nFabric & Home Care | 2022 | 6,699 |  |  | 1,275 |  |  | 969 |  |  | 20,680 |  |  | 4,284 |  |  | 3,297 | \n | 2021 | 6,275 |  |  | 1,348 |  |  | 1,027 |  |  | 19,417 |  |  | 4,689 |  |  | 3,626 | \nBaby, Feminine & Family Care | 2022 | 4,935 |  |  | 1,091 |  |  | 836 |  |  | 14,915 |  |  | 3,353 |  |  | 2,576 | \n | 2021 | 4,604 |  |  | 1,133 |  |  | 871 |  |  | 14,185 |  |  | 3,803 |  |  | 2,924 | \nCorporate | 2022 | 215 |  |  | (65) |  |  | 143 |  |  | 505 |  |  | (177) |  |  | 382 | \n | 2021 | 120 |  |  | (123) |  |  | 141 |  |  | 316 |  |  | (856) |  |  | (234) | \nTotal Company | 2022 | $ | 19,381 |  |  | $ | 4,071 |  |  | $ | 3,367 |  |  | $ | 60,672 |  |  | $ | 14,345 |  |  | $ | 11,735 | \n | 2021 | 18,109 |  |  | 3,877 |  |  | 3,249 |  |  | 57,172 |  |  | 14,051 |  |  | 11,444 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Beauty |  | Grooming |  | Health Care |  | Fabric & Home Care |  | Baby, Feminine & Family Care |  | Total Company\nGoodwill at June 30, 2021 | $ | 13,257 |  |  | $ | 13,095 |  |  | $ | 8,046 |  |  | $ | 1,873 |  |  | $ | 4,653 |  |  | $ | 40,924 | \nAcquisitions and divestitures | 770 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | 771 | \nTranslation and other | (368) |  |  | (257) |  |  | (216) |  |  | (32) |  |  | (112) |  |  | (985) | \nGoodwill at March 31, 2022 | $ | 13,659 |  |  | $ | 12,838 |  |  | $ | 7,831 |  |  | $ | 1,841 |  |  | $ | 4,541 |  |  | $ | 40,710 |   |  |  |  |  |  |  |  |  |  |  | \n | Gross Carrying Amount |  | Accumulated Amortization\nIntangible assets with determinable lives | $ | 9,147 |  |  | $ | (6,262) | \nIntangible assets with indefinite lives | 21,028 |  |  | \u2014 | \nTotal identifiable intangible assets | $ | 30,175 |  |  | $ | (6,262) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Approximate Percent Change in Estimated Fair Value\n | +25 bps Discount Rate |  | -25 bps Growth Rates |  | -50 bps Royalty Rate\nShave Care goodwill reporting unit | (6)% |  | (6)% |  | N/A\nGillette indefinite-lived intangible asset | (6)% |  | (6)% |  | (3)%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCONSOLIDATED AMOUNTS | Three Months Ended March 31 |  | Nine Months Ended March 31\n | 2022 |  | 2021 |  | 2022 |  | 2021\nNet earnings | $ | 3,367 |  |  | $ | 3,249 |  |  | $ | 11,735 |  |  | $ | 11,444 | \nLess:  Net earnings/(loss) attributable to noncontrolling interests | 12 |  |  | (20) |  |  | 45 |  |  | 44 | \nNet earnings attributable to P&G (Diluted) | 3,355 |  |  | 3,269 |  |  | 11,690 |  |  | 11,400 | \nLess:  Preferred dividends | 68 |  |  | 65 |  |  | 208 |  |  | 197 | \nNet earnings attributable to P&G available to common shareholders (Basic) | $ | 3,287 |  |  | $ | 3,204 |  |  | $ | 11,482 |  |  | $ | 11,203 | \n |  |  |  |  |  |  | \nSHARES IN MILLIONS |  |  |  |  |  |  | \nBasic weighted average common shares outstanding | 2,400.5 |  |  | 2,459.1 |  |  | 2,414.0 |  |  | 2,473.7 | \nAdd:  Effect of dilutive securities |  |  |  |  |  |  | \nConvertible preferred shares(1) | 78.9 |  |  | 82.3 |  |  | 79.7 |  |  | 83.1 | \nStock options and other unvested equity awards(2) | 50.8 |  |  | 48.9 |  |  | 50.7 |  |  | 53.6 | \nDiluted weighted average common shares outstanding | 2,530.2 |  |  | 2,590.3 |  |  | 2,544.4 |  |  | 2,610.4 | \n |  |  |  |  |  |  | \nNET EARNINGS PER SHARE(3) |  |  |  |  |  |  | \nBasic | $ | 1.37 |  |  | $ | 1.30 |  |  | $ | 4.76 |  |  | $ | 4.53 | \nDiluted | $ | 1.33 |  |  | $ | 1.26 |  |  | $ | 4.59 |  |  | $ | 4.37 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31 |  | Nine Months Ended March 31\n | 2022 |  | 2021 |  | 2022 |  | 2021\nShare-based compensation expense | $ | 130 |  |  | $ | 144 |  |  | $ | 398 |  |  | $ | 398 | \nNet periodic benefit cost for pension benefits | 47 |  |  | 48 |  |  | 143 |  |  | 141 | \nNet periodic benefit credit for other retiree benefits | (126) |  |  | (80) |  |  | (348) |  |  | (240) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Notional Amount |  | Fair\u00a0Value\u00a0Asset |  | Fair Value (Liability)\n | March 31, 2022 |  | June 30, 2021 |  | March 31, 2022 |  | June 30, 2021 |  | March 31, 2022 |  | June 30, 2021\nDERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS\nInterest rate contracts | $ | 5,241 |  |  | $ | 7,415 |  |  | $ | 15 |  |  | $ | 146 |  |  | $ | (182) |  |  | $ | \u2014 | \nDERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS\nForeign currency interest rate contracts | $ | 8,428 |  |  | $ | 8,484 |  |  | $ | 359 |  |  | $ | 89 |  |  | $ | (10) |  |  | $ | (94) | \nTOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | $ | 13,669 |  |  | $ | 15,899 |  |  | $ | 374 |  |  | $ | 235 |  |  | $ | (192) |  |  | $ | (94) | \n |  |  |  |  |  |  |  |  |  |  | \nDERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS\nForeign currency contracts | $ | 6,916 |  |  | $ | 5,060 |  |  | $ | 31 |  |  | $ | 20 |  |  | $ | (26) |  |  | $ | (22) | \n |  |  |  |  |  |  |  |  |  |  | \nTOTAL DERIVATIVES AT FAIR VALUE | $ | 20,585 |  |  | $ | 20,959 |  |  | $ | 405 |  |  | $ | 255 |  |  | $ | (218) |  |  | $ | (116) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Amount of Gain/(Loss) Recognized in OCI on Derivatives\n | Three Months Ended March 31 |  | Nine Months Ended March 31\n | 2022 |  | 2021 |  | 2022 |  | 2021\nDERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS(1) (2) |  |  |  | \nForeign exchange contracts | $ | 104 |  |  | $ | 393 |  |  | $ | 530 |  |  | $ | (145) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Amount of Gain/(Loss) Recognized in Earnings\n | Three Months Ended March 31 |  | Nine Months Ended March 31\n | 2022 |  | 2021 |  | 2022 |  | 2021\nDERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS |  |  |  | \nInterest rate contracts | $ | (216) |  |  | $ | (100) |  |  | $ | (313) |  |  | $ | (95) | \nDERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS |  |  |  | \nForeign currency contracts | $ | (2) |  |  | $ | (87) |  |  | $ | 28 |  |  | $ | 221 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Investment Securities |  | Post-retirement Benefits |  | Foreign Currency Translation |  | Total AOCI\nBalance at June 30, 2021 | $ | 15 |  |  | $ | (2,963) |  |  | $ | (10,796) |  |  | $ | (13,744) | \nOCI before reclassifications(1) | 6 |  |  | 812 |  |  | (683) |  |  | 135 | \nAmounts reclassified from AOCI into the Consolidated Statements of Earnings(2) | 1 |  |  | 156 |  |  |  |  | 157 | \nNet current period OCI | 7 |  |  | 968 |  |  | (683) |  |  | 292 | \nLess:  Other comprehensive income/(loss) attributable to non-controlling interests | \u2014 |  |  | \u2014 |  |  | (4) |  |  | (4) | \nBalance at March 31, 2022 | $ | 22 |  |  | $ | (1,995) |  |  | $ | (11,475) |  |  | $ | (13,448) |   |  |  |  |  | \nItem 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations  |  |  |  |  |  |  |  | \nReportable\u00a0Segments | Product Categories (Sub-Categories) | Major Brands\nBeauty | Hair Care (Conditioners, Shampoos, Styling Aids, Treatments) | Head & Shoulders,  Herbal Essences, Pantene, Rejoice\nSkin and Personal Care (Antiperspirants and Deodorants, Personal Cleansing, Skin Care) | Olay, Old Spice,  Safeguard, Secret, SK-II\nGrooming | Grooming(1)(Shave Care -Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Shave Care;Appliances) | Braun, Gillette, Venus\nHealth Care | Oral Care (Toothbrushes, Toothpastes, Other Oral Care) | Crest, Oral-B\nPersonal Health Care (Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Pain Relief, Other Personal Health Care) | Metamucil, Neurobion, Pepto-Bismol, Vicks\nFabric & Home Care | Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents) | Ariel, Downy, Gain, Tide\nHome Care (Air Care, Dish Care, P&G Professional, Surface Care) | Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer\nBaby, Feminine & Family Care | Baby Care (Baby Wipes, Taped Diapers and Pants) | Luvs, Pampers\nFeminine Care (Adult Incontinence, Feminine Care) | Always, Always Discreet, Tampax\nFamily Care (Paper Towels, Tissues, Toilet Paper) | Bounty, Charmin, Puffs  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2022 |  | Nine Months Ended March 31, 2022 |  | \n | Net Sales |  | Net Earnings |  | Net Sales |  | Net Earnings |  |  |  | \nBeauty | 17% |  | 20% |  | 19% |  | 23% |  |  |  | \nGrooming | 8% |  | 9% |  | 8% |  | 10% |  |  |  | \nHealth Care | 14% |  | 15% |  | 14% |  | 15% |  |  |  | \nFabric & Home Care | 35% |  | 30% |  | 34% |  | 29% |  |  |  | \nBaby, Feminine & Family Care | 26% |  | 26% |  | 25% |  | 23% |  |  |  | \nTotal Company | 100% |  | 100% |  | 100% |  | 100% |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31\nAmounts in millions, except per share amounts | 2022 |  | 2021 |  | % Chg\nNet sales | $19,381 |  | $18,109 |  | 7%\nOperating income | 4,024 |  | 3,785 |  | 6%\nNet earnings | 3,367 |  | 3,249 |  | 4%\nNet earnings attributable to Procter & Gamble | 3,355 |  | 3,269 |  | 3%\nDiluted net earnings per common share | 1.33 |  | 1.26 |  | 6%\n |  |  |  |  | \n\n | Three Months Ended March 31\nCOMPARISONS AS A PERCENTAGE OF NET SALES | 2022 |  | 2021 |  | Basis Pt Chg\nGross margin | 46.7% |  | 50.7% |  | (400)\nSelling, general & administrative expense | 26.0% |  | 29.8% |  | (380)\nOperating income | 20.8% |  | 20.9% |  | (10)\nEarnings before income taxes | 21.0% |  | 21.4% |  | (40)\nNet earnings | 17.4% |  | 17.9% |  | (50)\nNet earnings attributable to Procter & Gamble | 17.3% |  | 18.1% |  | (80)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Net Sales Change Drivers 2022 vs. 2021 (Three Months Ended March 31, 2022)(1)\n | Volume with Acquisitions & Divestitures |  | Volume Excluding Acquisitions & Divestitures |  | Foreign Exchange |  | Price |  | Mix |  | Other(2) |  | Net Sales Growth\nBeauty | \u2014% |  | (1)% |  | (2)% |  | 4% |  | \u2014% |  | \u2014% |  | 2%\nGrooming | 1% |  | 1% |  | (5)% |  | 6% |  | 1% |  | \u2014% |  | 3%\nHealth Care | 8% |  | 8% |  | (3)% |  | 3% |  | 5% |  | \u2014% |  | 13%\nFabric & Home Care | 4% |  | 5% |  | (3)% |  | 5% |  | 1% |  | \u2014% |  | 7%\nBaby, Feminine & Family Care | 2% |  | 2% |  | (3)% |  | 5% |  | 2% |  | 1% |  | 7%\nTotal Company | 3% |  | 3% |  | (3)% |  | 5% |  | 2% |  | \u2014% |  | 7%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended March 31\nAmounts in millions, except per share amounts | 2022 |  | 2021 |  | % Chg\nNet sales | $60,672 |  | $57,172 |  | 6%\nOperating income | 14,215 |  | 14,446 |  | (2)%\nNet earnings | 11,735 |  | 11,444 |  | 3%\nNet earnings attributable to Procter & Gamble | 11,690 |  | 11,400 |  | 3%\nDiluted net earnings per common share | 4.59 |  | 4.37 |  | 5%\nCore net earnings per common share | 4.59 |  | 4.53 |  | 1%\n\n | Nine Months Ended March 31\nCOMPARISONS AS A PERCENTAGE OF NET SALES | 2022 |  | 2021 |  | Basis Pt Chg\nGross margin | 48.3% |  | 52.2% |  | (390)\nSelling, general & administrative expense | 24.9% |  | 27.0% |  | (210)\nOperating income | 23.4% |  | 25.3% |  | (190)\nEarnings before income taxes | 23.6% |  | 24.6% |  | (100)\nNet earnings | 19.3% |  | 20.0% |  | (70)\nNet earnings attributable to Procter & Gamble | 19.3% |  | 19.9% |  | (60)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Net Sales Change Drivers 2022 vs. 2021 (Nine Months Ended March 31)(1)\n | Volume with Acquisitions & Divestitures |  | Volume Excluding Acquisitions & Divestitures |  | Foreign Exchange |  | Price |  | Mix |  | Other(2) |  | Net Sales Growth\nBeauty | \u2014% |  | \u2014% |  | \u2014% |  | 3% |  | \u2014% |  | \u2014% |  | 3%\nGrooming | 1% |  | 1% |  | (2)% |  | 4% |  | 1% |  | \u2014% |  | 4%\nHealth Care | 5% |  | 5% |  | \u2014% |  | 2% |  | 3% |  | \u2014% |  | 10%\nFabric & Home Care | 4% |  | 4% |  | (1)% |  | 3% |  | \u2014% |  | 1% |  | 7%\nBaby, Feminine & Family Care | 2% |  | 2% |  | (1)% |  | 3% |  | 1% |  | \u2014% |  | 5%\nTotal Company | 3% |  | 3% |  | (1)% |  | 3% |  | 1% |  | \u2014% |  | 6%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2022\n | Net Sales |  | % Change Versus Year Ago |  | Earnings/(Loss) Before Income Taxes |  | % Change Versus Year Ago |  | Net Earnings |  | % Change Versus Year Ago\nBeauty | $ | 3,389 |  |  | 2 | % |  | $ | 792 |  |  | 10 | % |  | $ | 644 |  |  | 12 | %\nGrooming | 1,481 |  |  | 3 | % |  | 353 |  |  | 12 | % |  | 290 |  |  | 13 | %\nHealth Care | 2,662 |  |  | 13 | % |  | 625 |  |  | 29 | % |  | 485 |  |  | 29 | %\nFabric & Home Care | 6,699 |  |  | 7 | % |  | 1,275 |  |  | (5) | % |  | 969 |  |  | (6) | %\nBaby, Feminine & Family Care | 4,935 |  |  | 7 | % |  | 1,091 |  |  | (4) | % |  | 836 |  |  | (4) | %\nCorporate | 215 |  |  | N/A |  | (65) |  |  | N/A |  | 143 |  |  | N/A\nTotal Company | $ | 19,381 |  |  | 7 | % |  | $ | 4,071 |  |  | 5 | % |  | $ | 3,367 |  |  | 4 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended March 31, 2022\n | Net Sales |  | % Change Versus Year Ago |  | Earnings/(Loss) Before Income Taxes |  | % Change Versus Year Ago |  | Net Earnings |  | % Change Versus Year Ago\nBeauty | $ | 11,279 |  |  | 3 | % |  | $ | 3,213 |  |  | 2 | % |  | $ | 2,582 |  |  | 3 | %\nGrooming | 4,979 |  |  | 4 | % |  | 1,447 |  |  | 13 | % |  | 1,183 |  |  | 11 | %\nHealth Care | 8,314 |  |  | 10 | % |  | 2,225 |  |  | 12 | % |  | 1,715 |  |  | 10 | %\nFabric & Home Care | 20,680 |  |  | 7 | % |  | 4,284 |  |  | (9) | % |  | 3,297 |  |  | (9) | %\nBaby, Feminine & Family Care | 14,915 |  |  | 5 | % |  | 3,353 |  |  | (12) | % |  | 2,576 |  |  | (12) | %\nCorporate | 505 |  |  | N/A |  | (177) |  |  | N/A |  | 382 |  |  | N/A\nTotal Company | $ | 60,672 |  |  | 6 | % |  | $ | 14,345 |  |  | 2 | % |  | $ | 11,735 |  |  | 3 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months Ended March 31, 2022 | Net Sales Growth |  | Foreign Exchange Impact |  | Acquisition & Divestiture Impact/Other(1) |  | Organic Sales Growth\nBeauty | 2% |  | 2% |  | (1)% |  | 3%\nGrooming | 3% |  | 5% |  | \u2014% |  | 8%\nHealth Care | 13% |  | 3% |  | \u2014% |  | 16%\nFabric & Home Care | 7% |  | 3% |  | \u2014% |  | 10%\nBaby, Feminine & Family Care | 7% |  | 3% |  | \u2014% |  | 10%\nTotal Company | 7% |  | 3% |  | \u2014% |  | 10%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNine Months Ended March 31, 2022 | Net Sales Growth |  | Foreign Exchange Impact |  | Acquisition & Divestiture Impact/Other(1) |  | Organic Sales Growth\nBeauty | 3% |  | \u2014% |  | \u2014% |  | 3%\nGrooming | 4% |  | 2% |  | \u2014% |  | 6%\nHealth Care | 10% |  | \u2014% |  | \u2014% |  | 10%\nFabric & Home Care | 7% |  | 1% |  | \u2014% |  | 8%\nBaby, Feminine & Family Care | 5% |  | 1% |  | \u2014% |  | 6%\nTotal Company | 6% |  | 1% |  | \u2014% |  | 7%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNine Months Ended March 31, 2022\nOperating Cash Flow |  | Capital Spending |  | U.S. Tax Act Payments |  | Adjusted Free Cash Flow\n$13,010 |  | $(2,464) |  | $225 |  | $10,771  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNine Months Ended March 31, 2022\nAdjusted Free Cash Flow |  | Net Earnings |  | Adjusted Free Cash Flow Productivity\n$10,771 |  | $11,735 |  | 92%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTHE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES(Amounts in Millions Except Per Share Amounts)Reconciliation of Non-GAAP Measures\n | Nine Months Ended March 31, 2022 |  | Nine Months Ended March 31, 2021\n | AS REPORTED (GAAP) |  | AS REPORTED (GAAP) |  | EARLY DEBT EXTINGUISHMENT |  |  |  | NON-GAAP (CORE)\nNET EARNINGS ATTRIBUTABLE TO P&G | 11,690 |  |  | 11,400 |  |  | 427 |  |  |  |  | 11,827 | \n |  |  |  |  |  |  |  |  | \nDILUTED NET EARNINGS PER COMMON SHARE(1) | $ | 4.59 |  |  | $ | 4.37 |  |  | $ | 0.16 |  |  |  |  | $ | 4.53 |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | CHANGE IN CURRENT YEAR REPORTED (GAAP) MEASURES VERSUS PRIOR YEAR NON-GAAP (CORE) MEASURES | \n | CORE NET EARNINGS ATTRIBUTABLE TO P&G | (1) | % |  | \n | CORE EPS | 1 | % |  |   |  |  |  |  | \nItem 3. | Quantitative and Qualitative Disclosures About Market Risk  |  |  |  |  | \nItem\u00a04. | Controls and Procedures  |  |  |  |  | \nItem\u00a01. | Legal Proceedings  |  |  |  |  | \nItem\u00a01A. | Risk Factors  |  |  |  |  | \nItem\u00a02. | Unregistered Sales of Equity Securities and Use of Proceeds  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number of Shares Purchased(1) |  | Average Price Paid per Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(3) |  | Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program\n1/01/2022 - 1/31/2022 | 5,597,022 |  |  | $160.80 |  | 5,597,022 |  |  | (3)\n2/01/2022 - 2/28/2022 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (3)\n3/01/2022 - 3/31/2022 | 2,323,360 |  |  | $150.64 |  | 2,323,360 |  |  | (3)\nTotal | 7,920,382 |  |  | $157.82 |  | 7,920,382 |  |  |   |  |  |  |  | \nItem\u00a06. | Exhibits  |  |  |  |  |  |  |  | \n3-1 |  | Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 11, 2011 and consolidated by the Board of Directors on April 8, 2016) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-K for the year ended June 30, 2016).\n |  | \n3-2 |  | Regulations (as approved by the Board of Directors on April 8, 2016, pursuant to authority granted by shareholders at the annual meeting on October 13, 2009) (Incorporated by reference to Exhibit (3-2) of the Company's Form 10-K for the year ended June 30, 2016).\n |  | \n4-1 |  | Indenture, dated as of September 3, 2009, between the Company and Deutsche Bank Trust Company Americas, as Trustee (Incorporated by reference to Exhibit (4-1) of the Company's Annual  Report on Form 10-K for the year ended June 30, 2015).\n |  | \n10-1 |  | Summary of the Company\u2019s Short Term Achievement Reward Program* +\n |  | \n31.1 |  |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Executive Officer +\n |  | \n31.2 |  |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Financial Officer +\n |  | \n32.1 |  |  | Section 1350 Certifications \u2013 Chief Executive Officer +\n |  | \n32.2 |  |  | Section 1350 Certifications \u2013 Chief Financial Officer +\n |  | \n101.SCH(1) |  | Inline XBRL Taxonomy Extension Schema Document\n |  | \n101.CAL(1) |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n |  | \n101.DEF(1) |  | Inline XBRL Taxonomy Definition Linkbase Document\n |  | \n101.LAB(1) |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n |  | \n101.PRE(1) |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n |  | \n104 |  |  | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)  |  |  |  |  | \n* | Compensatory plan or arrangement\n | \n+ | Filed herewith\n | \n(1) | Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | \n |  |  |  | THE PROCTER & GAMBLE COMPANY\n |  |  |  | \nApril 20, 2022 |  |  |  | /s/ MATTHEW W. JANZARUK\nDate |  |  |  | (Matthew W. Janzaruk)\n |  |  |  | Senior Vice President - Chief Accounting Officer(Principal Accounting Officer)  |  |  |  |  |  |  |  | \nExhibit |  | \n |  | \n3-1 |  | Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October\u00a011, 2011 and consolidated by the Board of Directors on April 8, 2016) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-K for the year ended June 30, 2016)\n |  | \n3-2 |  | Regulations (as approved by the Board of Directors on April 8, 2016, pursuant to authority granted by shareholders at the annual meeting on October 13, 2009) (Incorporated by reference to Exhibit (3-2) of the Company's Form 10-K for the year ended June 30, 2016)\n |  | \n4-1 |  | Indenture, dated as of September 3, 2009, between the Company and Deutsche Bank Trust Company Americas, as Trustee (Incorporated by reference to Exhibit (4-1) of the Company's Annual  Report on Form 10-K for the year ended June 30, 2015)\n |  | \n10-1 |  | Summary of the Company\u2019s Short Term Achievement Reward Program+\n |  | \n31.1 |  | Rule 13a-14(a)/Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Executive Officer+\n |  | \n31.2 |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Financial Officer+\n |  | \n32.1 |  | Section 1350 Certifications \u2013 Chief Executive Officer+\n |  | \n32.2 |  | Section 1350 Certifications \u2013 Chief Financial Officer+\n |  | \n101.SCH(1) |  | Inline XBRL Taxonomy Extension Schema Document\n |  | \n101.CAL(1) |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n |  | \n101.DEF(1) |  | Inline XBRL Taxonomy Definition Linkbase Document\n |  | \n101.LAB(1) |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n |  | \n101.PRE(1) |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n |  | \n104 |  | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)  |  |  |  |  | \n+ | Filed herewith\n | \n(1) | Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections."}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Procter and Gamble, in 2022 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  |  |  |  | \nx | True | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  |  |  |  | \no | False | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)\u00a0OF THE SECURITIES EXCHANGE ACT OF 1934  |  | \n  |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOhio | OH | 1-434 |  | 31-0411980\n(State of Incorporation) |  | (Commission File Number) |  | (I.R.S. Employer Identification Number)\nOne Procter & Gamble Plaza |  | Cincinnati | OH | \nOne Procter & Gamble Plaza, Cincinnati, Ohio | 45202\n(Address of principal executive offices) | (Zip Code)  |  | \n  |  |  |  |  |  |  |  | \nTitle of each class | Trading Symbol | Name of each exchange on which registered\nCommon Stock, without Par Value | PG | NYSE\n1.125% Notes due 2023 | PG23A | NYSE\n0.500% Notes due 2024 | PG24A | NYSE\n0.625% Notes due 2024 | PG24B | NYSE\n1.375% Notes due 2025 | PG25 | NYSE\n0.110% Notes due 2026 | PG26D | NYSE\n4.875% EUR notes due May 2027 | PG27A | NYSE\n1.200% Notes due 2028 | PG28 | NYSE\n1.250% Notes due 2029 | PG29B | NYSE\n1.800% Notes due 2029 | PG29A | NYSE\n6.250% GBP notes due January 2030 | PG30 | NYSE\n0.350% Notes due 2030 | PG30C | NYSE\n0.230% Notes due 2031 | PG31A | NYSE\n5.250% GBP notes due January 2033 | PG33 | NYSE\n1.875% Notes due 2038 | PG38 | NYSE\n0.900% Notes due 2041 | PG41 | NYSE  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Large accelerated filer | \u00fe |  |  | Accelerated filer | \u00a8 | \n | Non-accelerated filer | \u00a8 |  |  | Smaller reporting company | \u00a8 | False\n |  |  |  |  | Emerging growth company | \u00a8 | False  |  |  |  |  | \nItem 1. | Financial Statements  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30 |  | \nAmounts in millions except per share amounts | 2022 |  | 2021 |  |  |  | \nNET SALES | $ | 20,612 |  |  | $ | 20,338 |  |  |  |  | \nCost of products sold | 10,846 |  |  | 10,365 |  |  |  |  | \nSelling, general and administrative expense | 4,827 |  |  | 4,950 |  |  |  |  | \nOPERATING INCOME | 4,939 |  |  | 5,023 |  |  |  |  | \nInterest expense | (123) |  |  | (109) |  |  |  |  | \nInterest income | 42 |  |  | 11 |  |  |  |  | \nOther non-operating income, net | 139 |  |  | 110 |  |  |  |  | \nEARNINGS BEFORE INCOME TAXES | 4,997 |  |  | 5,035 |  |  |  |  | \nIncome taxes | 1,034 |  |  | 909 |  |  |  |  | \nNET EARNINGS | 3,963 |  |  | 4,126 |  |  |  |  | \nLess: Net earnings attributable to noncontrolling interests | 24 |  |  | 14 |  |  |  |  | \nNET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE | $ | 3,939 |  |  | $ | 4,112 |  |  |  |  | \n |  |  |  |  |  |  | \nNET EARNINGS PER SHARE(1) |  |  |  |  |  |  | \nBasic | $ | 1.62 |  |  | $ | 1.66 |  |  |  |  | \nDiluted | $ | 1.57 |  |  | $ | 1.61 |  |  |  |  | \n |  |  |  |  |  |  | \nDILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING | 2,503.6 |  |  | 2,558.9 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30 |  | \nAmounts in millions | 2022 |  | 2021 |  |  |  | \nNET EARNINGS | $ | 3,963 |  |  | $ | 4,126 |  |  |  |  | \nOTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX |  |  |  |  |  |  | \nForeign currency translation | (712) |  |  | (465) |  |  |  |  | \nUnrealized gains/(losses) on investment securities | (2) |  |  | 5 |  |  |  |  | \nUnrealized gains on defined benefit retirement plans | 87 |  |  | 142 |  |  |  |  | \nTOTAL OTHER COMPREHENSIVE LOSS, NET OF TAX | (627) |  |  | (318) |  |  |  |  | \nTOTAL COMPREHENSIVE INCOME | 3,336 |  |  | 3,808 |  |  |  |  | \nLess: Total comprehensive income attributable to noncontrolling interests | 19 |  |  | 14 |  |  |  |  | \nTOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE | $ | 3,317 |  |  | $ | 3,794 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAmounts in millions |  |  |  |  | September 30, 2022 |  | June 30, 2022\nAssets |  |  |  |  |  |  | \nCURRENT ASSETS |  |  |  |  |  |  | \nCash and cash equivalents |  |  |  |  | $ | 6,710 |  |  | $ | 7,214 | \nAccounts receivable |  |  |  |  | 5,720 |  |  | 5,143 | \nINVENTORIES |  |  |  |  |  |  | \nMaterials and supplies |  |  |  |  | 2,235 |  |  | 2,168 | \nWork in process |  |  |  |  | 898 |  |  | 856 | \nFinished goods |  |  |  |  | 4,457 |  |  | 3,900 | \nTotal inventories |  |  |  |  | 7,590 |  |  | 6,924 | \nPrepaid expenses and other current assets |  |  |  |  | 2,501 |  |  | 2,372 | \nTOTAL CURRENT ASSETS |  |  |  |  | 22,521 |  |  | 21,653 | \nPROPERTY, PLANT AND EQUIPMENT, NET |  |  |  |  | 20,593 |  |  | 21,195 | \nGOODWILL |  |  |  |  | 38,761 |  |  | 39,700 | \nTRADEMARKS AND OTHER INTANGIBLE ASSETS, NET |  |  |  | 23,465 |  |  | 23,679 | \nOTHER NONCURRENT ASSETS |  |  |  |  | 10,942 |  |  | 10,981 | \nTOTAL ASSETS |  |  |  |  | $ | 116,282 |  |  | $ | 117,208 | \n |  |  |  |  |  |  | \nLiabilities and Shareholders' Equity |  |  |  |  |  |  | \nCURRENT LIABILITIES |  |  |  |  |  |  | \nAccounts payable |  |  |  |  | $ | 14,845 |  |  | $ | 14,882 | \nAccrued and other liabilities |  |  |  |  | 10,056 |  |  | 9,554 | \nDebt due within one year |  |  |  |  | 11,717 |  |  | 8,645 | \nTOTAL CURRENT LIABILITIES |  |  |  |  | 36,618 |  |  | 33,081 | \nLONG-TERM DEBT |  |  |  |  | 21,286 |  |  | 22,848 | \nDEFERRED INCOME TAXES |  |  |  |  | 6,986 |  |  | 6,809 | \nOTHER NONCURRENT LIABILITIES |  |  |  |  | 7,058 |  |  | 7,616 | \nTOTAL LIABILITIES |  |  |  |  | 71,948 |  |  | 70,354 | \nSHAREHOLDERS\u2019 EQUITY |  |  |  |  |  |  | \nPreferred stock |  |  |  |  | 834 |  |  | 843 | \nCommon stock \u2013 shares issued \u2013 | September 2022 |  | 4,009.2 |  |  |  |  | \n | June 2022 |  | 4,009.2 |  |  | 4,009 |  |  | 4,009 | \nAdditional paid-in capital |  |  |  |  | 65,955 |  |  | 65,795 | \nReserve for ESOP debt retirement |  |  |  |  | (870) |  |  | (916) | \nAccumulated other comprehensive loss |  |  |  |  | (12,811) |  |  | (12,189) | \nTreasury stock |  |  |  |  | (127,205) |  |  | (123,382) | \nRetained earnings |  |  |  |  | 114,163 |  |  | 112,429 | \nNoncontrolling interest |  |  |  |  | 259 |  |  | 265 | \nTOTAL SHAREHOLDERS\u2019 EQUITY |  |  |  |  | 44,334 |  |  | 46,854 | \nTOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY |  |  |  | $ | 116,282 |  |  | $ | 117,208 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2022\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Add-itional Paid-In Capital | Reserve for ESOP Debt Retirement | AccumulatedOtherComp-rehensive Loss | Treasury Stock | Retained Earnings | Non-controlling Interest | Total Share-holders' Equity\nShares | Amount\nBALANCE JUNE 30, 2022 | 2,393,877 |  | $4,009 |  | $843 |  | $65,795 |  | ($916) |  | ($12,189) |  | ($123,382) |  | $112,429 |  | $265 |  | $46,854 | \nNet earnings |  |  |  |  |  |  |  | 3,939 |  | 24 |  | 3,963 | \nOther comprehensive loss |  |  |  |  |  | (622) |  |  |  | (5) |  | (627) | \nDividends and dividend equivalents($0.9133per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (2,189) |  |  | (2,189) | \nPreferred |  |  |  |  |  |  |  | (71) |  |  | (71) | \nTreasury stock purchases | (28,189) |  |  |  |  |  |  | (4,000) |  |  |  | (4,000) | \nEmployee stock plans | 3,011 |  |  |  | 159 |  |  |  | 169 |  |  |  | 328 | \nPreferred stock conversions | 998 |  |  | (9) |  | 1 |  |  |  | 8 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 46 |  |  |  | 55 |  |  | 101 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (25) |  | (25) | \nBALANCE SEPTEMBER 30, 2022 | 2,369,697 |  | $4,009 |  | $834 |  | $65,955 |  | ($870) |  | ($12,811) |  | ($127,205) |  | $114,163 |  | $259 |  | $44,334 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2021\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Add-itional Paid-In Capital | Reserve for ESOP Debt Retirement | AccumulatedOtherComp-rehensiveLoss | Treasury Stock | Retained Earnings | Non-controlling Interest | Total Share-holders' Equity\nShares | Amount\nBALANCE JUNE 30, 2021 | 2,429,706 |  | $4,009 |  | $870 |  | $64,848 |  | ($1,006) |  | ($13,744) |  | ($114,973) |  | $106,374 |  | $276 |  | $46,654 | \nNet earnings |  |  |  |  |  |  |  | 4,112 |  | 14 |  | 4,126 | \nOther comprehensive loss |  |  |  |  |  | (318) |  |  |  | \u2014 |  | (318) | \nDividends and dividend equivalents($0.8698per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (2,118) |  |  | (2,118) | \nPreferred |  |  |  |  |  |  |  | (70) |  |  | (70) | \nTreasury stock purchases | (19,353) |  |  |  |  |  |  | (2,750) |  |  |  | (2,750) | \nEmployee stock plans | 8,437 |  |  |  | 300 |  |  |  | 474 |  |  |  | 774 | \nPreferred stock conversions | 1,158 |  |  | (11) |  | 2 |  |  |  | 9 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 42 |  |  |  | 63 |  |  | 105 | \nNoncontrolling interest, net |  |  |  | (2) |  |  |  |  |  | 7 |  | 5 | \nBALANCE SEPTEMBER 30, 2021 | 2,419,948 |  | $4,009 |  | $859 |  | $65,148 |  | ($964) |  | ($14,062) |  | ($117,240) |  | $108,361 |  | $297 |  | $46,408 |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30\nAmounts in millions | 2022 |  | 2021\nCASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD | $ | 7,214 |  |  | $ | 10,288 | \nOPERATING ACTIVITIES |  |  | \nNet earnings | 3,963 |  |  | 4,126 | \nDepreciation and amortization | 663 |  |  | 711 | \nShare-based compensation expense | 105 |  |  | 116 | \nDeferred income taxes | (130) |  |  | 57 | \nGain on sale of assets | (1) |  |  | (73) | \nChanges in: |  |  | \nAccounts receivable | (740) |  |  | (1,012) | \nInventories | (893) |  |  | (409) | \nAccounts payable, accrued and other liabilities | 1,495 |  |  | 1,261 | \nOther operating assets and liabilities | (454) |  |  | (178) | \nOther | 62 |  |  | 44 | \nTOTAL OPERATING ACTIVITIES | 4,070 |  |  | 4,643 | \nINVESTING ACTIVITIES |  |  | \nCapital expenditures | (890) |  |  | (1,091) | \nProceeds from asset sales | 5 |  |  | 85 | \nAcquisitions, net of cash acquired | (2) |  |  | \u2014 | \nProceeds from sales and maturities of short-term investments | 55 |  |  | \u2014 | \nTOTAL INVESTING ACTIVITIES | (832) |  |  | (1,006) | \nFINANCING ACTIVITIES |  |  | \nDividends to shareholders | (2,255) |  |  | (2,182) | \nAdditions to short-term debt with original maturities of more than three months | 2,975 |  |  | 1,792 | \nReductions in short-term debt with original maturities of more than three months | (265) |  |  | (1,422) | \nNet additions to other short-term debt | 1,727 |  |  | 512 | \nReductions in long-term debt | (1,877) |  |  | (26) | \nTreasury stock purchases | (4,000) |  |  | (2,750) | \nImpact of stock options and other | 188 |  |  | 648 | \nTOTAL FINANCING ACTIVITIES | (3,507) |  |  | (3,428) | \nEFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (235) |  |  | (127) | \nCHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (504) |  |  | 82 | \nCASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD | $ | 6,710 |  |  | $ | 10,370 |   |  |  |  |  |  |  |  |  |  |  |  |  | \n | % of Net sales by operating segment(1)\n | Three Months Ended September 30 |  | \n | 2022 |  | 2021 |  |  |  | \nFabric Care | 23% |  | 23% |  |  |  | \nHome Care | 12% |  | 11% |  |  |  | \nSkin and Personal Care | 10% |  | 10% |  |  |  | \nBaby Care | 10% |  | 10% |  |  |  | \nHair Care | 9% |  | 10% |  |  |  | \nFamily Care | 8% |  | 8% |  |  |  | \nGrooming(2) | 8% |  | 7% |  |  |  | \nOral Care | 8% |  | 8% |  |  |  | \nFeminine Care | 6% |  | 6% |  |  |  | \nPersonal Health Care | 6% |  | 5% |  |  |  | \nOther | \u2014% |  | 2% |  |  |  | \nTotal | 100% |  | 100% |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended September 30 |  | \n |  | Net Sales |  | Earnings/(Loss) Before Income Taxes |  | Net Earnings/(Loss) |  |  |  |  |  | \nBeauty | 2022 | $ | 3,961 |  |  | $ | 1,271 |  |  | $ | 1,011 |  |  |  |  |  |  | \n | 2021 | 3,964 |  |  | 1,242 |  |  | 991 |  |  |  |  |  |  | \nGrooming | 2022 | 1,625 |  |  | 503 |  |  | 404 |  |  |  |  |  |  | \n | 2021 | 1,687 |  |  | 518 |  |  | 417 |  |  |  |  |  |  | \nHealth Care | 2022 | 2,757 |  |  | 800 |  |  | 617 |  |  |  |  |  |  | \n | 2021 | 2,676 |  |  | 695 |  |  | 529 |  |  |  |  |  |  | \nFabric & Home Care | 2022 | 7,082 |  |  | 1,543 |  |  | 1,172 |  |  |  |  |  |  | \n | 2021 | 7,009 |  |  | 1,546 |  |  | 1,191 |  |  |  |  |  |  | \nBaby, Feminine & Family Care | 2022 | 4,934 |  |  | 1,055 |  |  | 805 |  |  |  |  |  |  | \n | 2021 | 4,864 |  |  | 1,075 |  |  | 826 |  |  |  |  |  |  | \nCorporate | 2022 | 253 |  |  | (175) |  |  | (46) |  |  |  |  |  |  | \n | 2021 | 138 |  |  | (41) |  |  | 172 |  |  |  |  |  |  | \nTotal Company | 2022 | $ | 20,612 |  |  | $ | 4,997 |  |  | $ | 3,963 |  |  |  |  |  |  | \n | 2021 | 20,338 |  |  | 5,035 |  |  | 4,126 |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Beauty |  | Grooming |  | Health Care |  | Fabric & Home Care |  | Baby, Feminine & Family Care |  | Total Company\nGoodwill at June 30, 2022 | $ | 13,296 |  |  | $ | 12,571 |  |  | $ | 7,589 |  |  | $ | 1,808 |  |  | $ | 4,436 |  |  | $ | 39,700 | \nAcquisitions and divestitures | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nTranslation and other | (344) |  |  | (254) |  |  | (217) |  |  | (29) |  |  | (95) |  |  | (939) | \nGoodwill at September 30, 2022 | $ | 12,952 |  |  | $ | 12,317 |  |  | $ | 7,372 |  |  | $ | 1,779 |  |  | $ | 4,341 |  |  | $ | 38,761 |   |  |  |  |  |  |  |  |  |  |  | \n | Gross Carrying Amount |  | Accumulated Amortization\nIntangible assets with determinable lives | $ | 8,890 |  |  | $ | (6,284) | \nIntangible assets with indefinite lives | 20,859 |  |  | \u2014 | \nTotal identifiable intangible assets | $ | 29,749 |  |  | $ | (6,284) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Approximate Percent Change in Estimated Fair Value\n | +25 bps Discount Rate |  | -25 bps Growth Rates |  | -50 bps Royalty Rate\nGillette indefinite-lived intangible asset | (6)% |  | (6)% |  | (3)%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCONSOLIDATED AMOUNTS | Three Months Ended September 30 |  | \n | 2022 |  | 2021 |  |  |  | \nNet earnings | $ | 3,963 |  |  | $ | 4,126 |  |  |  |  | \nLess: Net earnings attributable to noncontrolling interests | 24 |  |  | 14 |  |  |  |  | \nNet earnings attributable to P&G (Diluted) | 3,939 |  |  | 4,112 |  |  |  |  | \nLess: Preferred dividends | 71 |  |  | 70 |  |  |  |  | \nNet earnings attributable to P&G available to common shareholders (Basic) | $ | 3,868 |  |  | $ | 4,042 |  |  |  |  | \n |  |  |  |  |  |  | \nSHARES IN MILLIONS |  |  |  |  |  |  | \nBasic weighted average common shares outstanding | 2,385.5 |  |  | 2,428.1 |  |  |  |  | \nAdd: Effect of dilutive securities |  |  |  |  |  |  | \nConvertible preferred shares(1) | 77.4 |  |  | 80.5 |  |  |  |  | \nStock options and other unvested equity awards(2) | 40.7 |  |  | 50.3 |  |  |  |  | \nDiluted weighted average common shares outstanding | 2,503.6 |  |  | 2,558.9 |  |  |  |  | \n |  |  |  |  |  |  | \nNET EARNINGS PER SHARE(3) |  |  |  |  |  |  | \nBasic | $ | 1.62 |  |  | $ | 1.66 |  |  |  |  | \nDiluted | $ | 1.57 |  |  | $ | 1.61 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30 |  | \n | 2022 |  | 2021 |  |  |  | \nShare-based compensation expense | $ | 105 |  |  | $ | 116 |  |  |  |  | \nNet periodic benefit cost for pension benefits | 43 |  |  | 48 |  |  |  |  | \nNet periodic benefit credit for other retiree benefits | (132) |  |  | (103) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Notional Amount |  | Fair\u00a0Value\u00a0Asset |  | Fair Value (Liability)\n | September 30, 2022 |  | June 30, 2022 |  | September 30, 2022 |  | June 30, 2022 |  | September 30, 2022 |  | June 30, 2022\nDERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS\nInterest rate contracts | $ | 3,743 |  |  | $ | 4,972 |  |  | $ | \u2014 |  |  | $ | 3 |  |  | $ | (435) |  |  | $ | (307) | \nDERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS\nForeign currency interest rate contracts | $ | 11,877 |  |  | $ | 7,943 |  |  | $ | 877 |  |  | $ | 561 |  |  | $ | (9) |  |  | $ | (1) | \nTOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | $ | 15,620 |  |  | $ | 12,915 |  |  | $ | 877 |  |  | $ | 564 |  |  | $ | (444) |  |  | $ | (308) | \n |  |  |  |  |  |  |  |  |  |  | \nDERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS\nForeign currency contracts | $ | 4,108 |  |  | $ | 5,625 |  |  | $ | 4 |  |  | $ | 6 |  |  | $ | (96) |  |  | $ | (61) | \n |  |  |  |  |  |  |  |  |  |  | \nTOTAL DERIVATIVES AT FAIR VALUE | $ | 19,728 |  |  | $ | 18,540 |  |  | $ | 881 |  |  | $ | 570 |  |  | $ | (540) |  |  | $ | (369) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Amount of Gain Recognized in OCI on Derivatives\n | Three Months Ended September 30 |  | \n | 2022 |  | 2021 |  |  |  | \nDERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS(1) (2) |  |  |  | \nForeign exchange contracts | $ | 708 |  |  | $ | 208 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Amount of Loss Recognized in Earnings\n | Three Months Ended September 30 |  | \n | 2022 |  | 2021 |  |  |  | \nDERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS |  |  |  | \nInterest rate contracts | $ | (131) |  |  | $ | (36) |  |  |  |  | \nDERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS |  |  |  | \nForeign currency contracts | $ | (146) |  |  | $ | (24) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Investment Securities |  | Post-retirement Benefit Plans |  | Foreign Currency Translation |  | Total AOCI\nBalance at June 30, 2022 | $ | 20 |  |  | $ | 27 |  |  | $ | (12,236) |  |  | $ | (12,189) | \nOCI before reclassifications(1) | (2) |  |  | 82 |  |  | (712) |  |  | (632) | \nAmounts reclassified to the Consolidated Statement of Earnings(2) | \u2014 |  |  | 5 |  |  | \u2014 |  |  | 5 | \nNet current period OCI | (2) |  |  | 87 |  |  | (712) |  |  | (627) | \nLess: OCI attributable to non-controlling interests | \u2014 |  |  | \u2014 |  |  | (5) |  |  | (5) | \nBalance at September 30, 2022 | $ | 18 |  |  | $ | 114 |  |  | $ | (12,943) |  |  | $ | (12,811) |   |  |  |  |  | \nItem 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations  |  |  |  |  |  |  |  | \nReportable\u00a0Segments | Product Categories (Sub-Categories) | Major Brands\nBeauty | Hair Care (Conditioners, Shampoos, Styling Aids, Treatments) | Head & Shoulders,  Herbal Essences, Pantene, Rejoice\nSkin and Personal Care (Antiperspirants and Deodorants, Personal Cleansing, Skin Care) | Olay, Old Spice,  Safeguard, Secret, SK-II\nGrooming(1) | Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming) | Braun, Gillette, Venus\nHealth Care | Oral Care (Toothbrushes, Toothpastes, Other Oral Care) | Crest, Oral-B\nPersonal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care) | Metamucil, Neurobion, Pepto-Bismol, Vicks\nFabric & Home Care | Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents) | Ariel, Downy, Gain, Tide\nHome Care (Air Care, Dish Care, P&G Professional, Surface Care) | Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer\nBaby, Feminine & Family Care | Baby Care (Baby Wipes, Taped Diapers and Pants) | Luvs, Pampers\nFeminine Care (Adult Incontinence, Feminine Care) | Always, Always Discreet, Tampax\nFamily Care (Paper Towels, Tissues, Toilet Paper) | Bounty, Charmin, Puffs  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2022 |  | \n | Net Sales |  | Net Earnings |  |  |  | \nBeauty | 19% |  | 25% |  |  |  | \nGrooming | 8% |  | 10% |  |  |  | \nHealth Care | 14% |  | 16% |  |  |  | \nFabric & Home Care | 35% |  | 29% |  |  |  | \nBaby, Feminine & Family Care | 24% |  | 20% |  |  |  | \nTotal Company | 100% |  | 100% |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30\nAmounts in millions, except per share amounts | 2022 |  | 2021 |  | % Chg\nNet sales | $20,612 |  | $20,338 |  | 1%\nOperating income | 4,939 |  | 5,023 |  | (2)%\nNet earnings | 3,963 |  | 4,126 |  | (4)%\nNet earnings attributable to Procter & Gamble | 3,939 |  | 4,112 |  | (4)%\nDiluted net earnings per common share | 1.57 |  | 1.61 |  | (2)%\n |  |  |  |  | \n\n | Three Months Ended September 30\nCOMPARISONS AS A PERCENTAGE OF NET SALES | 2022 |  | 2021 |  | Basis Pt Chg\nGross margin | 47.4% |  | 49.0% |  | (160)\nSelling, general & administrative expense | 23.4% |  | 24.3% |  | (90)\nOperating income | 24.0% |  | 24.7% |  | (70)\nEarnings before income taxes | 24.2% |  | 24.8% |  | (60)\nNet earnings | 19.2% |  | 20.3% |  | (110)\nNet earnings attributable to Procter & Gamble | 19.1% |  | 20.2% |  | (110)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Net Sales Change Drivers 2022 vs. 2021 (Three Months Ended September 30, 2022)(1)\n | Volume with Acquisitions & Divestitures |  | Volume Excluding Acquisitions & Divestitures |  | Foreign Exchange |  | Price |  | Mix |  | Other(2) |  | Net Sales Growth\nBeauty | (1)% |  | (1)% |  | (6)% |  | 7% |  | (2)% |  | 2% |  | \u2014%\nGrooming | \u2014% |  | 1% |  | (8)% |  | 8% |  | (4)% |  | \u2014% |  | (4)%\nHealth Care | (2)% |  | (2)% |  | (5)% |  | 6% |  | 4% |  | \u2014% |  | 3%\nFabric & Home Care | (4)% |  | (4)% |  | (6)% |  | 11% |  | 1% |  | (1)% |  | 1%\nBaby, Feminine & Family Care | (3)% |  | (3)% |  | (5)% |  | 8% |  | 1% |  | \u2014% |  | 1%\nTotal Company | (3)% |  | (3)% |  | (6)% |  | 9% |  | 1% |  | \u2014% |  | 1%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2022\n | Net Sales |  | % Change Versus Year Ago |  | Earnings/(Loss) Before Income Taxes |  | % Change Versus Year Ago |  | Net Earnings/(Loss) |  | % Change Versus Year Ago\nBeauty | $ | 3,961 |  |  | \u2014 | % |  | $ | 1,271 |  |  | 2 | % |  | $ | 1,011 |  |  | 2 | %\nGrooming | 1,625 |  |  | (4) | % |  | 503 |  |  | (3) | % |  | 404 |  |  | (3) | %\nHealth Care | 2,757 |  |  | 3 | % |  | 800 |  |  | 15 | % |  | 617 |  |  | 17 | %\nFabric & Home Care | 7,082 |  |  | 1 | % |  | 1,543 |  |  | \u2014 | % |  | 1,172 |  |  | (2) | %\nBaby, Feminine & Family Care | 4,934 |  |  | 1 | % |  | 1,055 |  |  | (2) | % |  | 805 |  |  | (3) | %\nCorporate | 253 |  |  | N/A |  | (175) |  |  | N/A |  | (46) |  |  | N/A\nTotal Company | $ | 20,612 |  |  | 1 | % |  | $ | 4,997 |  |  | (1) | % |  | $ | 3,963 |  |  | (4) | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months Ended September 30, 2022 | Net Sales Growth |  | Foreign Exchange Impact |  | Acquisition & Divestiture Impact/Other(1) |  | Organic Sales Growth\nBeauty | \u2014% |  | 6% |  | (2)% |  | 4%\nGrooming | (4)% |  | 8% |  | 1% |  | 5%\nHealth Care | 3% |  | 5% |  | \u2014% |  | 8%\nFabric & Home Care | 1% |  | 6% |  | 1% |  | 8%\nBaby, Feminine & Family Care | 1% |  | 5% |  | \u2014% |  | 6%\nTotal Company | 1% |  | 6% |  | \u2014% |  | 7%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months Ended September 30, 2022\nOperating Cash Flow |  | Capital Spending |  | U.S. Tax Act Payments |  | Adjusted Free Cash Flow\n$4,070 |  | $(890) |  | $225 |  | $3,405  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months Ended September 30, 2022\nAdjusted Free Cash Flow |  | Net Earnings |  | Adjusted Free Cash Flow Productivity\n$3,405 |  | $3,963 |  | 86%  |  |  |  |  | \nItem 3. | Quantitative and Qualitative Disclosures About Market Risk  |  |  |  |  | \nItem\u00a04. | Controls and Procedures  |  |  |  |  | \nItem\u00a01. | Legal Proceedings  |  |  |  |  | \nItem\u00a01A. | Risk Factors  |  |  |  |  | \nItem\u00a02. | Unregistered Sales of Equity Securities and Use of Proceeds  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number of Shares Purchased(1) |  | Average Price Paid per Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(3) |  | Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program\n7/01/2022 - 7/31/2022 | 6,223,741 |  |  | $144.15 |  | 4,865,898 |  |  | (3)\n8/01/2022 - 8/31/2022 | 11,296,995 |  |  | $146.06 |  | 11,296,995 |  |  | (3)\n9/01/2022 - 9/30/2022 | 12,025,751 |  |  | $137.21 |  | 12,025,751 |  |  | (3)\nTotal | 29,546,487 |  |  | $142.06 |  | 28,188,644 |  |  |   |  |  |  |  | \nItem\u00a06. | Exhibits  |  |  |  |  |  |  |  | \n3-1 |  | Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October\u00a011, 2011 and consolidated by the Board of Directors on April 8, 2016) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-K for the year ended June 30, 2016)\n |  | \n3-2 |  | Regulations (as approved by the Board of Directors on April 8, 2016, pursuant to authority granted by shareholders at the annual meeting on October 13, 2009) (Incorporated by reference to Exhibit (3-2) of the Company's Form 10-K for the year ended June 30, 2016)\n |  | \n31.1 |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Executive Officer+\n |  | \n31.2 |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Financial Officer+\n |  | \n32.1 |  | Section 1350 Certifications \u2013 Chief Executive Officer+\n |  | \n32.2 |  | Section 1350 Certifications \u2013 Chief Financial Officer+\n |  | \n101.SCH(1) |  | Inline XBRL Taxonomy Extension Schema Document\n |  | \n101.CAL(1) |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n |  | \n101.DEF(1) |  | Inline XBRL Taxonomy Definition Linkbase Document\n |  | \n101.LAB(1) |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n |  | \n101.PRE(1) |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n |  | \n104 |  |  | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)  |  |  |  |  | \n+ | Filed herewith\n | \n(1) | Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | \n |  |  |  | THE PROCTER & GAMBLE COMPANY\n |  |  |  | \nOctober 19, 2022 |  |  |  | /s/ MATTHEW W. JANZARUK\nDate |  |  |  | (Matthew W. Janzaruk)\n |  |  |  | Senior Vice President - Chief Accounting Officer(Principal Accounting Officer)"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Procter and Gamble, in 2022 Q3, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  |  |  |  | \nx | True | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  |  |  |  | \no | False | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)\u00a0OF THE SECURITIES EXCHANGE ACT OF 1934  |  | \n  |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOhio | OH | 1-434 |  | 31-0411980\n(State of Incorporation) |  | (Commission File Number) |  | (I.R.S. Employer Identification Number)\nOne Procter & Gamble Plaza |  | Cincinnati | OH | \nOne Procter & Gamble Plaza, Cincinnati, Ohio | 45202\n(Address of principal executive offices) | (Zip Code)  |  | \n  |  |  |  |  |  |  |  | \nTitle of each class | Trading Symbol | Name of each exchange on which registered\nCommon Stock, without Par Value | PG | NYSE\n1.125% Notes due 2023 | PG23A | NYSE\n0.500% Notes due 2024 | PG24A | NYSE\n0.625% Notes due 2024 | PG24B | NYSE\n1.375% Notes due 2025 | PG25 | NYSE\n0.110% Notes due 2026 | PG26D | NYSE\n4.875% EUR notes due May 2027 | PG27A | NYSE\n1.200% Notes due 2028 | PG28 | NYSE\n1.250% Notes due 2029 | PG29B | NYSE\n1.800% Notes due 2029 | PG29A | NYSE\n6.250% GBP notes due January 2030 | PG30 | NYSE\n0.350% Notes due 2030 | PG30C | NYSE\n0.230% Notes due 2031 | PG31A | NYSE\n5.250% GBP notes due January 2033 | PG33 | NYSE\n1.875% Notes due 2038 | PG38 | NYSE\n0.900% Notes due 2041 | PG41 | NYSE  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Large accelerated filer | \u00fe |  |  | Accelerated filer | \u00a8 | \n | Non-accelerated filer | \u00a8 |  |  | Smaller reporting company | \u00a8 | False\n |  |  |  |  | Emerging growth company | \u00a8 | False  |  |  |  |  | \nItem 1. | Financial Statements  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31 |  | Six Months Ended December 31\nAmounts in millions except per share amounts | 2022 |  | 2021 |  | 2022 |  | 2021\nNET SALES | $ | 20,773 |  |  | $ | 20,953 |  |  | $ | 41,385 |  |  | $ | 41,291 | \nCost of products sold | 10,897 |  |  | 10,664 |  |  | 21,743 |  |  | 21,029 | \nSelling, general and administrative expense | 5,091 |  |  | 5,121 |  |  | 9,918 |  |  | 10,071 | \nOPERATING INCOME | 4,785 |  |  | 5,168 |  |  | 9,724 |  |  | 10,191 | \nInterest expense | (171) |  |  | (106) |  |  | (294) |  |  | (215) | \nInterest income | 66 |  |  | 10 |  |  | 108 |  |  | 21 | \nOther non-operating income, net | 155 |  |  | 167 |  |  | 294 |  |  | 277 | \nEARNINGS BEFORE INCOME TAXES | 4,835 |  |  | 5,239 |  |  | 9,832 |  |  | 10,274 | \nIncome taxes | 876 |  |  | 997 |  |  | 1,910 |  |  | 1,906 | \nNET EARNINGS | 3,959 |  |  | 4,242 |  |  | 7,922 |  |  | 8,368 | \nLess: Net earnings attributable to noncontrolling interests | 26 |  |  | 19 |  |  | 50 |  |  | 33 | \nNET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE | $ | 3,933 |  |  | $ | 4,223 |  |  | $ | 7,872 |  |  | $ | 8,335 | \n |  |  |  |  |  |  | \nNET EARNINGS PER SHARE(1) |  |  |  |  |  |  | \nBasic | $ | 1.63 |  |  | $ | 1.72 |  |  | $ | 3.25 |  |  | $ | 3.39 | \nDiluted | $ | 1.59 |  |  | $ | 1.66 |  |  | $ | 3.16 |  |  | $ | 3.27 | \n |  |  |  |  |  |  | \nDILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING | 2,481.2 |  |  | 2,544.2 |  |  | 2,492.4 |  |  | 2,551.6 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31 |  | Six Months Ended December 31\nAmounts in millions | 2022 |  | 2021 |  | 2022 |  | 2021\nNET EARNINGS | $ | 3,959 |  |  | $ | 4,242 |  |  | $ | 7,922 |  |  | $ | 8,368 | \nOTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX |  |  |  |  |  |  | \nForeign currency translation | 379 |  |  | (241) |  |  | (333) |  |  | (706) | \nUnrealized gains/(losses) on investment securities | (1) |  |  | 2 |  |  | (3) |  |  | 7 | \nUnrealized gains/(losses) on defined benefit retirement plans | (76) |  |  | 737 |  |  | 11 |  |  | 879 | \nTOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX | 302 |  |  | 498 |  |  | (325) |  |  | 180 | \nTOTAL COMPREHENSIVE INCOME | 4,261 |  |  | 4,740 |  |  | 7,597 |  |  | 8,548 | \nLess: Total comprehensive income attributable to noncontrolling interests | 23 |  |  | 19 |  |  | 42 |  |  | 33 | \nTOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE | $ | 4,238 |  |  | $ | 4,721 |  |  | $ | 7,555 |  |  | $ | 8,515 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAmounts in millions |  |  |  |  | December 31, 2022 |  | June 30, 2022\nAssets |  |  |  |  |  |  | \nCURRENT ASSETS |  |  |  |  |  |  | \nCash and cash equivalents |  |  |  |  | $ | 6,854 |  |  | $ | 7,214 | \nAccounts receivable |  |  |  |  | 5,767 |  |  | 5,143 | \nINVENTORIES |  |  |  |  |  |  | \nMaterials and supplies |  |  |  |  | 2,232 |  |  | 2,168 | \nWork in process |  |  |  |  | 946 |  |  | 856 | \nFinished goods |  |  |  |  | 4,363 |  |  | 3,900 | \nTotal inventories |  |  |  |  | 7,541 |  |  | 6,924 | \nPrepaid expenses and other current assets |  |  |  |  | 1,704 |  |  | 2,372 | \nTOTAL CURRENT ASSETS |  |  |  |  | 21,866 |  |  | 21,653 | \nPROPERTY, PLANT AND EQUIPMENT, NET |  |  |  |  | 21,167 |  |  | 21,195 | \nGOODWILL |  |  |  |  | 39,951 |  |  | 39,700 | \nTRADEMARKS AND OTHER INTANGIBLE ASSETS, NET |  |  |  | 23,594 |  |  | 23,679 | \nOTHER NONCURRENT ASSETS |  |  |  |  | 11,137 |  |  | 10,981 | \nTOTAL ASSETS |  |  |  |  | $ | 117,715 |  |  | $ | 117,208 | \n |  |  |  |  |  |  | \nLiabilities and Shareholders' Equity |  |  |  |  |  |  | \nCURRENT LIABILITIES |  |  |  |  |  |  | \nAccounts payable |  |  |  |  | $ | 14,153 |  |  | $ | 14,882 | \nAccrued and other liabilities |  |  |  |  | 10,293 |  |  | 9,554 | \nDebt due within one year |  |  |  |  | 14,300 |  |  | 8,645 | \nTOTAL CURRENT LIABILITIES |  |  |  |  | 38,746 |  |  | 33,081 | \nLONG-TERM DEBT |  |  |  |  | 20,582 |  |  | 22,848 | \nDEFERRED INCOME TAXES |  |  |  |  | 6,462 |  |  | 6,809 | \nOTHER NONCURRENT LIABILITIES |  |  |  |  | 7,200 |  |  | 7,616 | \nTOTAL LIABILITIES |  |  |  |  | 72,990 |  |  | 70,354 | \nSHAREHOLDERS\u2019 EQUITY |  |  |  |  |  |  | \nPreferred stock |  |  |  |  | 831 |  |  | 843 | \nCommon stock \u2013 shares issued \u2013 | December 2022 |  | 4,009.2 |  |  |  |  | \n | June 2022 |  | 4,009.2 |  |  | 4,009 |  |  | 4,009 | \nAdditional paid-in capital |  |  |  |  | 66,145 |  |  | 65,795 | \nReserve for ESOP debt retirement |  |  |  |  | (870) |  |  | (916) | \nAccumulated other comprehensive loss |  |  |  |  | (12,506) |  |  | (12,189) | \nTreasury stock |  |  |  |  | (129,012) |  |  | (123,382) | \nRetained earnings |  |  |  |  | 115,858 |  |  | 112,429 | \nNoncontrolling interest |  |  |  |  | 270 |  |  | 265 | \nTOTAL SHAREHOLDERS\u2019 EQUITY |  |  |  |  | 44,725 |  |  | 46,854 | \nTOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY |  |  |  | $ | 117,715 |  |  | $ | 117,208 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31, 2022\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Add-itional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comp-rehensive Income/(Loss) | Treasury Stock | Retained Earnings | Non-controlling Interest | Total Share-holders' Equity\nShares | Amount\nBALANCE SEPTEMBER 30, 2022 | 2,369,697 |  | $4,009 |  | $834 |  | $65,955 |  | ($870) |  | ($12,811) |  | ($127,205) |  | $114,163 |  | $259 |  | $44,334 | \nNet earnings |  |  |  |  |  |  |  | 3,933 |  | 26 |  | 3,959 | \nOther comprehensive income/(loss) |  |  |  |  |  | 305 |  |  |  | (3) |  | 302 | \nDividends and dividend equivalents($0.9133per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (2,168) |  |  | (2,168) | \nPreferred |  |  |  |  |  |  |  | (70) |  |  | (70) | \nTreasury stock purchases | (14,426) |  |  |  |  |  |  | (2,002) |  |  |  | (2,002) | \nEmployee stock plans | 3,441 |  |  |  | 189 |  |  |  | 193 |  |  |  | 382 | \nPreferred stock conversions | 432 |  |  | (3) |  | 1 |  |  |  | 2 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | \u2014 |  |  |  | \u2014 |  |  | \u2014 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (12) |  | (12) | \nBALANCE DECEMBER 31, 2022 | 2,359,144 |  | $4,009 |  | $831 |  | $66,145 |  | ($870) |  | ($12,506) |  | ($129,012) |  | $115,858 |  | $270 |  | $44,725 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended December 31, 2022\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Add-itional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comp-rehensive Income/(Loss) | Treasury Stock | Retained Earnings | Non-controlling Interest | Total Share-holders' Equity\nShares | Amount\nBALANCE JUNE 30, 2022 | 2,393,877 |  | $4,009 |  | $843 |  | $65,795 |  | ($916) |  | ($12,189) |  | ($123,382) |  | $112,429 |  | $265 |  | $46,854 | \nNet earnings |  |  |  |  |  |  |  | 7,872 |  | 50 |  | 7,922 | \nOther comprehensive income/(loss) |  |  |  |  |  | (317) |  |  |  | (8) |  | (325) | \nDividends and dividend equivalents(1.8266per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (4,357) |  |  | (4,357) | \nPreferred |  |  |  |  |  |  |  | (141) |  |  | (141) | \nTreasury stock purchases | (42,615) |  |  |  |  |  |  | (6,002) |  |  |  | (6,002) | \nEmployee stock plans | 6,452 |  |  |  | 348 |  |  |  | 362 |  |  |  | 710 | \nPreferred stock conversions | 1,430 |  |  | (12) |  | 2 |  |  |  | 10 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 46 |  |  |  | 55 |  |  | 101 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (37) |  | (37) | \nBALANCE DECEMBER 31, 2022 | 2,359,144 |  | $4,009 |  | $831 |  | $66,145 |  | ($870) |  | ($12,506) |  | ($129,012) |  | $115,858 |  | $270 |  | $44,725 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31, 2021\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Add-itional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comp-rehensive Income/(Loss) | Treasury Stock | Retained Earnings | Non-controlling Interest | Total Share-holders' Equity\nShares | Amount\nBALANCE SEPTEMBER 30, 2021 | 2,419,948 |  | $4,009 |  | $859 |  | $65,148 |  | ($964) |  | ($14,062) |  | ($117,240) |  | $108,361 |  | $297 |  | $46,408 | \nNet earnings |  |  |  |  |  |  |  | 4,223 |  | 19 |  | 4,242 | \nOther comprehensive income/(loss) |  |  |  |  |  | 498 |  |  |  | \u2014 |  | 498 | \nDividends and dividend equivalents($0.8698per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (2,108) |  |  | (2,108) | \nPreferred |  |  |  |  |  |  |  | (70) |  |  | (70) | \nTreasury stock purchases | (31,433) |  |  |  |  |  |  | (4,754) |  |  |  | (4,754) | \nEmployee stock plans | 7,986 |  |  |  | 284 |  |  |  | 448 |  |  |  | 732 | \nPreferred stock conversions | 565 |  |  | (3) |  | \u2014 |  |  |  | 3 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | (1) |  |  |  | (13) |  |  | (14) | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (41) |  | (41) | \nBALANCE DECEMBER 31, 2021 | 2,397,066 |  | $4,009 |  | $856 |  | $65,432 |  | ($965) |  | ($13,564) |  | ($121,543) |  | $110,393 |  | $275 |  | $44,893 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended December 31, 2021\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Add-itional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comp-rehensive Income/(Loss) | Treasury Stock | Retained Earnings | Non-controlling Interest | Total Share-holders' Equity\nShares | Amount\nBALANCE JUNE 30, 2021 | 2,429,706 |  | $4,009 |  | $870 |  | $64,848 |  | ($1,006) |  | ($13,744) |  | ($114,973) |  | $106,374 |  | $276 |  | $46,654 | \nNet earnings |  |  |  |  |  |  |  | 8,335 |  | 33 |  | 8,368 | \nOther comprehensive income/(loss) |  |  |  |  |  | 180 |  |  |  | \u2014 |  | 180 | \nDividends and dividend equivalents(1.7396per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (4,226) |  |  | (4,226) | \nPreferred |  |  |  |  |  |  |  | (140) |  |  | (140) | \nTreasury stock purchases | (50,786) |  |  |  |  |  |  | (7,504) |  |  |  | (7,504) | \nEmployee stock plans | 16,423 |  |  |  | 584 |  |  |  | 922 |  |  |  | 1,506 | \nPreferred stock conversions | 1,723 |  |  | (14) |  | 2 |  |  |  | 12 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 41 |  |  |  | 50 |  |  | 91 | \nNoncontrolling interest, net |  |  |  | (2) |  |  |  |  |  | (34) |  | (36) | \nBALANCE DECEMBER 31, 2021 | 2,397,066 |  | $4,009 |  | $856 |  | $65,432 |  | ($965) |  | ($13,564) |  | ($121,543) |  | $110,393 |  | $275 |  | $44,893 |   |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended December 31\nAmounts in millions | 2022 |  | 2021\nCASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD | $ | 7,214 |  |  | $ | 10,288 | \nOPERATING ACTIVITIES |  |  | \nNet earnings | 7,922 |  |  | 8,368 | \nDepreciation and amortization | 1,316 |  |  | 1,395 | \nShare-based compensation expense | 250 |  |  | 268 | \nDeferred income taxes | (398) |  |  | (101) | \nGain on sale of assets | (3) |  |  | (82) | \nChanges in: |  |  | \nAccounts receivable | (654) |  |  | (644) | \nInventories | (655) |  |  | (840) | \nAccounts payable, accrued and other liabilities | 177 |  |  | 1,431 | \nOther operating assets and liabilities | (535) |  |  | (84) | \nOther | 224 |  |  | 53 | \nTOTAL OPERATING ACTIVITIES | 7,644 |  |  | 9,764 | \nINVESTING ACTIVITIES |  |  | \nCapital expenditures | (1,598) |  |  | (1,717) | \nProceeds from asset sales | 8 |  |  | 97 | \nAcquisitions, net of cash acquired | (76) |  |  | (349) | \nOther investing activity | 344 |  |  | 3 | \nTOTAL INVESTING ACTIVITIES | (1,322) |  |  | (1,966) | \nFINANCING ACTIVITIES |  |  | \nDividends to shareholders | (4,486) |  |  | (4,353) | \nAdditions to short-term debt with original maturities of more than three months | 10,447 |  |  | 6,747 | \nReductions in short-term debt with original maturities of more than three months | (3,260) |  |  | (1,730) | \nNet reductions to other short-term debt | (1,759) |  |  | (1,124) | \nAdditions to long-term debt | \u2014 |  |  | 2,136 | \nReductions in long-term debt | (1,877) |  |  | (1,673) | \nTreasury stock purchases | (6,002) |  |  | (7,504) | \nImpact of stock options and other | 437 |  |  | 1,215 | \nTOTAL FINANCING ACTIVITIES | (6,500) |  |  | (6,286) | \nEFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (182) |  |  | (256) | \nCHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (360) |  |  | 1,256 | \nCASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD | $ | 6,854 |  |  | $ | 11,544 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | % of Net sales by operating segment(1)\n | Three Months Ended December 31 |  | Six Months Ended December 31\n | 2022 |  | 2021 |  | 2022 |  | 2021\nFabric Care | 23% |  | 22% |  | 23% |  | 23%\nHome Care | 11% |  | 11% |  | 11% |  | 11%\nSkin and Personal Care | 10% |  | 10% |  | 10% |  | 10%\nBaby Care | 10% |  | 11% |  | 10% |  | 10%\nHair Care | 8% |  | 9% |  | 9% |  | 9%\nFamily Care | 8% |  | 8% |  | 8% |  | 8%\nGrooming(2) | 8% |  | 7% |  | 8% |  | 7%\nOral Care | 8% |  | 8% |  | 8% |  | 8%\nFeminine Care | 7% |  | 6% |  | 7% |  | 6%\nPersonal Health Care | 7% |  | 6% |  | 6% |  | 6%\nOther | \u2014% |  | 2% |  | \u2014% |  | 2%\nTotal | 100% |  | 100% |  | 100% |  | 100%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended December 31 |  | Six Months Ended December 31\n |  | Net Sales |  | Earnings/(Loss) Before Income Taxes |  | Net Earnings/(Loss) |  | Net Sales |  | Earnings/(Loss) Before Income Taxes |  | Net Earnings/(Loss)\nBeauty | 2022 | $ | 3,807 |  |  | $ | 1,145 |  |  | $ | 911 |  |  | $ | 7,768 |  |  | $ | 2,416 |  |  | $ | 1,922 | \n | 2021 | 3,926 |  |  | 1,179 |  |  | 947 |  |  | 7,890 |  |  | 2,421 |  |  | 1,938 | \nGrooming | 2022 | 1,643 |  |  | 496 |  |  | 404 |  |  | 3,268 |  |  | 999 |  |  | 808 | \n | 2021 | 1,811 |  |  | 576 |  |  | 476 |  |  | 3,498 |  |  | 1,094 |  |  | 893 | \nHealth Care | 2022 | 3,051 |  |  | 887 |  |  | 686 |  |  | 5,808 |  |  | 1,687 |  |  | 1,303 | \n | 2021 | 2,976 |  |  | 905 |  |  | 701 |  |  | 5,652 |  |  | 1,600 |  |  | 1,230 | \nFabric & Home Care | 2022 | 7,032 |  |  | 1,538 |  |  | 1,171 |  |  | 14,114 |  |  | 3,081 |  |  | 2,343 | \n | 2021 | 6,972 |  |  | 1,463 |  |  | 1,137 |  |  | 13,981 |  |  | 3,009 |  |  | 2,328 | \nBaby, Feminine & Family Care | 2022 | 5,065 |  |  | 1,112 |  |  | 848 |  |  | 9,999 |  |  | 2,167 |  |  | 1,653 | \n | 2021 | 5,116 |  |  | 1,187 |  |  | 914 |  |  | 9,980 |  |  | 2,262 |  |  | 1,740 | \nCorporate | 2022 | 175 |  |  | (343) |  |  | (61) |  |  | 428 |  |  | (518) |  |  | (107) | \n | 2021 | 152 |  |  | (71) |  |  | 67 |  |  | 290 |  |  | (112) |  |  | 239 | \nTotal Company | 2022 | $ | 20,773 |  |  | $ | 4,835 |  |  | $ | 3,959 |  |  | $ | 41,385 |  |  | $ | 9,832 |  |  | $ | 7,922 | \n | 2021 | 20,953 |  |  | 5,239 |  |  | 4,242 |  |  | 41,291 |  |  | 10,274 |  |  | 8,368 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Beauty |  | Grooming |  | Health Care |  | Fabric & Home Care |  | Baby, Feminine & Family Care |  | Total Company\nGoodwill at June 30, 2022 | $ | 13,296 |  |  | $ | 12,571 |  |  | $ | 7,589 |  |  | $ | 1,808 |  |  | $ | 4,436 |  |  | $ | 39,700 | \nAcquisitions and divestitures | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 34 |  |  | 34 | \nTranslation and other | 88 |  |  | 53 |  |  | 44 |  |  | 4 |  |  | 28 |  |  | 217 | \nGoodwill at December 31, 2022 | $ | 13,384 |  |  | $ | 12,624 |  |  | $ | 7,633 |  |  | $ | 1,812 |  |  | $ | 4,498 |  |  | $ | 39,951 |   |  |  |  |  |  |  |  |  |  |  | \n | Gross Carrying Amount |  | Accumulated Amortization\nIntangible assets with determinable lives | $ | 8,897 |  |  | $ | (6,268) | \nIntangible assets with indefinite lives | 20,965 |  |  | \u2014 | \nTotal identifiable intangible assets | $ | 29,862 |  |  | $ | (6,268) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Approximate Percent Change in Estimated Fair Value\n | +25 bps Discount Rate |  | -25 bps Growth Rates |  | -50 bps Royalty Rate\nGillette indefinite-lived intangible asset | (6)% |  | (6)% |  | (4)%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCONSOLIDATED AMOUNTS | Three Months Ended December 31 |  | Six Months Ended December 31\n | 2022 |  | 2021 |  | 2022 |  | 2021\nNet earnings | $ | 3,959 |  |  | $ | 4,242 |  |  | $ | 7,922 |  |  | $ | 8,368 | \nLess: Net earnings attributable to noncontrolling interests | 26 |  |  | 19 |  |  | 50 |  |  | 33 | \nNet earnings attributable to P&G (Diluted) | 3,933 |  |  | 4,223 |  |  | 7,872 |  |  | 8,335 | \nLess: Preferred dividends | 70 |  |  | 70 |  |  | 141 |  |  | 140 | \nNet earnings attributable to P&G available to common shareholders (Basic) | $ | 3,863 |  |  | $ | 4,153 |  |  | $ | 7,731 |  |  | $ | 8,195 | \n |  |  |  |  |  |  | \nSHARES IN MILLIONS |  |  |  |  |  |  | \nBasic weighted average common shares outstanding | 2,365.9 |  |  | 2,413.4 |  |  | 2,375.7 |  |  | 2,420.7 | \nAdd: Effect of dilutive securities |  |  |  |  |  |  | \nConvertible preferred shares(1) | 76.7 |  |  | 79.6 |  |  | 77.0 |  |  | 80.1 | \nStock options and other unvested equity awards(2) | 38.6 |  |  | 51.2 |  |  | 39.7 |  |  | 50.8 | \nDiluted weighted average common shares outstanding | 2,481.2 |  |  | 2,544.2 |  |  | 2,492.4 |  |  | 2,551.6 | \n |  |  |  |  |  |  | \nNET EARNINGS PER SHARE(3) |  |  |  |  |  |  | \nBasic | $ | 1.63 |  |  | $ | 1.72 |  |  | $ | 3.25 |  |  | $ | 3.39 | \nDiluted | $ | 1.59 |  |  | $ | 1.66 |  |  | $ | 3.16 |  |  | $ | 3.27 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31 |  | Six Months Ended December 31\n | 2022 |  | 2021 |  | 2022 |  | 2021\nShare-based compensation expense | $ | 145 |  |  | $ | 152 |  |  | $ | 250 |  |  | $ | 268 | \nNet periodic benefit cost for pension benefits | 44 |  |  | 47 |  |  | 87 |  |  | 95 | \nNet periodic benefit credit for other retiree benefits | (132) |  |  | (119) |  |  | (264) |  |  | (222) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Notional Amount |  | Fair\u00a0Value\u00a0Asset |  | Fair Value (Liability)\n | December 31, 2022 |  | June 30, 2022 |  | December 31, 2022 |  | June 30, 2022 |  | December 31, 2022 |  | June 30, 2022\nDERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS\nInterest rate contracts | $ | 3,983 |  |  | $ | 4,972 |  |  | $ | \u2014 |  |  | $ | 3 |  |  | $ | (484) |  |  | $ | (307) | \nDERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS\nForeign currency interest rate contracts | $ | 11,381 |  |  | $ | 7,943 |  |  | $ | 47 |  |  | $ | 561 |  |  | $ | (474) |  |  | $ | (1) | \nTOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | $ | 15,364 |  |  | $ | 12,915 |  |  | $ | 47 |  |  | $ | 564 |  |  | $ | (958) |  |  | $ | (308) | \n |  |  |  |  |  |  |  |  |  |  | \nDERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS\nForeign currency contracts | $ | 5,203 |  |  | $ | 5,625 |  |  | $ | 47 |  |  | $ | 6 |  |  | $ | (4) |  |  | $ | (61) | \n |  |  |  |  |  |  |  |  |  |  | \nTOTAL DERIVATIVES AT FAIR VALUE | $ | 20,567 |  |  | $ | 18,540 |  |  | $ | 94 |  |  | $ | 570 |  |  | $ | (962) |  |  | $ | (369) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Amount of Gain/(Loss) Recognized in OCI on Derivatives\n | Three Months Ended December 31 |  | Six Months Ended December 31\n | 2022 |  | 2021 |  | 2022 |  | 2021\nDERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS(1) (2) |  |  |  | \nForeign exchange contracts | $ | (1,013) |  |  | $ | 218 |  |  | $ | (305) |  |  | $ | 426 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Amount of Gain/(Loss) Recognized in Earnings\n | Three Months Ended December 31 |  | Six Months Ended December 31\n | 2022 |  | 2021 |  | 2022 |  | 2021\nDERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS |  |  |  | \nInterest rate contracts | $ | (49) |  |  | $ | (61) |  |  | $ | (180) |  |  | $ | (97) | \nDERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS |  |  |  | \nForeign currency contracts | $ | 95 |  |  | $ | 54 |  |  | $ | (51) |  |  | $ | 30 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Investment Securities |  | Post-retirement Benefit Plans |  | Foreign Currency Translation |  | Total AOCI\nBalance at June 30, 2022 | $ | 20 |  |  | $ | 27 |  |  | $ | (12,236) |  |  | $ | (12,189) | \nOCI before reclassifications(1) | (3) |  |  | 2 |  |  | (333) |  |  | (334) | \nAmounts reclassified to the Consolidated Statement of Earnings(2) | \u2014 |  |  | 9 |  |  | \u2014 |  |  | 9 | \nNet current period OCI | (3) |  |  | 11 |  |  | (333) |  |  | (325) | \nLess: OCI attributable to non-controlling interests | \u2014 |  |  | \u2014 |  |  | (8) |  |  | (8) | \nBalance at December 31, 2022 | $ | 17 |  |  | $ | 38 |  |  | $ | (12,561) |  |  | $ | (12,506) |   |  |  |  |  | \nItem 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations  |  |  |  |  |  |  |  | \nReportable\u00a0Segments | Product Categories (Sub-Categories) | Major Brands\nBeauty | Hair Care (Conditioners, Shampoos, Styling Aids, Treatments) | Head & Shoulders,  Herbal Essences, Pantene, Rejoice\nSkin and Personal Care (Antiperspirants and Deodorants, Personal Cleansing, Skin Care) | Olay, Old Spice,  Safeguard, Secret, SK-II\nGrooming(1) | Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming) | Braun, Gillette, Venus\nHealth Care | Oral Care (Toothbrushes, Toothpastes, Other Oral Care) | Crest, Oral-B\nPersonal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care) | Metamucil, Neurobion, Pepto-Bismol, Vicks\nFabric & Home Care | Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents) | Ariel, Downy, Gain, Tide\nHome Care (Air Care, Dish Care, P&G Professional, Surface Care) | Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer\nBaby, Feminine & Family Care | Baby Care (Baby Wipes, Taped Diapers and Pants) | Luvs, Pampers\nFeminine Care (Adult Incontinence, Feminine Care) | Always, Always Discreet, Tampax\nFamily Care (Paper Towels, Tissues, Toilet Paper) | Bounty, Charmin, Puffs  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31, 2022 |  | Six Months Ended December 31, 2022\n | Net Sales |  | Net Earnings |  | Net Sales |  | Net Earnings\nBeauty | 18% |  | 23% |  | 19% |  | 24%\nGrooming | 8% |  | 10% |  | 8% |  | 10%\nHealth Care | 15% |  | 17% |  | 14% |  | 16%\nFabric & Home Care | 34% |  | 29% |  | 34% |  | 29%\nBaby, Feminine & Family Care | 25% |  | 21% |  | 25% |  | 21%\nTotal Company | 100% |  | 100% |  | 100% |  | 100%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31\nAmounts in millions, except per share amounts | 2022 |  | 2021 |  | % Chg\nNet sales | $20,773 |  | $20,953 |  | (1)%\nOperating income | 4,785 |  | 5,168 |  | (7)%\nNet earnings | 3,959 |  | 4,242 |  | (7)%\nNet earnings attributable to Procter & Gamble | 3,933 |  | 4,223 |  | (7)%\nDiluted net earnings per common share | 1.59 |  | 1.66 |  | (4)%\n |  |  |  |  | \n\n | Three Months Ended December 31\nCOMPARISONS AS A PERCENTAGE OF NET SALES | 2022 |  | 2021 |  | Basis Pt Chg\nGross margin | 47.5% |  | 49.1% |  | (160)\nSelling, general & administrative expense | 24.5% |  | 24.4% |  | 10\nOperating income | 23.0% |  | 24.7% |  | (170)\nEarnings before income taxes | 23.3% |  | 25.0% |  | (170)\nNet earnings | 19.1% |  | 20.2% |  | (110)\nNet earnings attributable to Procter & Gamble | 18.9% |  | 20.2% |  | (130)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Net Sales Change Drivers 2022 vs. 2021 (Three Months Ended December 31, 2022)(1)\n | Volume with Acquisitions & Divestitures |  | Volume Excluding Acquisitions & Divestitures |  | Foreign Exchange |  | Price |  | Mix |  | Other(2) |  | Net Sales Growth\nBeauty | (4)% |  | (4)% |  | (8)% |  | 9% |  | (2)% |  | 2% |  | (3)%\nGrooming | (8)% |  | (8)% |  | (9)% |  | 11% |  | (3)% |  | \u2014% |  | (9)%\nHealth Care | (1)% |  | (1)% |  | (6)% |  | 5% |  | 4% |  | \u2014% |  | 2%\nFabric & Home Care | (7)% |  | (7)% |  | (7)% |  | 13% |  | 2% |  | \u2014% |  | 1%\nBaby, Feminine & Family Care | (6)% |  | (6)% |  | (5)% |  | 8% |  | 2% |  | \u2014% |  | (1)%\nTotal Company | (6)% |  | (6)% |  | (6)% |  | 10% |  | 1% |  | \u2014% |  | (1)%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended December 31\nAmounts in millions, except per share amounts | 2022 |  | 2021 |  | % Chg\nNet sales | $41,385 |  | $41,291 |  | \u2014%\nOperating income | 9,724 |  | 10,191 |  | (5)%\nNet earnings | 7,922 |  | 8,368 |  | (5)%\nNet earnings attributable to Procter & Gamble | 7,872 |  | 8,335 |  | (6)%\nDiluted net earnings per common share | 3.16 |  | 3.27 |  | (3)%\n\n | Six Months Ended December 31\nCOMPARISONS AS A PERCENTAGE OF NET SALES | 2022 |  | 2021 |  | Basis Pt Chg\nGross margin | 47.5% |  | 49.1% |  | (160)\nSelling, general & administrative expense | 24.0% |  | 24.4% |  | (40)\nOperating income | 23.5% |  | 24.7% |  | (120)\nEarnings before income taxes | 23.8% |  | 24.9% |  | (110)\nNet earnings | 19.1% |  | 20.3% |  | (120)\nNet earnings attributable to Procter & Gamble | 19.0% |  | 20.2% |  | (120)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Net Sales Change Drivers 2022 vs. 2021 (Six Months Ended December 31, 2022)(1)\n | Volume with Acquisitions & Divestitures |  | Volume Excluding Acquisitions & Divestitures |  | Foreign Exchange |  | Price |  | Mix |  | Other(2) |  | Net Sales Growth\nBeauty | (2)% |  | (3)% |  | (7)% |  | 8% |  | (2)% |  | 1% |  | (2)%\nGrooming | (4)% |  | (4)% |  | (9)% |  | 10% |  | (4)% |  | \u2014% |  | (7)%\nHealth Care | (1)% |  | (1)% |  | (5)% |  | 5% |  | 4% |  | \u2014% |  | 3%\nFabric & Home Care | (6)% |  | (5)% |  | (7)% |  | 12% |  | 1% |  | 1% |  | 1%\nBaby, Feminine & Family Care | (4)% |  | (4)% |  | (5)% |  | 8% |  | 1% |  | \u2014% |  | \u2014%\nTotal Company | (4)% |  | (4)% |  | (6)% |  | 9% |  | 1% |  | \u2014% |  | \u2014%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31, 2022\n | Net Sales |  | % Change Versus Year Ago |  | Earnings/(Loss) Before Income Taxes |  | % Change Versus Year Ago |  | Net Earnings/(Loss) |  | % Change Versus Year Ago\nBeauty | $ | 3,807 |  |  | (3) | % |  | $ | 1,145 |  |  | (3) | % |  | $ | 911 |  |  | (4) | %\nGrooming | 1,643 |  |  | (9) | % |  | 496 |  |  | (14) | % |  | 404 |  |  | (15) | %\nHealth Care | 3,051 |  |  | 2 | % |  | 887 |  |  | (2) | % |  | 686 |  |  | (2) | %\nFabric & Home Care | 7,032 |  |  | 1 | % |  | 1,538 |  |  | 5 | % |  | 1,171 |  |  | 3 | %\nBaby, Feminine & Family Care | 5,065 |  |  | (1) | % |  | 1,112 |  |  | (6) | % |  | 848 |  |  | (7) | %\nCorporate | 175 |  |  | N/A |  | (343) |  |  | N/A |  | (61) |  |  | N/A\nTotal Company | $ | 20,773 |  |  | (1) | % |  | $ | 4,835 |  |  | (8) | % |  | $ | 3,959 |  |  | (7) | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended December 31, 2022\n | Net Sales |  | % Change Versus Year Ago |  | Earnings/(Loss) Before Income Taxes |  | % Change Versus Year Ago |  | Net Earnings/(Loss) |  | % Change Versus Year Ago\nBeauty | $ | 7,768 |  |  | (2) | % |  | $ | 2,416 |  |  | \u2014 | % |  | $ | 1,922 |  |  | (1) | %\nGrooming | 3,268 |  |  | (7) | % |  | 999 |  |  | (9) | % |  | 808 |  |  | (10) | %\nHealth Care | 5,808 |  |  | 3 | % |  | 1,687 |  |  | 5 | % |  | 1,303 |  |  | 6 | %\nFabric & Home Care | 14,114 |  |  | 1 | % |  | 3,081 |  |  | 2 | % |  | 2,343 |  |  | 1 | %\nBaby, Feminine & Family Care | 9,999 |  |  | \u2014 | % |  | 2,167 |  |  | (4) | % |  | 1,653 |  |  | (5) | %\nCorporate | 428 |  |  | N/A |  | (518) |  |  | N/A |  | (107) |  |  | N/A\nTotal Company | $ | 41,385 |  |  | \u2014 | % |  | $ | 9,832 |  |  | (4) | % |  | $ | 7,922 |  |  | (5) | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months Ended December 31, 2022 | Net Sales Growth |  | Foreign Exchange Impact |  | Acquisition & Divestiture Impact/Other(1) |  | Organic Sales Growth\nBeauty | (3)% |  | 8% |  | (2)% |  | 3%\nGrooming | (9)% |  | 9% |  | \u2014% |  | \u2014%\nHealth Care | 2% |  | 6% |  | \u2014% |  | 8%\nFabric & Home Care | 1% |  | 7% |  | \u2014% |  | 8%\nBaby, Feminine & Family Care | (1)% |  | 5% |  | \u2014% |  | 4%\nTotal Company | (1)% |  | 6% |  | \u2014% |  | 5%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSix Months Ended December 31, 2022 | Net Sales Growth |  | Foreign Exchange Impact |  | Acquisition & Divestiture Impact/Other(1) |  | Organic Sales Growth\nBeauty | (2)% |  | 7% |  | (2)% |  | 3%\nGrooming | (7)% |  | 9% |  | \u2014% |  | 2%\nHealth Care | 3% |  | 5% |  | \u2014% |  | 8%\nFabric & Home Care | 1% |  | 7% |  | \u2014% |  | 8%\nBaby, Feminine & Family Care | \u2014% |  | 5% |  | \u2014% |  | 5%\nTotal Company | \u2014% |  | 6% |  | \u2014% |  | 6%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSix Months Ended December 31, 2022\nOperating Cash Flow |  | Capital Spending |  | U.S. Tax Act Payments |  | Adjusted Free Cash Flow\n$7,644 |  | $(1,598) |  | $225 |  | $6,271  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSix Months Ended December 31, 2022\nAdjusted Free Cash Flow |  | Net Earnings |  | Adjusted Free Cash Flow Productivity\n$6,271 |  | $7,922 |  | 79%  |  |  |  |  | \nItem 3. | Quantitative and Qualitative Disclosures About Market Risk  |  |  |  |  | \nItem\u00a04. | Controls and Procedures  |  |  |  |  | \nItem\u00a01. | Legal Proceedings  |  |  |  |  | \nItem\u00a01A. | Risk Factors  |  |  |  |  | \nItem\u00a02. | Unregistered Sales of Equity Securities and Use of Proceeds  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number of Shares Purchased(1) |  | Average Price Paid per Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(3) |  | Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program\n10/01/2022 - 10/31/2022 | 5,472,573 |  |  | $127.91 |  | 5,472,573 |  |  | (3)\n11/01/2022 - 11/30/2022 | 4,643,725 |  |  | $139.97 |  | 4,643,725 |  |  | (3)\n12/01/2022 - 12/31/2022 | 4,298,255 |  |  | $151.22 |  | 4,298,255 |  |  | (3)\nTotal | 14,414,553 |  |  | $138.75 |  | 14,414,553 |  |  |   |  |  |  |  | \nItem\u00a06. | Exhibits  |  |  |  |  |  |  |  | \n3-1 |  | Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October\u00a011, 2011 and consolidated by the Board of Directors on April 8, 2016) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-K for the year ended June 30, 2016)\n |  | \n3-2 |  | Regulations (as approved by the Board of Directors on December 13, 2022, pursuant to authority granted by shareholders at the annual meeting on October 13, 2009) (Incorporated by reference to Exhibit (3-2) of the Company\u2019s Current Report on Form 8-K filed December 13, 2022)\n |  | \n10-1 |  | Summary of the Company\u2019s Short Term Achievement Reward Program* +\n |  | \n31.1 |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Executive Officer+\n |  | \n31.2 |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Financial Officer+\n |  | \n32.1 |  | Section 1350 Certifications \u2013 Chief Executive Officer+\n |  | \n32.2 |  | Section 1350 Certifications \u2013 Chief Financial Officer+\n |  | \n101.SCH(1) |  | Inline XBRL Taxonomy Extension Schema Document\n |  | \n101.CAL(1) |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n |  | \n101.DEF(1) |  | Inline XBRL Taxonomy Definition Linkbase Document\n |  | \n101.LAB(1) |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n |  | \n101.PRE(1) |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n |  | \n104 |  |  | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)  |  |  |  |  | \n* | Compensatory plan or arrangement\n | \n+ | Filed herewith\n | \n(1) | Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | \n |  |  |  | THE PROCTER & GAMBLE COMPANY\n |  |  |  | \nJanuary 19, 2023 |  |  |  | /s/ MATTHEW W. JANZARUK\nDate |  |  |  | (Matthew W. Janzaruk)\n |  |  |  | Senior Vice President - Chief Accounting Officer(Principal Accounting Officer)"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Procter and Gamble, in 2023 Q1, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  |  |  |  | \nx | True | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  |  |  |  | \no | False | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)\u00a0OF THE SECURITIES EXCHANGE ACT OF 1934  |  | \n  |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOhio | OH | 1-434 |  | 31-0411980\n(State of Incorporation) |  | (Commission File Number) |  | (I.R.S. Employer Identification Number)\nOne Procter & Gamble Plaza |  | Cincinnati | OH | \nOne Procter & Gamble Plaza, Cincinnati, Ohio | 45202\n(Address of principal executive offices) | (Zip Code)  |  | \n  |  |  |  |  |  |  |  | \nTitle of each class | Trading Symbol | Name of each exchange on which registered\nCommon Stock, without Par Value | PG | NYSE\n1.125% Notes due 2023 | PG23A | NYSE\n0.500% Notes due 2024 | PG24A | NYSE\n0.625% Notes due 2024 | PG24B | NYSE\n1.375% Notes due 2025 | PG25 | NYSE\n0.110% Notes due 2026 | PG26D | NYSE\n4.875% EUR notes due May 2027 | PG27A | NYSE\n1.200% Notes due 2028 | PG28 | NYSE\n1.250% Notes due 2029 | PG29B | NYSE\n1.800% Notes due 2029 | PG29A | NYSE\n6.250% GBP notes due January 2030 | PG30 | NYSE\n0.350% Notes due 2030 | PG30C | NYSE\n0.230% Notes due 2031 | PG31A | NYSE\n5.250% GBP notes due January 2033 | PG33 | NYSE\n1.875% Notes due 2038 | PG38 | NYSE\n0.900% Notes due 2041 | PG41 | NYSE  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Large accelerated filer | \u00fe |  |  | Accelerated filer | \u00a8 | \n | Non-accelerated filer | \u00a8 |  |  | Smaller reporting company | \u00a8 | False\n |  |  |  |  | Emerging growth company | \u00a8 | False  |  |  |  |  | \nItem 1. | Financial Statements  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31 |  | Nine Months Ended March 31\nAmounts in millions except per share amounts | 2023 |  | 2022 |  | 2023 |  | 2022\nNET SALES | $ | 20,068 |  |  | $ | 19,381 |  |  | $ | 61,453 |  |  | $ | 60,672 | \nCost of products sold | 10,404 |  |  | 10,326 |  |  | 32,147 |  |  | 31,355 | \nSelling, general and administrative expense | 5,416 |  |  | 5,031 |  |  | 15,334 |  |  | 15,102 | \nOPERATING INCOME | 4,248 |  |  | 4,024 |  |  | 13,972 |  |  | 14,215 | \nInterest expense | (222) |  |  | (109) |  |  | (516) |  |  | (324) | \nInterest income | 83 |  |  | 9 |  |  | 191 |  |  | 30 | \nOther non-operating income, net | 179 |  |  | 147 |  |  | 473 |  |  | 424 | \nEARNINGS BEFORE INCOME TAXES | 4,288 |  |  | 4,071 |  |  | 14,120 |  |  | 14,345 | \nIncome taxes | 864 |  |  | 704 |  |  | 2,774 |  |  | 2,610 | \nNET EARNINGS | 3,424 |  |  | 3,367 |  |  | 11,346 |  |  | 11,735 | \nLess: Net earnings attributable to noncontrolling interests | 27 |  |  | 12 |  |  | 77 |  |  | 45 | \nNET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE | $ | 3,397 |  |  | $ | 3,355 |  |  | $ | 11,269 |  |  | $ | 11,690 | \n |  |  |  |  |  |  | \nNET EARNINGS PER SHARE(1) |  |  |  |  |  |  | \nBasic | $ | 1.41 |  |  | $ | 1.37 |  |  | $ | 4.67 |  |  | $ | 4.76 | \nDiluted | $ | 1.37 |  |  | $ | 1.33 |  |  | $ | 4.53 |  |  | $ | 4.59 | \n |  |  |  |  |  |  | \nDILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING | 2,473.2 |  |  | 2,530.2 |  |  | 2,486.0 |  |  | 2,544.4 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31 |  | Nine Months Ended March 31\nAmounts in millions | 2023 |  | 2022 |  | 2023 |  | 2022\nNET EARNINGS | $ | 3,424 |  |  | $ | 3,367 |  |  | $ | 11,346 |  |  | $ | 11,735 | \nOTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX |  |  |  |  |  |  | \nForeign currency translation | 259 |  |  | 23 |  |  | (74) |  |  | (683) | \nUnrealized gains/(losses) on investment securities | 1 |  |  | \u2014 |  |  | (2) |  |  | 7 | \nUnrealized gains/(losses) on defined benefit retirement plans | (19) |  |  | 89 |  |  | (8) |  |  | 968 | \nTOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX | 241 |  |  | 112 |  |  | (84) |  |  | 292 | \nTOTAL COMPREHENSIVE INCOME | 3,665 |  |  | 3,479 |  |  | 11,262 |  |  | 12,027 | \nLess: Total comprehensive income attributable to noncontrolling interests | 28 |  |  | 8 |  |  | 70 |  |  | 41 | \nTOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE | $ | 3,637 |  |  | $ | 3,471 |  |  | $ | 11,192 |  |  | $ | 11,986 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAmounts in millions |  |  |  |  | March 31, 2023 |  | June 30, 2022\nAssets |  |  |  |  |  |  | \nCURRENT ASSETS |  |  |  |  |  |  | \nCash and cash equivalents |  |  |  |  | $ | 7,596 |  |  | $ | 7,214 | \nAccounts receivable |  |  |  |  | 5,471 |  |  | 5,143 | \nINVENTORIES |  |  |  |  |  |  | \nMaterials and supplies |  |  |  |  | 2,010 |  |  | 2,168 | \nWork in process |  |  |  |  | 966 |  |  | 856 | \nFinished goods |  |  |  |  | 4,507 |  |  | 3,900 | \nTotal inventories |  |  |  |  | 7,483 |  |  | 6,924 | \nPrepaid expenses and other current assets |  |  |  |  | 1,755 |  |  | 2,372 | \nTOTAL CURRENT ASSETS |  |  |  |  | 22,305 |  |  | 21,653 | \nPROPERTY, PLANT AND EQUIPMENT, NET |  |  |  |  | 21,564 |  |  | 21,195 | \nGOODWILL |  |  |  |  | 40,718 |  |  | 39,700 | \nTRADEMARKS AND OTHER INTANGIBLE ASSETS, NET |  |  |  | 23,832 |  |  | 23,679 | \nOTHER NONCURRENT ASSETS |  |  |  |  | 11,432 |  |  | 10,981 | \nTOTAL ASSETS |  |  |  |  | $ | 119,851 |  |  | $ | 117,208 | \n |  |  |  |  |  |  | \nLiabilities and Shareholders' Equity |  |  |  |  |  |  | \nCURRENT LIABILITIES |  |  |  |  |  |  | \nAccounts payable |  |  |  |  | $ | 13,790 |  |  | $ | 14,882 | \nAccrued and other liabilities |  |  |  |  | 10,523 |  |  | 9,554 | \nDebt due within one year |  |  |  |  | 13,717 |  |  | 8,645 | \nTOTAL CURRENT LIABILITIES |  |  |  |  | 38,030 |  |  | 33,081 | \nLONG-TERM DEBT |  |  |  |  | 22,874 |  |  | 22,848 | \nDEFERRED INCOME TAXES |  |  |  |  | 6,422 |  |  | 6,809 | \nOTHER NONCURRENT LIABILITIES |  |  |  |  | 7,104 |  |  | 7,616 | \nTOTAL LIABILITIES |  |  |  |  | 74,430 |  |  | 70,354 | \nSHAREHOLDERS\u2019 EQUITY |  |  |  |  |  |  | \nPreferred stock |  |  |  |  | 822 |  |  | 843 | \nCommon stock \u2013 shares issued \u2013 | March 2023 |  | 4,009.2 |  |  |  |  | \n | June 2022 |  | 4,009.2 |  |  | 4,009 |  |  | 4,009 | \nAdditional paid-in capital |  |  |  |  | 66,316 |  |  | 65,795 | \nReserve for ESOP debt retirement |  |  |  |  | (821) |  |  | (916) | \nAccumulated other comprehensive loss |  |  |  |  | (12,266) |  |  | (12,189) | \nTreasury stock |  |  |  |  | (130,002) |  |  | (123,382) | \nRetained earnings |  |  |  |  | 117,082 |  |  | 112,429 | \nNoncontrolling interest |  |  |  |  | 281 |  |  | 265 | \nTOTAL SHAREHOLDERS\u2019 EQUITY |  |  |  |  | 45,421 |  |  | 46,854 | \nTOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY |  |  |  | $ | 119,851 |  |  | $ | 117,208 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2023\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Additional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comprehensive Income/(Loss) | Treasury Stock | Retained Earnings | Noncontrolling Interest | Total Shareholders' Equity\nShares | Amount\nBALANCE DECEMBER 31, 2022 | 2,359,144 |  | $4,009 |  | $831 |  | $66,145 |  | ($870) |  | ($12,506) |  | ($129,012) |  | $115,858 |  | $270 |  | $44,725 | \nNet earnings |  |  |  |  |  |  |  | 3,397 |  | 27 |  | 3,424 | \nOther comprehensive income/(loss) |  |  |  |  |  | 240 |  |  |  | 1 |  | 241 | \nDividends and dividend equivalents($0.9133per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (2,160) |  |  | (2,160) | \nPreferred |  |  |  |  |  |  |  | (69) |  |  | (69) | \nTreasury stock purchases | (9,406) |  |  |  |  |  |  | (1,351) |  |  |  | (1,351) | \nEmployee stock plans | 6,290 |  |  |  | 170 |  |  |  | 353 |  |  |  | 523 | \nPreferred stock conversions | 941 |  |  | (9) |  | 1 |  |  |  | 8 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 49 |  |  |  | 56 |  |  | 105 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (17) |  | (17) | \nBALANCE MARCH 31, 2023 | 2,356,969 |  | $4,009 |  | $822 |  | $66,316 |  | ($821) |  | ($12,266) |  | ($130,002) |  | $117,082 |  | $281 |  | $45,421 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended March 31, 2023\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Additional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comprehensive Income/(Loss) | Treasury Stock | Retained Earnings | Noncontrolling Interest | Total Shareholders' Equity\nShares | Amount\nBALANCE JUNE 30, 2022 | 2,393,877 |  | $4,009 |  | $843 |  | $65,795 |  | ($916) |  | ($12,189) |  | ($123,382) |  | $112,429 |  | $265 |  | $46,854 | \nNet earnings |  |  |  |  |  |  |  | 11,269 |  | 77 |  | 11,346 | \nOther comprehensive income/(loss) |  |  |  |  |  | (77) |  |  |  | (7) |  | (84) | \nDividends and dividend equivalents($2.7399per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (6,517) |  |  | (6,517) | \nPreferred |  |  |  |  |  |  |  | (210) |  |  | (210) | \nTreasury stock purchases | (52,021) |  |  |  |  |  |  | (7,353) |  |  |  | (7,353) | \nEmployee stock plans | 12,742 |  |  |  | 518 |  |  |  | 715 |  |  |  | 1,233 | \nPreferred stock conversions | 2,371 |  |  | (21) |  | 3 |  |  |  | 18 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 95 |  |  |  | 111 |  |  | 206 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (54) |  | (54) | \nBALANCE MARCH 31, 2023 | 2,356,969 |  | $4,009 |  | $822 |  | $66,316 |  | ($821) |  | ($12,266) |  | ($130,002) |  | $117,082 |  | $281 |  | $45,421 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2022\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Additional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comprehensive Income/(Loss) | Treasury Stock | Retained Earnings | Noncontrolling Interest | Total Shareholders' Equity\nShares | Amount\nBALANCE DECEMBER 31, 2021 | 2,397,066 |  | $4,009 |  | $856 |  | $65,432 |  | ($965) |  | ($13,564) |  | ($121,543) |  | $110,393 |  | $275 |  | $44,893 | \nNet earnings |  |  |  |  |  |  |  | 3,355 |  | 12 |  | 3,367 | \nOther comprehensive income/(loss) |  |  |  |  |  | 116 |  |  |  | (4) |  | 112 | \nDividends and dividend equivalents($0.8698per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (2,092) |  |  | (2,092) | \nPreferred |  |  |  |  |  |  |  | (68) |  |  | (68) | \nTreasury stock purchases | (7,909) |  |  |  |  |  |  | (1,249) |  |  |  | (1,249) | \nEmployee stock plans | 9,108 |  |  |  | 180 |  |  |  | 512 |  |  |  | 692 | \nPreferred stock conversions | 1,032 |  |  | (10) |  | 2 |  |  |  | 8 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 49 |  |  |  | 57 |  |  | 106 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (15) |  | (15) | \nBALANCE MARCH 31, 2022 | 2,399,297 |  | $4,009 |  | $846 |  | $65,614 |  | ($916) |  | ($13,448) |  | ($122,272) |  | $111,645 |  | $268 |  | $45,746 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended March 31, 2022\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Additional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comprehensive Income/(Loss) | Treasury Stock | Retained Earnings | Noncontrolling Interest | Total Shareholders' Equity\nShares | Amount\nBALANCE JUNE 30, 2021 | 2,429,706 |  | $4,009 |  | $870 |  | $64,848 |  | ($1,006) |  | ($13,744) |  | ($114,973) |  | $106,374 |  | $276 |  | $46,654 | \nNet earnings |  |  |  |  |  |  |  | 11,690 |  | 45 |  | 11,735 | \nOther comprehensive income/(loss) |  |  |  |  |  | 296 |  |  |  | (4) |  | 292 | \nDividends and dividend equivalents($2.6094per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (6,318) |  |  | (6,318) | \nPreferred |  |  |  |  |  |  |  | (208) |  |  | (208) | \nTreasury stock purchases | (58,695) |  |  |  |  |  |  | (8,753) |  |  |  | (8,753) | \nEmployee stock plans | 25,531 |  |  |  | 764 |  |  |  | 1,434 |  |  |  | 2,198 | \nPreferred stock conversions | 2,755 |  |  | (24) |  | 4 |  |  |  | 20 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 90 |  |  |  | 107 |  |  | 197 | \nNoncontrolling interest, net |  |  |  | (2) |  |  |  |  |  | (49) |  | (51) | \nBALANCE MARCH 31, 2022 | 2,399,297 |  | $4,009 |  | $846 |  | $65,614 |  | ($916) |  | ($13,448) |  | ($122,272) |  | $111,645 |  | $268 |  | $45,746 |   |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended March 31\nAmounts in millions | 2023 |  | 2022\nCASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD | $ | 7,214 |  |  | $ | 10,288 | \nOPERATING ACTIVITIES |  |  | \nNet earnings | 11,346 |  |  | 11,735 | \nDepreciation and amortization | 2,008 |  |  | 2,085 | \nShare-based compensation expense | 406 |  |  | 398 | \nDeferred income taxes | (360) |  |  | (259) | \nGain on sale of assets | (4) |  |  | (84) | \nChanges in: |  |  | \nAccounts receivable | (301) |  |  | (916) | \nInventories | (503) |  |  | (1,252) | \nAccounts payable, accrued and other liabilities | (609) |  |  | 1,347 | \nOther operating assets and liabilities | (839) |  |  | (131) | \nOther | 363 |  |  | 87 | \nTOTAL OPERATING ACTIVITIES | 11,507 |  |  | 13,010 | \nINVESTING ACTIVITIES |  |  | \nCapital expenditures | (2,328) |  |  | (2,464) | \nProceeds from asset sales | 9 |  |  | 99 | \nAcquisitions, net of cash acquired | (714) |  |  | (1,381) | \nOther investing activity | 331 |  |  | 4 | \nTOTAL INVESTING ACTIVITIES | (2,702) |  |  | (3,742) | \nFINANCING ACTIVITIES |  |  | \nDividends to shareholders | (6,710) |  |  | (6,508) | \nAdditions to short-term debt with original maturities of more than three months | 13,778 |  |  | 10,146 | \nReductions in short-term debt with original maturities of more than three months | (9,134) |  |  | (8,163) | \nNet reductions to other short-term debt | (387) |  |  | (849) | \nAdditions to long-term debt | 2,569 |  |  | 4,385 | \nReductions in long-term debt | (1,877) |  |  | (2,776) | \nTreasury stock purchases | (7,353) |  |  | (8,753) | \nImpact of stock options and other | 861 |  |  | 1,800 | \nTOTAL FINANCING ACTIVITIES | (8,253) |  |  | (10,718) | \nEFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (170) |  |  | (312) | \nCHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | 382 |  |  | (1,762) | \nCASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD | $ | 7,596 |  |  | $ | 8,526 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | % of Net sales by operating segment(1)\n | Three Months Ended March 31 |  | Nine Months Ended March 31\n | 2023 |  | 2022 |  | 2023 |  | 2022\nFabric Care | 23% |  | 23% |  | 23% |  | 23%\nHome Care | 12% |  | 12% |  | 12% |  | 11%\nBaby Care | 10% |  | 11% |  | 10% |  | 10%\nSkin and Personal Care | 9% |  | 9% |  | 10% |  | 10%\nHair Care | 9% |  | 8% |  | 9% |  | 9%\nFamily Care | 9% |  | 9% |  | 8% |  | 9%\nOral Care | 8% |  | 8% |  | 8% |  | 8%\nGrooming(2) | 8% |  | 7% |  | 8% |  | 6%\nFeminine Care | 6% |  | 6% |  | 6% |  | 6%\nPersonal Health Care | 6% |  | 6% |  | 6% |  | 6%\nOther(2) | \u2014% |  | 1% |  | \u2014% |  | 2%\nTotal | 100% |  | 100% |  | 100% |  | 100%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended March 31 |  | Nine Months Ended March 31\n |  | Net Sales |  | Earnings/(Loss) Before Income Taxes |  | Net Earnings/(Loss) |  | Net Sales |  | Earnings/(Loss) Before Income Taxes |  | Net Earnings/(Loss)\nBeauty | 2023 | $ | 3,494 |  |  | $ | 763 |  |  | $ | 608 |  |  | $ | 11,262 |  |  | $ | 3,179 |  |  | $ | 2,530 | \n | 2022 | 3,389 |  |  | 792 |  |  | 644 |  |  | 11,279 |  |  | 3,213 |  |  | 2,582 | \nGrooming | 2023 | 1,495 |  |  | 382 |  |  | 308 |  |  | 4,763 |  |  | 1,381 |  |  | 1,116 | \n | 2022 | 1,481 |  |  | 353 |  |  | 290 |  |  | 4,979 |  |  | 1,447 |  |  | 1,183 | \nHealth Care | 2023 | 2,828 |  |  | 667 |  |  | 523 |  |  | 8,636 |  |  | 2,354 |  |  | 1,826 | \n | 2022 | 2,662 |  |  | 625 |  |  | 485 |  |  | 8,314 |  |  | 2,225 |  |  | 1,715 | \nFabric & Home Care | 2023 | 7,016 |  |  | 1,538 |  |  | 1,174 |  |  | 21,130 |  |  | 4,619 |  |  | 3,517 | \n | 2022 | 6,699 |  |  | 1,275 |  |  | 969 |  |  | 20,680 |  |  | 4,284 |  |  | 3,297 | \nBaby, Feminine & Family Care | 2023 | 5,062 |  |  | 1,206 |  |  | 925 |  |  | 15,061 |  |  | 3,373 |  |  | 2,578 | \n | 2022 | 4,935 |  |  | 1,091 |  |  | 836 |  |  | 14,915 |  |  | 3,353 |  |  | 2,576 | \nCorporate | 2023 | 173 |  |  | (268) |  |  | (114) |  |  | 601 |  |  | (786) |  |  | (221) | \n | 2022 | 215 |  |  | (65) |  |  | 143 |  |  | 505 |  |  | (177) |  |  | 382 | \nTotal Company | 2023 | $ | 20,068 |  |  | $ | 4,288 |  |  | $ | 3,424 |  |  | $ | 61,453 |  |  | $ | 14,120 |  |  | $ | 11,346 | \n | 2022 | 19,381 |  |  | 4,071 |  |  | 3,367 |  |  | 60,672 |  |  | 14,345 |  |  | 11,735 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Beauty |  | Grooming |  | Health Care |  | Fabric & Home Care |  | Baby, Feminine & Family Care |  | Total Company\nGoodwill at June 30, 2022 | $ | 13,296 |  |  | $ | 12,571 |  |  | $ | 7,589 |  |  | $ | 1,808 |  |  | $ | 4,436 |  |  | $ | 39,700 | \nAcquisitions and divestitures | 404 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 34 |  |  | 438 | \nTranslation and other | 221 |  |  | 148 |  |  | 130 |  |  | 16 |  |  | 65 |  |  | 580 | \nGoodwill at March 31, 2023 | $ | 13,921 |  |  | $ | 12,719 |  |  | $ | 7,719 |  |  | $ | 1,824 |  |  | $ | 4,535 |  |  | $ | 40,718 |   |  |  |  |  |  |  |  |  |  |  | \n | Gross Carrying Amount |  | Accumulated Amortization\nIntangible assets with determinable lives | $ | 9,170 |  |  | $ | (6,335) | \nIntangible assets with indefinite lives | 20,997 |  |  | \u2014 | \nTotal identifiable intangible assets | $ | 30,167 |  |  | $ | (6,335) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Approximate Percent Change in Estimated Fair Value\n | +25 bps Discount Rate |  | -25 bps Growth Rates |  | -50 bps Royalty Rate\nGillette indefinite-lived intangible asset | (6)% |  | (6)% |  | (4)%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCONSOLIDATED AMOUNTS | Three Months Ended March 31 |  | Nine Months Ended March 31\n | 2023 |  | 2022 |  | 2023 |  | 2022\nNet earnings | $ | 3,424 |  |  | $ | 3,367 |  |  | $ | 11,346 |  |  | $ | 11,735 | \nLess: Net earnings attributable to noncontrolling interests | 27 |  |  | 12 |  |  | 77 |  |  | 45 | \nNet earnings attributable to P&G (Diluted) | 3,397 |  |  | 3,355 |  |  | 11,269 |  |  | 11,690 | \nLess: Preferred dividends | 69 |  |  | 68 |  |  | 210 |  |  | 208 | \nNet earnings attributable to P&G available to common shareholders (Basic) | $ | 3,328 |  |  | $ | 3,287 |  |  | $ | 11,059 |  |  | $ | 11,482 | \n |  |  |  |  |  |  | \nSHARES IN MILLIONS |  |  |  |  |  |  | \nBasic weighted average common shares outstanding | 2,359.1 |  |  | 2,400.5 |  |  | 2,370.2 |  |  | 2,414.0 | \nAdd: Effect of dilutive securities |  |  |  |  |  |  | \nConvertible preferred shares(1) | 76.0 |  |  | 78.9 |  |  | 76.7 |  |  | 79.7 | \nStock options and other unvested equity awards(2) | 38.1 |  |  | 50.8 |  |  | 39.1 |  |  | 50.7 | \nDiluted weighted average common shares outstanding | 2,473.2 |  |  | 2,530.2 |  |  | 2,486.0 |  |  | 2,544.4 | \n |  |  |  |  |  |  | \nNET EARNINGS PER SHARE(3) |  |  |  |  |  |  | \nBasic | $ | 1.41 |  |  | $ | 1.37 |  |  | $ | 4.67 |  |  | $ | 4.76 | \nDiluted | $ | 1.37 |  |  | $ | 1.33 |  |  | $ | 4.53 |  |  | $ | 4.59 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31 |  | Nine Months Ended March 31\n | 2023 |  | 2022 |  | 2023 |  | 2022\nShare-based compensation expense | $ | 156 |  |  | $ | 130 |  |  | $ | 406 |  |  | $ | 398 | \nNet periodic benefit cost for pension benefits | 45 |  |  | 47 |  |  | 132 |  |  | 143 | \nNet periodic benefit credit for other retiree benefits | (131) |  |  | (126) |  |  | (395) |  |  | (348) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Notional Amount |  | Fair\u00a0Value\u00a0Asset |  | Fair Value (Liability)\n | March 31, 2023 |  | June 30, 2022 |  | March 31, 2023 |  | June 30, 2022 |  | March 31, 2023 |  | June 30, 2022\nDERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS\nInterest rate contracts | $ | 4,054 |  |  | $ | 4,972 |  |  | $ | \u2014 |  |  | $ | 3 |  |  | $ | (445) |  |  | $ | (307) | \nDERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS\nForeign currency interest rate contracts | $ | 10,349 |  |  | $ | 7,943 |  |  | $ | 4 |  |  | $ | 561 |  |  | $ | (685) |  |  | $ | (1) | \nTOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | $ | 14,403 |  |  | $ | 12,915 |  |  | $ | 4 |  |  | $ | 564 |  |  | $ | (1,130) |  |  | $ | (308) | \n |  |  |  |  |  |  |  |  |  |  | \nDERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS\nForeign currency contracts | $ | 5,698 |  |  | $ | 5,625 |  |  | $ | 39 |  |  | $ | 6 |  |  | $ | (18) |  |  | $ | (61) | \n |  |  |  |  |  |  |  |  |  |  | \nTOTAL DERIVATIVES AT FAIR VALUE | $ | 20,101 |  |  | $ | 18,540 |  |  | $ | 43 |  |  | $ | 570 |  |  | $ | (1,148) |  |  | $ | (369) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Amount of Gain/(Loss) Recognized in OCI on Derivatives\n | Three Months Ended March 31 |  | Nine Months Ended March 31\n | 2023 |  | 2022 |  | 2023 |  | 2022\nDERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS(1) (2) |  |  |  | \nForeign exchange contracts | $ | (266) |  |  | $ | 104 |  |  | $ | (571) |  |  | $ | 530 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Amount of Gain/(Loss) Recognized in Earnings\n | Three Months Ended March 31 |  | Nine Months Ended March 31\n | 2023 |  | 2022 |  | 2023 |  | 2022\nDERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS |  |  |  | \nInterest rate contracts | $ | 39 |  |  | $ | (216) |  |  | $ | (141) |  |  | $ | (313) | \nDERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS |  |  |  | \nForeign currency contracts | $ | 38 |  |  | $ | (2) |  |  | $ | (13) |  |  | $ | 28 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Investment Securities |  | Postretirement Benefit Plans |  | Foreign Currency Translation |  | Total AOCI\nBalance at June 30, 2022 | $ | 20 |  |  | $ | 27 |  |  | $ | (12,236) |  |  | $ | (12,189) | \nOCI before reclassifications(1) | (2) |  |  | (22) |  |  | (74) |  |  | (98) | \nAmounts reclassified to the Consolidated Statement of Earnings(2) | \u2014 |  |  | 14 |  |  | \u2014 |  |  | 14 | \nNet current period OCI | (2) |  |  | (8) |  |  | (74) |  |  | (84) | \nLess: OCI attributable to noncontrolling interests |  |  | \u2014 |  |  | (7) |  |  | (7) | \nBalance at March 31, 2023 | $ | 18 |  |  | $ | 19 |  |  | $ | (12,303) |  |  | $ | (12,266) |   |  |  |  |  | \nItem 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations  |  |  |  |  |  |  |  | \nReportable\u00a0Segments | Product Categories (Sub-Categories) | Major Brands\nBeauty | Hair Care (Conditioners, Shampoos, Styling Aids, Treatments) | Head & Shoulders, Herbal Essences, Pantene, Rejoice\nSkin and Personal Care (Antiperspirants and Deodorants, Personal Cleansing, Skin Care) | Olay, Old Spice, Safeguard, Secret, SK-II\nGrooming(1) | Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming) | Braun, Gillette, Venus\nHealth Care | Oral Care (Toothbrushes, Toothpastes, Other Oral Care) | Crest, Oral-B\nPersonal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care) | Metamucil, Neurobion, Pepto-Bismol, Vicks\nFabric & Home Care | Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents) | Ariel, Downy, Gain, Tide\nHome Care (Air Care, Dish Care, P&G Professional, Surface Care) | Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer\nBaby, Feminine & Family Care | Baby Care (Baby Wipes, Taped Diapers and Pants) | Luvs, Pampers\nFeminine Care (Adult Incontinence, Feminine Care) | Always, Always Discreet, Tampax\nFamily Care (Paper Towels, Tissues, Toilet Paper) | Bounty, Charmin, Puffs  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2023 |  | Nine Months Ended March 31, 2023\n | Net Sales |  | Net Earnings |  | Net Sales |  | Net Earnings\nBeauty | 18% |  | 17% |  | 19% |  | 22%\nGrooming | 8% |  | 9% |  | 8% |  | 10%\nHealth Care | 14% |  | 15% |  | 14% |  | 16%\nFabric & Home Care | 35% |  | 33% |  | 35% |  | 30%\nBaby, Feminine & Family Care | 25% |  | 26% |  | 24% |  | 22%\nTotal Company | 100% |  | 100% |  | 100% |  | 100%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31\nAmounts in millions, except per share amounts | 2023 |  | 2022 |  | % Chg\nNet sales | $20,068 |  | $19,381 |  | 4%\nOperating income | 4,248 |  | 4,024 |  | 6%\nNet earnings | 3,424 |  | 3,367 |  | 2%\nNet earnings attributable to Procter & Gamble | 3,397 |  | 3,355 |  | 1%\nDiluted net earnings per common share | 1.37 |  | 1.33 |  | 3%\n |  |  |  |  | \n\n | Three Months Ended March 31\nCOMPARISONS AS A PERCENTAGE OF NET SALES | 2023 |  | 2022 |  | Basis Pt Chg\nGross margin | 48.2% |  | 46.7% |  | 150\nSelling, general & administrative expense | 27.0% |  | 26.0% |  | 100\nOperating income | 21.2% |  | 20.8% |  | 40\nEarnings before income taxes | 21.4% |  | 21.0% |  | 40\nNet earnings | 17.1% |  | 17.4% |  | (30)\nNet earnings attributable to Procter & Gamble | 16.9% |  | 17.3% |  | (40)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Net Sales Change Drivers 2023 vs. 2022 (Three Months Ended March 31, 2023)(1)\n | Volume with Acquisitions & Divestitures |  | Volume Excluding Acquisitions & Divestitures |  | Foreign Exchange |  | Price |  | Mix |  | Other(2) |  | Net Sales Growth\nBeauty | 1% |  | \u2014% |  | (5)% |  | 8% |  | (1)% |  | \u2014% |  | 3%\nGrooming | (1)% |  | (1)% |  | (6)% |  | 10% |  | (2)% |  | \u2014% |  | 1%\nHealth Care | 1% |  | 1% |  | (3)% |  | 6% |  | 3% |  | (1)% |  | 6%\nFabric & Home Care | (5)% |  | (5)% |  | (4)% |  | 13% |  | 1% |  | \u2014% |  | 5%\nBaby, Feminine & Family Care | (4)% |  | (4)% |  | (3)% |  | 8% |  | 2% |  | \u2014% |  | 3%\nTotal Company | (3)% |  | (3)% |  | (4)% |  | 10% |  | 1% |  | \u2014% |  | 4%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended March 31\nAmounts in millions, except per share amounts | 2023 |  | 2022 |  | % Chg\nNet sales | $61,453 |  | $60,672 |  | 1%\nOperating income | 13,972 |  | 14,215 |  | (2)%\nNet earnings | 11,346 |  | 11,735 |  | (3)%\nNet earnings attributable to Procter & Gamble | 11,269 |  | 11,690 |  | (4)%\nDiluted net earnings per common share | 4.53 |  | 4.59 |  | (1)%\n\n | Nine Months Ended March 31\nCOMPARISONS AS A PERCENTAGE OF NET SALES | 2023 |  | 2022 |  | Basis Pt Chg\nGross margin | 47.7% |  | 48.3% |  | (60)\nSelling, general & administrative expense | 25.0% |  | 24.9% |  | 10\nOperating income | 22.7% |  | 23.4% |  | (70)\nEarnings before income taxes | 23.0% |  | 23.6% |  | (60)\nNet earnings | 18.5% |  | 19.3% |  | (80)\nNet earnings attributable to Procter & Gamble | 18.3% |  | 19.3% |  | (100)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Net Sales Change Drivers 2023 vs. 2022 (Nine Months Ended March 31, 2023)(1)\n | Volume with Acquisitions & Divestitures |  | Volume Excluding Acquisitions & Divestitures |  | Foreign Exchange |  | Price |  | Mix |  | Other(2) |  | Net Sales Growth\nBeauty | (1)% |  | (2)% |  | (6)% |  | 8% |  | (2)% |  | 1% |  | \u2014%\nGrooming | (3)% |  | (3)% |  | (8)% |  | 10% |  | (3)% |  | \u2014% |  | (4)%\nHealth Care | (1)% |  | (1)% |  | (5)% |  | 6% |  | 4% |  | \u2014% |  | 4%\nFabric & Home Care | (5)% |  | (5)% |  | (6)% |  | 12% |  | 1% |  | \u2014% |  | 2%\nBaby, Feminine & Family Care | (4)% |  | (4)% |  | (4)% |  | 8% |  | 1% |  | \u2014% |  | 1%\nTotal Company | (4)% |  | (4)% |  | (6)% |  | 10% |  | 1% |  | \u2014% |  | 1%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2023\n | Net Sales |  | % Change Versus Year Ago |  | Earnings/(Loss) Before Income Taxes |  | % Change Versus Year Ago |  | Net Earnings/(Loss) |  | % Change Versus Year Ago\nBeauty | $ | 3,494 |  |  | 3 | % |  | $ | 763 |  |  | (4) | % |  | $ | 608 |  |  | (6) | %\nGrooming | 1,495 |  |  | 1 | % |  | 382 |  |  | 8 | % |  | 308 |  |  | 6 | %\nHealth Care | 2,828 |  |  | 6 | % |  | 667 |  |  | 7 | % |  | 523 |  |  | 8 | %\nFabric & Home Care | 7,016 |  |  | 5 | % |  | 1,538 |  |  | 21 | % |  | 1,174 |  |  | 21 | %\nBaby, Feminine & Family Care | 5,062 |  |  | 3 | % |  | 1,206 |  |  | 11 | % |  | 925 |  |  | 11 | %\nCorporate | 173 |  |  | N/A |  | (268) |  |  | N/A |  | (114) |  |  | N/A\nTotal Company | $ | 20,068 |  |  | 4 | % |  | $ | 4,288 |  |  | 5 | % |  | $ | 3,424 |  |  | 2 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended March 31, 2023\n | Net Sales |  | % Change Versus Year Ago |  | Earnings/(Loss) Before Income Taxes |  | % Change Versus Year Ago |  | Net Earnings/(Loss) |  | % Change Versus Year Ago\nBeauty | $ | 11,262 |  |  | \u2014 | % |  | $ | 3,179 |  |  | (1) | % |  | $ | 2,530 |  |  | (2) | %\nGrooming | 4,763 |  |  | (4) | % |  | 1,381 |  |  | (5) | % |  | 1,116 |  |  | (6) | %\nHealth Care | 8,636 |  |  | 4 | % |  | 2,354 |  |  | 6 | % |  | 1,826 |  |  | 6 | %\nFabric & Home Care | 21,130 |  |  | 2 | % |  | 4,619 |  |  | 8 | % |  | 3,517 |  |  | 7 | %\nBaby, Feminine & Family Care | 15,061 |  |  | 1 | % |  | 3,373 |  |  | 1 | % |  | 2,578 |  |  | \u2014 | %\nCorporate | 601 |  |  | N/A |  | (786) |  |  | N/A |  | (221) |  |  | N/A\nTotal Company | $ | 61,453 |  |  | 1 | % |  | $ | 14,120 |  |  | (2) | % |  | $ | 11,346 |  |  | (3) | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months Ended March 31, 2023 | Net Sales Growth |  | Foreign Exchange Impact |  | Acquisition & Divestiture Impact/Other(1) |  | Organic Sales Growth\nBeauty | 3% |  | 5% |  | (1)% |  | 7%\nGrooming | 1% |  | 6% |  | \u2014% |  | 7%\nHealth Care | 6% |  | 3% |  | \u2014% |  | 9%\nFabric & Home Care | 5% |  | 4% |  | \u2014% |  | 9%\nBaby, Feminine & Family Care | 3% |  | 3% |  | \u2014% |  | 6%\nTotal Company | 4% |  | 4% |  | (1)% |  | 7%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNine Months Ended March 31, 2023 | Net Sales Growth |  | Foreign Exchange Impact |  | Acquisition & Divestiture Impact/Other(1) |  | Organic Sales Growth\nBeauty | \u2014% |  | 6% |  | (2)% |  | 4%\nGrooming | (4)% |  | 8% |  | \u2014% |  | 4%\nHealth Care | 4% |  | 5% |  | \u2014% |  | 9%\nFabric & Home Care | 2% |  | 6% |  | \u2014% |  | 8%\nBaby, Feminine & Family Care | 1% |  | 4% |  | \u2014% |  | 5%\nTotal Company | 1% |  | 6% |  | \u2014% |  | 7%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNine Months Ended March 31, 2023\nOperating Cash Flow |  | Capital Spending |  | U.S. Tax Act Payments |  | Adjusted Free Cash Flow\n$11,507 |  | $(2,328) |  | $225 |  | $9,404  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNine Months Ended March 31, 2023\nAdjusted Free Cash Flow |  | Net Earnings |  | Adjusted Free Cash Flow Productivity\n$9,404 |  | $11,346 |  | 83%  |  |  |  |  | \nItem 3. | Quantitative and Qualitative Disclosures About Market Risk  |  |  |  |  | \nItem\u00a04. | Controls and Procedures  |  |  |  |  | \nItem\u00a01. | Legal Proceedings  |  |  |  |  | \nItem\u00a01A. | Risk Factors  |  |  |  |  | \nItem\u00a02. | Unregistered Sales of Equity Securities and Use of Proceeds  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number of Shares Purchased(1) |  | Average Price Paid per Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(3) |  | Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program\n1/01/2023 - 1/31/2023 | 4,751,590 |  |  | $147.32 |  | 4,751,590 |  |  | (3)\n2/01/2023 - 2/28/2023 | 4,652,753 |  |  | $139.70 |  | 4,652,753 |  |  | (3)\n3/01/2023 - 3/31/2023 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (3)\nTotal | 9,404,343 |  |  | $143.55 |  | 9,404,343 |  |  |   |  |  |  |  | \nItem\u00a06. | Exhibits  |  |  |  |  |  |  |  | \n3-1 |  | Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October\u00a011, 2011 and consolidated by the Board of Directors on April 8, 2016) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-K for the year ended June 30, 2016)\n |  | \n3-2 |  | Regulations (as approved by the Board of Directors on December 13, 2022, pursuant to authority granted by shareholders at the annual meeting on October 13, 2009) (Incorporated by reference to Exhibit (3-2) of the Company\u2019s Current Report on Form 8-K filed December 13, 2022)\n |  | \n10-1 |  | Company\u2019s Form of Separation Letter and Release* +\n |  | \n31.1 |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Executive Officer+\n |  | \n31.2 |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Financial Officer+\n |  | \n32.1 |  | Section 1350 Certifications \u2013 Chief Executive Officer+\n |  | \n32.2 |  | Section 1350 Certifications \u2013 Chief Financial Officer+\n |  | \n101.SCH(1) |  | Inline XBRL Taxonomy Extension Schema Document\n |  | \n101.CAL(1) |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n |  | \n101.DEF(1) |  | Inline XBRL Taxonomy Definition Linkbase Document\n |  | \n101.LAB(1) |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n |  | \n101.PRE(1) |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n |  | \n104 |  |  | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)  |  |  |  |  | \n* | Compensatory plan or arrangement\n | \n+ | Filed herewith\n | \n(1) | Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | \n |  |  |  | THE PROCTER & GAMBLE COMPANY\n |  |  |  | \nApril 21, 2023 |  |  |  | /s/ MATTHEW W. JANZARUK\nDate |  |  |  | (Matthew W. Janzaruk)\n |  |  |  | Senior Vice President - Chief Accounting Officer(Principal Accounting Officer)"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Procter and Gamble, in 2023 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  |  |  |  | \nx | True | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  |  |  |  | \no | False | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)\u00a0OF THE SECURITIES EXCHANGE ACT OF 1934  |  | \n  |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOhio | OH | 1-434 |  | 31-0411980\n(State of Incorporation) |  | (Commission File Number) |  | (I.R.S. Employer Identification Number)\nOne Procter & Gamble Plaza |  | Cincinnati | OH | \nOne Procter & Gamble Plaza, Cincinnati, Ohio | 45202\n(Address of principal executive offices) | (Zip Code)  |  | \n  |  |  |  |  |  |  |  | \nTitle of each class | Trading Symbol | Name of each exchange on which registered\nCommon Stock, without Par Value | PG | NYSE\n1.125% Notes due 2023 | PG23A | NYSE\n0.500% Notes due 2024 | PG24A | NYSE\n0.625% Notes due 2024 | PG24B | NYSE\n1.375% Notes due 2025 | PG25 | NYSE\n0.110% Notes due 2026 | PG26D | NYSE\n3.250% EUR Notes due 2026 | PG26E | NYSE\n4.875% EUR notes due May 2027 | PG27A | NYSE\n1.200% Notes due 2028 | PG28 | NYSE\n1.250% Notes due 2029 | PG29B | NYSE\n1.800% Notes due 2029 | PG29A | NYSE\n6.250% GBP notes due January 2030 | PG30 | NYSE\n0.350% Notes due 2030 | PG30C | NYSE\n0.230% Notes due 2031 | PG31A | NYSE\n3.250% EUR Notes due 2031 | PG31B | NYSE\n5.250% GBP notes due January 2033 | PG33 | NYSE\n1.875% Notes due 2038 | PG38 | NYSE\n0.900% Notes due 2041 | PG41 | NYSE  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Large accelerated filer | \u00fe |  |  | Accelerated filer | \u00a8 | \n | Non-accelerated filer | \u00a8 |  |  | Smaller reporting company | \u00a8 | False\n |  |  |  |  | Emerging growth company | \u00a8 | False  |  |  |  |  |  |  |  |  |  |  | \nFORM 10-Q TABLE OF CONTENTS | Page\nPART I | Item 1. | Financial Statements | 1\n |  | Consolidated Statements of Earnings | 1\n |  | Consolidated Statements of Comprehensive Income | 1\n |  | Consolidated Balance Sheets | 2\n |  | Consolidated Statements of Shareholders' Equity | 3\n |  | Consolidated Statements of Cash Flows | 4\n |  | Notes to Consolidated Financial Statements | 5\n |  | Note 1: Basis of Presentation | 5\n |  | Note 2: New Accounting Pronouncements and Policies | 5\n |  | Note 3: Segment Information | 5\n |  | Note 4: Goodwill andIntangible Assets | 6\n |  | Note 5: Earnings Per Share | 8\n |  | Note 6: Share-Based Compensation and Postretirement Benefits | 8\n |  | Note 7: Risk Management Activities and Fair Value Measurements | 8\n |  | Note 8: Accumulated Other Comprehensive Income/(Loss) | 10\n |  | Note 9: Commitments and Contingencies | 10\n |  | Note 10: Supplier Finance Programs | 11\n | Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 11\n | Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 16\n | Item 4. | Controls and Procedures | 16\nPART II | Item 1. | Legal Proceedings | 16\n | Item 1A. | Risk Factors | 16\n | Item 2. | Unregistered Sales of Equity Securities,Use of Proceeds, and Issuer Purchases of Equity Securities | 16\n | Item 5. | Other Information | 17\n | Item 6. | Exhibits | 17\n |  | Signature | 17  |  |  |  |  | \nItem 1. | Financial Statements  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30 |  | \nAmounts in millions except per share amounts | 2023 |  | 2022 |  |  |  | \nNET SALES | $ | 21,871 |  |  | $ | 20,612 |  |  |  |  | \nCost of products sold | 10,501 |  |  | 10,846 |  |  |  |  | \nSelling, general and administrative expense | 5,604 |  |  | 4,827 |  |  |  |  | \nOPERATING INCOME | 5,767 |  |  | 4,939 |  |  |  |  | \nInterest expense | (225) |  |  | (123) |  |  |  |  | \nInterest income | 128 |  |  | 42 |  |  |  |  | \nOther non-operating income, net | 132 |  |  | 139 |  |  |  |  | \nEARNINGS BEFORE INCOME TAXES | 5,802 |  |  | 4,997 |  |  |  |  | \nIncome taxes | 1,246 |  |  | 1,034 |  |  |  |  | \nNET EARNINGS | 4,556 |  |  | 3,963 |  |  |  |  | \nLess: Net earnings attributable to noncontrolling interests | 35 |  |  | 24 |  |  |  |  | \nNET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE | $ | 4,521 |  |  | $ | 3,939 |  |  |  |  | \n |  |  |  |  |  |  | \nNET EARNINGS PER COMMON SHARE(1) |  |  |  |  |  |  | \nBasic | $ | 1.89 |  |  | $ | 1.62 |  |  |  |  | \nDiluted | $ | 1.83 |  |  | $ | 1.57 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30 |  | \nAmounts in millions | 2023 |  | 2022 |  |  |  | \nNET EARNINGS | $ | 4,556 |  |  | $ | 3,963 |  |  |  |  | \nOTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX |  |  |  |  |  |  | \nForeign currency translation | (409) |  |  | (712) |  |  |  |  | \nUnrealized losses on investment securities | (1) |  |  | (2) |  |  |  |  | \nUnrealized gains on defined benefit postretirement plans | 45 |  |  | 87 |  |  |  |  | \nTOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX | (366) |  |  | (627) |  |  |  |  | \nTOTAL COMPREHENSIVE INCOME | 4,190 |  |  | 3,336 |  |  |  |  | \nLess: Total comprehensive income attributable to noncontrolling interests | 33 |  |  | 19 |  |  |  |  | \nTOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE | $ | 4,157 |  |  | $ | 3,317 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAmounts in millions |  |  |  |  | September 30, 2023 |  | June 30, 2023\nAssets |  |  |  |  |  |  | \nCURRENT ASSETS |  |  |  |  |  |  | \nCash and cash equivalents |  |  |  |  | $ | 9,733 |  |  | $ | 8,246 | \nAccounts receivable |  |  |  |  | 6,215 |  |  | 5,471 | \nINVENTORIES |  |  |  |  |  |  | \nMaterials and supplies |  |  |  |  | 1,759 |  |  | 1,863 | \nWork in process |  |  |  |  | 972 |  |  | 956 | \nFinished goods |  |  |  |  | 4,386 |  |  | 4,254 | \nTotal inventories |  |  |  |  | 7,117 |  |  | 7,073 | \nPrepaid expenses and other current assets |  |  |  |  | 1,875 |  |  | 1,858 | \nTOTAL CURRENT ASSETS |  |  |  |  | 24,940 |  |  | 22,648 | \nPROPERTY, PLANT AND EQUIPMENT, NET |  |  |  |  | 21,636 |  |  | 21,909 | \nGOODWILL |  |  |  |  | 40,239 |  |  | 40,659 | \nTRADEMARKS AND OTHER INTANGIBLE ASSETS, NET |  |  |  | 23,637 |  |  | 23,783 | \nOTHER NONCURRENT ASSETS |  |  |  |  | 12,079 |  |  | 11,830 | \nTOTAL ASSETS |  |  |  |  | $ | 122,531 |  |  | $ | 120,829 | \n |  |  |  |  |  |  | \nLiabilities and Shareholders' Equity |  |  |  |  |  |  | \nCURRENT LIABILITIES |  |  |  |  |  |  | \nAccounts payable |  |  |  |  | $ | 14,435 |  |  | $ | 14,598 | \nAccrued and other liabilities |  |  |  |  | 10,912 |  |  | 10,929 | \nDebt due within one year |  |  |  |  | 11,811 |  |  | 10,229 | \nTOTAL CURRENT LIABILITIES |  |  |  |  | 37,158 |  |  | 35,756 | \nLONG-TERM DEBT |  |  |  |  | 24,069 |  |  | 24,378 | \nDEFERRED INCOME TAXES |  |  |  |  | 6,814 |  |  | 6,478 | \nOTHER NONCURRENT LIABILITIES |  |  |  |  | 6,477 |  |  | 7,152 | \nTOTAL LIABILITIES |  |  |  |  | 74,517 |  |  | 73,764 | \nSHAREHOLDERS\u2019 EQUITY |  |  |  |  |  |  | \nPreferred stock |  |  |  |  | 812 |  |  | 819 | \nCommon stock \u2013 shares issued \u2013 | September 2023 |  | 4,009.2 |  |  |  |  | \n | June 2023 |  | 4,009.2 |  |  | 4,009 |  |  | 4,009 | \nAdditional paid-in capital |  |  |  |  | 66,822 |  |  | 66,556 | \nReserve for ESOP debt retirement |  |  |  |  | (782) |  |  | (821) | \nAccumulated other comprehensive loss |  |  |  |  | (12,583) |  |  | (12,220) | \nTreasury stock |  |  |  |  | (131,029) |  |  | (129,736) | \nRetained earnings |  |  |  |  | 120,443 |  |  | 118,170 | \nNoncontrolling interest |  |  |  |  | 321 |  |  | 288 | \nTOTAL SHAREHOLDERS\u2019 EQUITY |  |  |  |  | 48,014 |  |  | 47,065 | \nTOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY |  |  |  | $ | 122,531 |  |  | $ | 120,829 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2023\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Additional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comprehensive Income/(Loss) | Treasury Stock | Retained Earnings | Noncontrolling Interest | Total Shareholders' Equity\nShares | Amount\nBALANCE JUNE 30, 2023 | 2,362,120 |  | $4,009 |  | $819 |  | $66,556 |  | ($821) |  | ($12,220) |  | ($129,736) |  | $118,170 |  | $288 |  | $47,065 | \nNet earnings |  |  |  |  |  |  |  | 4,521 |  | 35 |  | 4,556 | \nOther comprehensive income/(loss) |  |  |  |  |  | (363) |  |  |  | (2) |  | (366) | \nDividends and dividend equivalents($0.9407per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (2,225) |  |  | (2,225) | \nPreferred |  |  |  |  |  |  |  | (70) |  |  | (70) | \nTreasury stock purchases | (9,843) |  |  |  |  |  |  | (1,508) |  |  |  | (1,508) | \nEmployee stock plans | 3,721 |  |  |  | 265 |  |  |  | 209 |  |  |  | 474 | \nPreferred stock conversions | 888 |  |  | (7) |  | 1 |  |  |  | 6 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 39 |  |  |  | 48 |  |  | 87 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | \u2014 |  | \u2014 | \nBALANCE SEPTEMBER 30, 2023 | 2,356,886 |  | $4,009 |  | $812 |  | $66,822 |  | ($782) |  | ($12,583) |  | ($131,029) |  | $120,443 |  | $321 |  | $48,014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2022\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Additional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comprehensive Income/(Loss) | Treasury Stock | Retained Earnings | Noncontrolling Interest | Total Shareholders' Equity\nShares | Amount\nBALANCE JUNE 30, 2022 | 2,393,877 |  | $4,009 |  | $843 |  | $65,795 |  | ($916) |  | ($12,189) |  | ($123,382) |  | $112,429 |  | $265 |  | $46,854 | \nNet earnings |  |  |  |  |  |  |  | 3,939 |  | 24 |  | 3,963 | \nOther comprehensive income/(loss) |  |  |  |  |  | (622) |  |  |  | (5) |  | (627) | \nDividends and dividend equivalents($0.9133per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (2,189) |  |  | (2,189) | \nPreferred |  |  |  |  |  |  |  | (71) |  |  | (71) | \nTreasury stock purchases | (28,189) |  |  |  |  |  |  | (4,000) |  |  |  | (4,000) | \nEmployee stock plans | 3,011 |  |  |  | 159 |  |  |  | 169 |  |  |  | 328 | \nPreferred stock conversions | 998 |  |  | (9) |  | 1 |  |  |  | 8 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 46 |  |  |  | 55 |  |  | 101 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (25) |  | (25) | \nBALANCE SEPTEMBER 30, 2022 | 2,369,697 |  | $4,009 |  | $834 |  | $65,955 |  | ($870) |  | ($12,811) |  | ($127,205) |  | $114,163 |  | $259 |  | $44,334 |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30\nAmounts in millions | 2023 |  | 2022\nCASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD | $ | 8,246 |  |  | $ | 7,214 | \nOPERATING ACTIVITIES |  |  | \nNet earnings | 4,556 |  |  | 3,963 | \nDepreciation and amortization | 702 |  |  | 663 | \nShare-based compensation expense | 125 |  |  | 105 | \nDeferred income taxes | 102 |  |  | (130) | \nGain on sale of assets | (3) |  |  | (1) | \nChanges in: |  |  | \nAccounts receivable | (830) |  |  | (740) | \nInventories | (142) |  |  | (893) | \nAccounts payable and accrued and other liabilities | 857 |  |  | 1,495 | \nOther operating assets and liabilities | (671) |  |  | (454) | \nOther | 208 |  |  | 62 | \nTOTAL OPERATING ACTIVITIES | 4,904 |  |  | 4,070 | \nINVESTING ACTIVITIES |  |  | \nCapital expenditures | (925) |  |  | (890) | \nProceeds from asset sales | 3 |  |  | 5 | \nAcquisitions, net of cash acquired | \u2014 |  |  | (2) | \nOther investing activity | (300) |  |  | 55 | \nTOTAL INVESTING ACTIVITIES | (1,222) |  |  | (832) | \nFINANCING ACTIVITIES |  |  | \nDividends to shareholders | (2,290) |  |  | (2,255) | \nAdditions to short-term debt with original maturities of more than three months | 2,179 |  |  | 2,975 | \nReductions in short-term debt with original maturities of more than three months | (1,906) |  |  | (265) | \nNet additions to other short-term debt | 2,172 |  |  | 1,727 | \nReductions in long-term debt | (1,004) |  |  | (1,877) | \nTreasury stock purchases | (1,500) |  |  | (4,000) | \nImpact of stock options and other | 312 |  |  | 188 | \nTOTAL FINANCING ACTIVITIES | (2,038) |  |  | (3,507) | \nEFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (156) |  |  | (235) | \nCHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | 1,487 |  |  | (504) | \nCASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD | $ | 9,733 |  |  | $ | 6,710 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | % of Net sales by operating segment(1)\n | Three Months Ended September 30 |  | \n | 2023 |  | 2022 |  |  |  | \nFabric Care | 23 | % |  | 23 | % |  |  |  | \nHome Care | 12 | % |  | 12 | % |  |  |  | \nSkin and Personal Care | 10 | % |  | 10 | % |  |  |  | \nBaby Care | 9 | % |  | 10 | % |  |  |  | \nHair Care | 9 | % |  | 9 | % |  |  |  | \nFamily Care | 8 | % |  | 8 | % |  |  |  | \nGrooming | 8 | % |  | 8 | % |  |  |  | \nOral Care | 8 | % |  | 8 | % |  |  |  | \nFeminine Care | 7 | % |  | 6 | % |  |  |  | \nPersonal Health Care | 6 | % |  | 6 | % |  |  |  | \nTotal | 100 | % |  | 100 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended September 30 |  | \n |  | Net Sales |  | Earnings/(Loss) Before Income Taxes |  | Net Earnings/(Loss) |  |  |  |  |  | \nBeauty | 2023 | $ | 4,097 |  |  | $ | 1,249 |  |  | $ | 971 |  |  |  |  |  |  | \n | 2022 | 3,961 |  |  | 1,271 |  |  | 1,011 |  |  |  |  |  |  | \nGrooming | 2023 | 1,724 |  |  | 533 |  |  | 421 |  |  |  |  |  |  | \n | 2022 | 1,625 |  |  | 503 |  |  | 404 |  |  |  |  |  |  | \nHealth Care | 2023 | 3,074 |  |  | 889 |  |  | 689 |  |  |  |  |  |  | \n | 2022 | 2,757 |  |  | 800 |  |  | 617 |  |  |  |  |  |  | \nFabric & Home Care | 2023 | 7,646 |  |  | 2,031 |  |  | 1,569 |  |  |  |  |  |  | \n | 2022 | 7,082 |  |  | 1,543 |  |  | 1,172 |  |  |  |  |  |  | \nBaby, Feminine & Family Care | 2023 | 5,186 |  |  | 1,408 |  |  | 1,075 |  |  |  |  |  |  | \n | 2022 | 4,934 |  |  | 1,055 |  |  | 805 |  |  |  |  |  |  | \nCorporate | 2023 | 144 |  |  | (308) |  |  | (168) |  |  |  |  |  |  | \n | 2022 | 253 |  |  | (175) |  |  | (46) |  |  |  |  |  |  | \nTotal Company | 2023 | $ | 21,871 |  |  | $ | 5,802 |  |  | $ | 4,556 |  |  |  |  |  |  | \n | 2022 | 20,612 |  |  | 4,997 |  |  | 3,963 |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Beauty |  | Grooming |  | Health Care |  | Fabric & Home Care |  | Baby, Feminine & Family Care |  | Total Company\nGoodwill at June 30, 2023 | $ | 13,888 |  |  | $ | 12,703 |  |  | $ | 7,718 |  |  | $ | 1,821 |  |  | $ | 4,529 |  |  | $ | 40,659 | \nAcquisitions and divestitures | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nTranslation and other | (152) |  |  | (109) |  |  | (100) |  |  | (14) |  |  | (44) |  |  | (420) | \nGoodwill at September 30, 2023 | $ | 13,736 |  |  | $ | 12,594 |  |  | $ | 7,618 |  |  | $ | 1,807 |  |  | $ | 4,485 |  |  | $ | 40,239 |   |  |  |  |  |  |  |  |  |  |  | \n | Gross Carrying Amount |  | Accumulated Amortization\nIntangible assets with determinable lives | $ | 8,990 |  |  | $ | (6,308) | \nIntangible assets with indefinite lives | 20,955 |  |  | \u2014 | \nTotal identifiable intangible assets | $ | 29,945 |  |  | $ | (6,308) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Approximate Percent Change in Estimated Fair Value\n | +25 bps Discount Rate |  | -25 bps Growth Rates |  | -50 bps Royalty Rate\nGillette indefinite-lived intangible asset | (6) | % |  | (6) | % |  | (4) | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCONSOLIDATED AMOUNTS | Three Months Ended September 30 |  | \n | 2023 |  | 2022 |  |  |  | \nNet earnings | $ | 4,556 |  |  | $ | 3,963 |  |  |  |  | \nLess: Net earnings attributable to noncontrolling interests | 35 |  |  | 24 |  |  |  |  | \nNet earnings attributable to P&G (Diluted) | 4,521 |  |  | 3,939 |  |  |  |  | \nLess: Preferred dividends | 70 |  |  | 71 |  |  |  |  | \nNet earnings attributable to P&G available to common shareholders (Basic) | $ | 4,450 |  |  | $ | 3,868 |  |  |  |  | \n |  |  |  |  |  |  | \nSHARES IN MILLIONS |  |  |  |  |  |  | \nBasic weighted average common shares outstanding | 2,360.0 |  |  | 2,385.5 |  |  |  |  | \nAdd: Effect of dilutive securities |  |  |  |  |  |  | \nConvertible preferred shares(1) | 74.6 |  |  | 77.4 |  |  |  |  | \nStock options and other unvested equity awards(2) | 40.6 |  |  | 40.7 |  |  |  |  | \nDiluted weighted average common shares outstanding | 2,475.2 |  |  | 2,503.6 |  |  |  |  | \n |  |  |  |  |  |  | \nNET EARNINGS PER COMMON SHARE(3) |  |  |  |  |  |  | \nBasic | $ | 1.89 |  |  | $ | 1.62 |  |  |  |  | \nDiluted | $ | 1.83 |  |  | $ | 1.57 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30 |  | \n | 2023 |  | 2022 |  |  |  | \nShare-based compensation expense | $ | 125 |  |  | $ | 105 |  |  |  |  | \nNet periodic benefit cost for pension benefits | 57 |  |  | 43 |  |  |  |  | \nNet periodic benefit credit for other retiree benefits | (156) |  |  | (132) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Notional Amount |  | Fair\u00a0Value\u00a0Asset |  | Fair Value (Liability)\n | September 30, 2023 |  | June 30, 2023 |  | September 30, 2023 |  | June 30, 2023 |  | September 30, 2023 |  | June 30, 2023\nDERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS\nInterest rate contracts | $ | 2,961 |  |  | $ | 4,044 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | (434) |  |  | $ | (445) | \nDERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS\nForeign currency interest rate contracts | $ | 13,207 |  |  | $ | 11,005 |  |  | $ | 211 |  |  | $ | 26 |  |  | $ | (230) |  |  | $ | (631) | \nTOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | $ | 16,168 |  |  | $ | 15,049 |  |  | $ | 211 |  |  | $ | 26 |  |  | $ | (664) |  |  | $ | (1,076) | \n |  |  |  |  |  |  |  |  |  |  | \nDERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS\nForeign currency contracts | $ | 4,310 |  |  | $ | 3,489 |  |  | $ | 4 |  |  | $ | 7 |  |  | $ | (34) |  |  | $ | (42) | \n |  |  |  |  |  |  |  |  |  |  | \nTOTAL DERIVATIVES AT FAIR VALUE | $ | 20,478 |  |  | $ | 18,538 |  |  | $ | 216 |  |  | $ | 33 |  |  | $ | (698) |  |  | $ | (1,118) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Amount of Gain Recognized in OCI on Derivatives\n | Three Months Ended September 30 |  | \n | 2023 |  | 2022 |  |  |  | \nDERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS(1) (2) |  |  |  | \nForeign exchange contracts | $ | 285 |  |  | $ | 708 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Amount of Gain/(Loss) Recognized in Earnings\n | Three Months Ended September 30 |  | \n | 2023 |  | 2022 |  |  |  | \nDERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS |  |  |  | \nInterest rate contracts | $ | 11 |  |  | $ | (131) |  |  |  |  | \nDERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS |  |  |  | \nForeign currency contracts | $ | (71) |  |  | $ | (146) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Investment Securities |  | Postretirement Benefit Plans |  | Foreign Currency Translation |  | Total AOCI\nBalance at June 30, 2023 | $ | 13 |  |  | $ | 67 |  |  | $ | (12,300) |  |  | $ | (12,220) | \nOCI before reclassifications(1) | (1) |  |  | 44 |  |  | (409) |  |  | (367) | \nAmounts reclassified to the Consolidated Statement of Earnings(2) | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 1 | \nNet current period OCI | (1) |  |  | 45 |  |  | (409) |  |  | (366) | \nLess: OCI attributable to noncontrolling interests | \u2014 |  |  | \u2014 |  |  | (2) |  |  | (2) | \nBalance at September 30, 2023 | $ | 11 |  |  | $ | 112 |  |  | $ | (12,707) |  |  | $ | (12,583) |   |  |  |  |  | \nItem 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations  |  |  |  |  |  |  |  | \nReportable\u00a0Segments | Product Categories (Sub-Categories) | Major Brands\nBeauty | Hair Care (Conditioners, Shampoos, Styling Aids, Treatments) | Head & Shoulders, Herbal Essences, Pantene, Rejoice\nSkin and Personal Care (Antiperspirants and Deodorants, Personal Cleansing, Skin Care) | Olay, Old Spice, Safeguard, Secret, SK-II\nGrooming | Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming) | Braun, Gillette, Venus\nHealth Care | Oral Care (Toothbrushes, Toothpastes, Other Oral Care) | Crest, Oral-B\nPersonal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care) | Metamucil, Neurobion, Pepto-Bismol, Vicks\nFabric & Home Care | Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents) | Ariel, Downy, Gain, Tide\nHome Care (Air Care, Dish Care, P&G Professional, Surface Care) | Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer\nBaby, Feminine & Family Care | Baby Care (Baby Wipes, Taped Diapers and Pants) | Luvs, Pampers\nFeminine Care (Adult Incontinence, Feminine Care) | Always, Always Discreet, Tampax\nFamily Care (Paper Towels, Tissues, Toilet Paper) | Bounty, Charmin, Puffs  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2023 |  | \n | Net Sales |  | Net Earnings |  |  |  | \nBeauty | 19 | % |  | 20 | % |  |  |  | \nGrooming | 8 | % |  | 9 | % |  |  |  | \nHealth Care | 14 | % |  | 15 | % |  |  |  | \nFabric & Home Care | 35 | % |  | 33 | % |  |  |  | \nBaby, Feminine & Family Care | 24 | % |  | 23 | % |  |  |  | \nTotal Company | 100 | % |  | 100 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30\nAmounts in millions, except per share amounts | 2023 |  | 2022 |  | % Chg\nNet sales | $ | 21,871 |  | $ | 20,612 |  | 6%\nOperating income | 5,767 |  | 4,939 |  | 17%\nEarnings before income taxes | 5,802 |  | 4,997 |  | 16%\nNet earnings | 4,556 |  | 3,963 |  | 15%\nNet earnings attributable to Procter & Gamble | 4,521 |  | 3,939 |  | 15%\nDiluted net earnings per common share | 1.83 |  | 1.57 |  | 17%\n |  |  |  |  | \n\n | Three Months Ended September 30\nCOMPARISONS AS A PERCENTAGE OF NET SALES | 2023 |  | 2022 |  | Basis Pt Chg\nGross margin | 52.0 | % |  | 47.4 | % |  | 460 | \nSelling, general & administrative expense | 25.6 | % |  | 23.4 | % |  | 220 | \nOperating income | 26.4 | % |  | 24.0 | % |  | 240 | \nEarnings before income taxes | 26.5 | % |  | 24.2 | % |  | 230 | \nNet earnings | 20.8 | % |  | 19.2 | % |  | 160 | \nNet earnings attributable to Procter & Gamble | 20.7 | % |  | 19.1 | % |  | 160 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Net Sales Change Drivers 2023 vs. 2022 (Three Months Ended September 30)(1)\n | Volume with Acquisitions & Divestitures |  | Volume Excluding Acquisitions & Divestitures |  | Foreign Exchange |  | Price |  | Mix |  | Other(2) |  | Net Sales Growth\nBeauty | \u2014 | % |  | \u2014 | % |  | (3) | % |  | 7 | % |  | (2) | % |  | 1 | % |  | 3 | %\nGrooming | (2) | % |  | (2) | % |  | (3) | % |  | 9 | % |  | 1 | % |  | 1 | % |  | 6 | %\nHealth Care | 2 | % |  | 2 | % |  | 1 | % |  | 6 | % |  | 2 | % |  | \u2014 | % |  | 11 | %\nFabric & Home Care | (1) | % |  | \u2014 | % |  | (1) | % |  | 8 | % |  | 1 | % |  | 1 | % |  | 8 | %\nBaby, Feminine & Family Care | (3) | % |  | (3) | % |  | (2) | % |  | 8 | % |  | 2 | % |  | \u2014 | % |  | 5 | %\nTotal Company | (1) | % |  | (1) | % |  | (1) | % |  | 7 | % |  | 1 | % |  | \u2014 | % |  | 6 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2023\n | Net Sales |  | % Change Versus Year Ago |  | Earnings/(Loss) Before Income Taxes |  | % Change Versus Year Ago |  | Net Earnings/(Loss) |  | % Change Versus Year Ago\nBeauty | $ | 4,097 |  |  | 3 | % |  | $ | 1,249 |  |  | (2) | % |  | $ | 971 |  |  | (4) | %\nGrooming | 1,724 |  |  | 6 | % |  | 533 |  |  | 6 | % |  | 421 |  |  | 4 | %\nHealth Care | 3,074 |  |  | 11 | % |  | 889 |  |  | 11 | % |  | 689 |  |  | 12 | %\nFabric & Home Care | 7,646 |  |  | 8 | % |  | 2,031 |  |  | 32 | % |  | 1,569 |  |  | 34 | %\nBaby, Feminine & Family Care | 5,186 |  |  | 5 | % |  | 1,408 |  |  | 33 | % |  | 1,075 |  |  | 34 | %\nCorporate | 144 |  |  | N/A |  | (308) |  |  | N/A |  | (168) |  |  | N/A\nTotal Company | $ | 21,871 |  |  | 6 | % |  | $ | 5,802 |  |  | 16 | % |  | $ | 4,556 |  |  | 15 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months Ended September 30, 2023 | Net Sales Growth |  | Foreign Exchange Impact |  | Acquisition & Divestiture Impact/Other(1) |  | Organic Sales Growth\nBeauty | 3 | % |  | 3 | % |  | (1) | % |  | 5 | %\nGrooming | 6 | % |  | 3 | % |  | \u2014 | % |  | 9 | %\nHealth Care | 11 | % |  | (1) | % |  | \u2014 | % |  | 10 | %\nFabric & Home Care | 8 | % |  | 1 | % |  | \u2014 | % |  | 9 | %\nBaby, Feminine & Family Care | 5 | % |  | 2 | % |  | \u2014 | % |  | 7 | %\nTotal Company | 6 | % |  | 1 | % |  | \u2014 | % |  | 7 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months Ended September 30, 2023\nOperating Cash Flow |  | Capital Spending |  | U.S. Tax Act Payments |  | Adjusted Free Cash Flow\n$ | 4,904 |  |  | $ | (925) |  |  | $ | 422 |  |  | $ | 4,401 |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months Ended September 30, 2023\nAdjusted Free Cash Flow |  | Net Earnings |  | Adjusted Free Cash Flow Productivity\n$ | 4,401 |  |  | $ | 4,556 |  |  | 97 | %  |  |  |  |  | \nItem 3. | Quantitative and Qualitative Disclosures About Market Risk  |  |  |  |  | \nItem\u00a04. | Controls and Procedures  |  |  |  |  | \nItem\u00a01. | Legal Proceedings  |  |  |  |  | \nItem\u00a01A. | Risk Factors  |  |  |  |  | \nItem\u00a02. | Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number of Shares Purchased(1) |  | Average Price Paid per Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(3) |  | Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program\n7/01/2023 - 7/31/2023 | 7,834,268 |  |  | $151.24 |  | 6,613,447 |  |  | (3)\n8/01/2023 - 8/31/2023 | 3,227,792 |  |  | $154.89 |  | 3,227,792 |  |  | (3)\n9/01/2023 - 9/30/2023 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (3)\nTotal | 11,062,060 |  |  | $152.31 |  | 9,841,239 |  |  |   |  |  |  |  | \nItem\u00a05. | Other Information  |  |  |  |  | \nItem\u00a06. | Exhibits  |  |  |  |  |  |  |  | \n3-1 |  | Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October\u00a011, 2011 and consolidated by the Board of Directors on April 8, 2016) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-K for the year ended June 30, 2016)\n |  | \n3-2 |  | Regulations (as approved by the Board of Directors on December 13, 2022, pursuant to authority granted by shareholders at the annual meeting on October 13, 2009) (Incorporated by reference to Exhibit (3-2) of the Company\u2019s Current Report on Form 8-K filed December 13, 2022)\n |  | \n10-1 |  | Summary of the Company's Short Term Achievement Reward Program* +\n |  | \n10-2 |  | Short Term Achievement Reward Program \u2013 related correspondence and terms and conditions* +\n |  | \n10-3 |  | The Procter & Gamble Performance Stock Program Summary* +\n |  | \n10-4 |  | Performance Stock Program related correspondence and terms and conditions* +\n |  | \n10-5 |  | Long-Term Incentive Program related correspondence and terms and conditions* +\n |  | \n10-6 |  | The Procter & Gamble 2019 Stock and Incentive Compensation Plan \u2013 Additional terms and conditions* +\n |  | \n31.1 |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Executive Officer+\n |  | \n31.2 |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Financial Officer+\n |  | \n32.1 |  | Section 1350 Certifications \u2013 Chief Executive Officer+\n |  | \n32.2 |  | Section 1350 Certifications \u2013 Chief Financial Officer+\n |  | \n101.SCH(1) |  | Inline XBRL Taxonomy Extension Schema Document\n |  | \n101.CAL(1) |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n |  | \n101.DEF(1) |  | Inline XBRL Taxonomy Definition Linkbase Document\n |  | \n101.LAB(1) |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n |  | \n101.PRE(1) |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n |  | \n104 |  |  | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)  |  |  |  |  | \n* | Compensatory plan or arrangement\n | \n+ | Filed herewith\n | \n(1) | Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | \n |  |  |  | THE PROCTER & GAMBLE COMPANY\n |  |  |  | \nOctober 18, 2023 |  |  |  | /s/ MATTHEW W. JANZARUK\nDate |  |  |  | (Matthew W. Janzaruk)\n |  |  |  | Senior Vice President - Chief Accounting Officer(Principal Accounting Officer)"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Procter and Gamble, in 2023 Q3, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  |  |  |  | \nx | True | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  |  |  |  | \no | False | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)\u00a0OF THE SECURITIES EXCHANGE ACT OF 1934  |  | \n  |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOhio | OH | 1-434 |  | 31-0411980\n(State of Incorporation) |  | (Commission File Number) |  | (I.R.S. Employer Identification Number)\nOne Procter & Gamble Plaza |  | Cincinnati | OH | \nOne Procter & Gamble Plaza, Cincinnati, Ohio | 45202\n(Address of principal executive offices) | (Zip Code)  |  | \n  |  |  |  |  |  |  |  | \nTitle of each class | Trading Symbol | Name of each exchange on which registered\nCommon Stock, without Par Value | PG | NYSE\n0.500% Notes due 2024 | PG24A | NYSE\n0.625% Notes due 2024 | PG24B | NYSE\n1.375% Notes due 2025 | PG25 | NYSE\n0.110% Notes due 2026 | PG26D | NYSE\n3.250% EUR Notes due 2026 | PG26E | NYSE\n4.875% EUR notes due May 2027 | PG27A | NYSE\n1.200% Notes due 2028 | PG28 | NYSE\n1.250% Notes due 2029 | PG29B | NYSE\n1.800% Notes due 2029 | PG29A | NYSE\n6.250% GBP notes due January 2030 | PG30 | NYSE\n0.350% Notes due 2030 | PG30C | NYSE\n0.230% Notes due 2031 | PG31A | NYSE\n3.250% EUR Notes due 2031 | PG31B | NYSE\n5.250% GBP notes due January 2033 | PG33 | NYSE\n1.875% Notes due 2038 | PG38 | NYSE\n0.900% Notes due 2041 | PG41 | NYSE  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Large accelerated filer | \u00fe |  |  | Accelerated filer | \u00a8 | \n | Non-accelerated filer | \u00a8 |  |  | Smaller reporting company | \u00a8 | False\n |  |  |  |  | Emerging growth company | \u00a8 | False  |  |  |  |  |  |  |  |  |  |  | \nFORM 10-Q TABLE OF CONTENTS | Page\nPART I | Item 1. | Financial Statements | 1\n |  | Consolidated Statements of Earnings | 1\n |  | Consolidated Statements of Comprehensive Income | 1\n |  | Consolidated Balance Sheets | 2\n |  | Consolidated Statements of Shareholders' Equity | 3\n |  | Consolidated Statements of Cash Flows | 5\n |  | Notes to Consolidated Financial Statements | 6\n |  | Note 1: Basis of Presentation | 6\n |  | Note 2: New Accounting Pronouncements and Policies | 6\n |  | Note 3: Segment Information | 6\n |  | Note 4: Goodwill and Intangible Assets | 7\n |  | Note 5: Earnings Per Share | 9\n |  | Note 6: Share-Based Compensation and Postretirement Benefits | 9\n |  | Note 7: Risk Management Activities and Fair Value Measurements | 10\n |  | Note 8: Accumulated Other Comprehensive Income/(Loss) | 11\n |  | Note 9: Commitments and Contingencies | 11\n |  | Note 10: Supplier Finance Programs | 12\n |  | Note 11:Restructuring Program | 12\n | Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 13\n | Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 29\n | Item 4. | Controls and Procedures | 29\nPART II | Item 1. | Legal Proceedings | 29\n | Item 1A. | Risk Factors | 30\n | Item 2. | Unregistered Sales of Equity Securities, Use of Proceedsand Issuer Purchases of Equity Securities | 30\n | Item 5. | Other Information | 30\n | Item 6. | Exhibits | 31\n |  | Signature | 31  |  |  |  |  | \nItem 1. | Financial Statements  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31 |  | Six Months Ended December 31\nAmounts in millions except per share amounts | 2023 |  | 2022 |  | 2023 |  | 2022\nNET SALES | $ | 21,441 |  |  | $ | 20,773 |  |  | $ | 43,312 |  |  | $ | 41,385 | \nCost of products sold | 10,144 |  |  | 10,897 |  |  | 20,645 |  |  | 21,743 | \nSelling, general and administrative expense | 5,522 |  |  | 5,091 |  |  | 11,127 |  |  | 9,918 | \nIndefinite-lived intangible asset impairment charge | 1,341 |  |  | \u2014 |  |  | 1,341 |  |  | \u2014 | \nOPERATING INCOME | 4,433 |  |  | 4,785 |  |  | 10,200 |  |  | 9,724 | \nInterest expense | (248) |  |  | (171) |  |  | (472) |  |  | (294) | \nInterest income | 133 |  |  | 66 |  |  | 262 |  |  | 108 | \nOther non-operating income, net | 177 |  |  | 155 |  |  | 309 |  |  | 294 | \nEARNINGS BEFORE INCOME TAXES | 4,496 |  |  | 4,835 |  |  | 10,299 |  |  | 9,832 | \nIncome taxes | 1,003 |  |  | 876 |  |  | 2,250 |  |  | 1,910 | \nNET EARNINGS | 3,493 |  |  | 3,959 |  |  | 8,049 |  |  | 7,922 | \nLess: Net earnings attributable to noncontrolling interests | 25 |  |  | 26 |  |  | 60 |  |  | 50 | \nNET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE | $ | 3,468 |  |  | $ | 3,933 |  |  | $ | 7,988 |  |  | $ | 7,872 | \n |  |  |  |  |  |  | \nNET EARNINGS PER COMMON SHARE(1) |  |  |  |  |  |  | \nBasic | $ | 1.44 |  |  | $ | 1.63 |  |  | $ | 3.33 |  |  | $ | 3.25 | \nDiluted | $ | 1.40 |  |  | $ | 1.59 |  |  | $ | 3.23 |  |  | $ | 3.16 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31 |  | Six Months Ended December 31\nAmounts in millions | 2023 |  | 2022 |  | 2023 |  | 2022\nNET EARNINGS | $ | 3,493 |  |  | $ | 3,959 |  |  | $ | 8,049 |  |  | $ | 7,922 | \nOTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX |  |  |  |  |  |  | \nForeign currency translation | 492 |  |  | 379 |  |  | 83 |  |  | (333) | \nUnrealized losses on investment securities | (1) |  |  | (1) |  |  | (2) |  |  | (3) | \nUnrealized gains/(losses) on defined benefit postretirement plans | (75) |  |  | (76) |  |  | (30) |  |  | 11 | \nTOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX | 416 |  |  | 302 |  |  | 51 |  |  | (325) | \nTOTAL COMPREHENSIVE INCOME | 3,909 |  |  | 4,261 |  |  | 8,100 |  |  | 7,597 | \nLess: Total comprehensive income attributable to noncontrolling interests | 25 |  |  | 23 |  |  | 58 |  |  | 42 | \nTOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE | $ | 3,884 |  |  | $ | 4,238 |  |  | $ | 8,041 |  |  | $ | 7,555 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAmounts in millions |  |  |  |  | December 31, 2023 |  | June 30, 2023\nAssets |  |  |  |  |  |  | \nCURRENT ASSETS |  |  |  |  |  |  | \nCash and cash equivalents |  |  |  |  | $ | 7,890 |  |  | $ | 8,246 | \nAccounts receivable |  |  |  |  | 6,334 |  |  | 5,471 | \nINVENTORIES |  |  |  |  |  |  | \nMaterials and supplies |  |  |  |  | 1,780 |  |  | 1,863 | \nWork in process |  |  |  |  | 962 |  |  | 956 | \nFinished goods |  |  |  |  | 4,410 |  |  | 4,254 | \nTotal inventories |  |  |  |  | 7,151 |  |  | 7,073 | \nPrepaid expenses and other current assets |  |  |  |  | 1,736 |  |  | 1,858 | \nTOTAL CURRENT ASSETS |  |  |  |  | 23,111 |  |  | 22,648 | \nPROPERTY, PLANT AND EQUIPMENT, NET |  |  |  |  | 22,132 |  |  | 21,909 | \nGOODWILL |  |  |  |  | 40,916 |  |  | 40,659 | \nTRADEMARKS AND OTHER INTANGIBLE ASSETS, NET |  |  |  | 22,302 |  |  | 23,783 | \nOTHER NONCURRENT ASSETS |  |  |  |  | 12,248 |  |  | 11,830 | \nTOTAL ASSETS |  |  |  |  | $ | 120,709 |  |  | $ | 120,829 | \n |  |  |  |  |  |  | \nLiabilities and Shareholders' Equity |  |  |  |  |  |  | \nCURRENT LIABILITIES |  |  |  |  |  |  | \nAccounts payable |  |  |  |  | $ | 14,234 |  |  | $ | 14,598 | \nAccrued and other liabilities |  |  |  |  | 11,100 |  |  | 10,929 | \nDebt due within one year |  |  |  |  | 10,616 |  |  | 10,229 | \nTOTAL CURRENT LIABILITIES |  |  |  |  | 35,950 |  |  | 35,756 | \nLONG-TERM DEBT |  |  |  |  | 23,096 |  |  | 24,378 | \nDEFERRED INCOME TAXES |  |  |  |  | 6,219 |  |  | 6,478 | \nOTHER NONCURRENT LIABILITIES |  |  |  |  | 6,614 |  |  | 7,152 | \nTOTAL LIABILITIES |  |  |  |  | 71,880 |  |  | 73,764 | \nSHAREHOLDERS\u2019 EQUITY |  |  |  |  |  |  | \nPreferred stock |  |  |  |  | 809 |  |  | 819 | \nCommon stock \u2013 shares issued \u2013 | December 2023 |  | 4,009.2 |  |  |  |  | \n | June 2023 |  | 4,009.2 |  |  | 4,009 |  |  | 4,009 | \nAdditional paid-in capital |  |  |  |  | 66,935 |  |  | 66,556 | \nReserve for ESOP debt retirement |  |  |  |  | (782) |  |  | (821) | \nAccumulated other comprehensive loss |  |  |  |  | (12,167) |  |  | (12,220) | \nTreasury stock |  |  |  |  | (131,887) |  |  | (129,736) | \nRetained earnings |  |  |  |  | 121,617 |  |  | 118,170 | \nNoncontrolling interest |  |  |  |  | 294 |  |  | 288 | \nTOTAL SHAREHOLDERS\u2019 EQUITY |  |  |  |  | 48,829 |  |  | 47,065 | \nTOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY |  |  |  | $ | 120,709 |  |  | $ | 120,829 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31, 2023\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Additional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comprehensive Income/(Loss) | Treasury Stock | Retained Earnings | Noncontrolling Interest | Total Shareholders' Equity\nShares | Amount\nBALANCE SEPTEMBER 30, 2023 | 2,356,886 |  | $4,009 |  | $812 |  | $66,822 |  | ($782) |  | ($12,583) |  | ($131,029) |  | $120,443 |  | $321 |  | $48,014 | \nNet earnings |  |  |  |  |  |  |  | 3,468 |  | 25 |  | 3,493 | \nOther comprehensive income/(loss) |  |  |  |  |  | 416 |  |  |  | \u2014 |  | 416 | \nDividends and dividend equivalents($0.9407per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (2,225) |  |  | (2,225) | \nPreferred |  |  |  |  |  |  |  | (70) |  |  | (70) | \nTreasury stock purchases | (6,879) |  |  |  |  |  |  | (1,008) |  |  |  | (1,008) | \nEmployee stock plans | 2,630 |  |  |  | 113 |  |  |  | 147 |  |  |  | 260 | \nPreferred stock conversions | 385 |  |  | (3) |  | \u2014 |  |  |  | 3 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | \u2014 |  |  |  | \u2014 |  |  | \u2014 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (52) |  | (52) | \nBALANCE DECEMBER 31, 2023 | 2,353,021 |  | $4,009 |  | $809 |  | $66,935 |  | ($782) |  | ($12,167) |  | ($131,887) |  | $121,617 |  | $294 |  | $48,829 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended December 31, 2023\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Additional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comprehensive Income/(Loss) | Treasury Stock | Retained Earnings | Noncontrolling Interest | Total Shareholders' Equity\nShares | Amount\nBALANCE JUNE 30, 2023 | 2,362,120 |  | $4,009 |  | $819 |  | $66,556 |  | ($821) |  | ($12,220) |  | ($129,736) |  | $118,170 |  | $288 |  | $47,065 | \nNet earnings |  |  |  |  |  |  |  | 7,988 |  | 60 |  | 8,049 | \nOther comprehensive income/(loss) |  |  |  |  |  | 53 |  |  |  | (2) |  | 51 | \nDividends and dividend equivalents(1.8814per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (4,450) |  |  | (4,450) | \nPreferred |  |  |  |  |  |  |  | (140) |  |  | (140) | \nTreasury stock purchases | (16,722) |  |  |  |  |  |  | (2,516) |  |  |  | (2,516) | \nEmployee stock plans | 6,351 |  |  |  | 378 |  |  |  | 356 |  |  |  | 734 | \nPreferred stock conversions | 1,273 |  |  | (10) |  | 1 |  |  |  | 9 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 39 |  |  |  | 48 |  |  | 87 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (52) |  | (52) | \nBALANCE DECEMBER 31, 2023 | 2,353,021 |  | $4,009 |  | $809 |  | $66,935 |  | ($782) |  | ($12,167) |  | ($131,887) |  | $121,617 |  | $294 |  | $48,829 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31, 2022\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Additional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comprehensive Income/(Loss) | Treasury Stock | Retained Earnings | Noncontrolling Interest | Total Shareholders' Equity\nShares | Amount\nBALANCE SEPTEMBER 30, 2022 | 2,369,697 |  | $4,009 |  | $834 |  | $65,955 |  | ($870) |  | ($12,811) |  | ($127,205) |  | $114,163 |  | $259 |  | $44,334 | \nNet earnings |  |  |  |  |  |  |  | 3,933 |  | 26 |  | 3,959 | \nOther comprehensive income/(loss) |  |  |  |  |  | 305 |  |  |  | (3) |  | 302 | \nDividends and dividend equivalents($0.9133per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (2,168) |  |  | (2,168) | \nPreferred |  |  |  |  |  |  |  | (70) |  |  | (70) | \nTreasury stock purchases | (14,426) |  |  |  |  |  |  | (2,002) |  |  |  | (2,002) | \nEmployee stock plans | 3,441 |  |  |  | 189 |  |  |  | 193 |  |  |  | 382 | \nPreferred stock conversions | 432 |  |  | (3) |  | 1 |  |  |  | 2 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | \u2014 |  |  |  | \u2014 |  |  | \u2014 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (12) |  | (12) | \nBALANCE DECEMBER 31, 2022 | 2,359,144 |  | $4,009 |  | $831 |  | $66,145 |  | ($870) |  | ($12,506) |  | ($129,012) |  | $115,858 |  | $270 |  | $44,725 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended December 31, 2022\nDollars in millions;shares in thousands | Common Stock | Preferred Stock | Additional Paid-In Capital | Reserve for ESOP Debt Retirement | Accumulated Other Comprehensive Income/(Loss) | Treasury Stock | Retained Earnings | Noncontrolling Interest | Total Shareholders' Equity\nShares | Amount\nBALANCE JUNE 30, 2022 | 2,393,877 |  | $4,009 |  | $843 |  | $65,795 |  | ($916) |  | ($12,189) |  | ($123,382) |  | $112,429 |  | $265 |  | $46,854 | \nNet earnings |  |  |  |  |  |  |  | 7,872 |  | 50 |  | 7,922 | \nOther comprehensive income/(loss) |  |  |  |  |  | (317) |  |  |  | (8) |  | (325) | \nDividends and dividend equivalents(1.8266per share): |  |  |  |  |  |  |  |  |  | \nCommon |  |  |  |  |  |  |  | (4,357) |  |  | (4,357) | \nPreferred |  |  |  |  |  |  |  | (141) |  |  | (141) | \nTreasury stock purchases | (42,615) |  |  |  |  |  |  | (6,002) |  |  |  | (6,002) | \nEmployee stock plans | 6,452 |  |  |  | 348 |  |  |  | 362 |  |  |  | 710 | \nPreferred stock conversions | 1,430 |  |  | (12) |  | 2 |  |  |  | 10 |  |  |  | \u2014 | \nESOP debt impacts |  |  |  |  | 46 |  |  |  | 55 |  |  | 101 | \nNoncontrolling interest, net |  |  |  | \u2014 |  |  |  |  |  | (37) |  | (37) | \nBALANCE DECEMBER 31, 2022 | 2,359,144 |  | $4,009 |  | $831 |  | $66,145 |  | ($870) |  | ($12,506) |  | ($129,012) |  | $115,858 |  | $270 |  | $44,725 |   |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended December 31\nAmounts in millions | 2023 |  | 2022\nCASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD | $ | 8,246 |  |  | $ | 7,214 | \nOPERATING ACTIVITIES |  |  | \nNet earnings | 8,049 |  |  | 7,922 | \nDepreciation and amortization | 1,423 |  |  | 1,316 | \nShare-based compensation expense | 275 |  |  | 250 | \nDeferred income taxes | (154) |  |  | (398) | \nGain on sale of assets | (3) |  |  | (3) | \nIndefinite-lived intangible asset impairment charge | 1,341 |  |  | \u2014 | \nChanges in: |  |  | \nAccounts receivable | (839) |  |  | (654) | \nInventories | (32) |  |  | (655) | \nAccounts payable and accrued and other liabilities | 302 |  |  | 177 | \nOther operating assets and liabilities | (704) |  |  | (535) | \nOther | 346 |  |  | 224 | \nTOTAL OPERATING ACTIVITIES | 10,004 |  |  | 7,644 | \nINVESTING ACTIVITIES |  |  | \nCapital expenditures | (1,742) |  |  | (1,598) | \nProceeds from asset sales | 8 |  |  | 8 | \nAcquisitions, net of cash acquired | \u2014 |  |  | (76) | \nOther investing activity | (489) |  |  | 344 | \nTOTAL INVESTING ACTIVITIES | (2,224) |  |  | (1,322) | \nFINANCING ACTIVITIES |  |  | \nDividends to shareholders | (4,578) |  |  | (4,486) | \nAdditions to short-term debt with original maturities of more than three months | 2,798 |  |  | 10,447 | \nReductions in short-term debt with original maturities of more than three months | (5,862) |  |  | (3,260) | \nNet additions/(reductions) to other short-term debt | 3,740 |  |  | (1,759) | \nAdditions to long-term debt | 254 |  |  | \u2014 | \nReductions in long-term debt | (2,335) |  |  | (1,877) | \nTreasury stock purchases | (2,503) |  |  | (6,002) | \nImpact of stock options and other | 397 |  |  | 437 | \nTOTAL FINANCING ACTIVITIES | (8,087) |  |  | (6,500) | \nEFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (49) |  |  | (182) | \nCHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (356) |  |  | (360) | \nCASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD | $ | 7,890 |  |  | $ | 6,854 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | % of Net sales by operating segment(1)\n | Three Months Ended December 31 |  | Six Months Ended December 31\n | 2023 |  | 2022 |  | 2023 |  | 2022\nFabric Care | 23 | % |  | 23 | % |  | 23 | % |  | 23 | %\nHome Care | 12 | % |  | 11 | % |  | 12 | % |  | 11 | %\nBaby Care | 9 | % |  | 10 | % |  | 10 | % |  | 10 | %\nHair Care | 9 | % |  | 8 | % |  | 9 | % |  | 9 | %\nSkin and Personal Care | 9 | % |  | 10 | % |  | 9 | % |  | 10 | %\nFamily Care | 9 | % |  | 8 | % |  | 8 | % |  | 8 | %\nOral Care | 9 | % |  | 8 | % |  | 8 | % |  | 8 | %\nGrooming | 8 | % |  | 8 | % |  | 8 | % |  | 8 | %\nPersonal Health Care | 6 | % |  | 7 | % |  | 7 | % |  | 6 | %\nFeminine Care | 6 | % |  | 7 | % |  | 6 | % |  | 7 | %\nTotal | 100 | % |  | 100 | % |  | 100 | % |  | 100 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended December 31 |  | Six Months Ended December 31\n |  | Net Sales |  | Earnings/(Loss) Before Income Taxes |  | Net Earnings/(Loss) |  | Net Sales |  | Earnings/(Loss) Before Income Taxes |  | Net Earnings/(Loss)\nBeauty | 2023 | $ | 3,849 |  |  | $ | 1,112 |  |  | $ | 868 |  |  | $ | 7,946 |  |  | $ | 2,361 |  |  | $ | 1,839 | \n | 2022 | 3,807 |  |  | 1,145 |  |  | 911 |  |  | 7,768 |  |  | 2,416 |  |  | 1,922 | \nGrooming | 2023 | 1,734 |  |  | 538 |  |  | 440 |  |  | 3,458 |  |  | 1,071 |  |  | 862 | \n | 2022 | 1,643 |  |  | 496 |  |  | 404 |  |  | 3,268 |  |  | 999 |  |  | 808 | \nHealth Care | 2023 | 3,172 |  |  | 932 |  |  | 719 |  |  | 6,245 |  |  | 1,821 |  |  | 1,408 | \n | 2022 | 3,051 |  |  | 887 |  |  | 686 |  |  | 5,808 |  |  | 1,687 |  |  | 1,303 | \nFabric & Home Care | 2023 | 7,415 |  |  | 2,018 |  |  | 1,577 |  |  | 15,061 |  |  | 4,049 |  |  | 3,146 | \n | 2022 | 7,032 |  |  | 1,538 |  |  | 1,171 |  |  | 14,114 |  |  | 3,081 |  |  | 2,343 | \nBaby, Feminine & Family Care | 2023 | 5,146 |  |  | 1,437 |  |  | 1,102 |  |  | 10,332 |  |  | 2,845 |  |  | 2,177 | \n | 2022 | 5,065 |  |  | 1,112 |  |  | 848 |  |  | 9,999 |  |  | 2,167 |  |  | 1,653 | \nCorporate | 2023 | 126 |  |  | (1,541) |  |  | (1,214) |  |  | 270 |  |  | (1,849) |  |  | (1,383) | \n | 2022 | 175 |  |  | (343) |  |  | (61) |  |  | 428 |  |  | (518) |  |  | (107) | \nTotal Company | 2023 | $ | 21,441 |  |  | $ | 4,496 |  |  | $ | 3,493 |  |  | $ | 43,312 |  |  | $ | 10,299 |  |  | $ | 8,049 | \n | 2022 | 20,773 |  |  | 4,835 |  |  | 3,959 |  |  | 41,385 |  |  | 9,832 |  |  | 7,922 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Beauty |  | Grooming |  | Health Care |  | Fabric & Home Care |  | Baby, Feminine & Family Care |  | Total Company\nGoodwill at June 30, 2023 | $ | 13,888 |  |  | $ | 12,703 |  |  | $ | 7,718 |  |  | $ | 1,821 |  |  | $ | 4,529 |  |  | $ | 40,659 | \nAcquisitions and divestitures | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nTranslation and other | 99 |  |  | 71 |  |  | 56 |  |  | 6 |  |  | 25 |  |  | 257 | \nGoodwill at December 31, 2023 | $ | 13,987 |  |  | $ | 12,774 |  |  | $ | 7,774 |  |  | $ | 1,827 |  |  | $ | 4,554 |  |  | $ | 40,916 |   |  |  |  |  |  |  |  |  |  |  | \n | Gross Carrying Amount |  | Accumulated Amortization\nIntangible assets with determinable lives | $ | 9,071 |  |  | $ | (6,444) | \nIntangible assets with indefinite lives | 19,675 |  |  | \u2014 | \nTotal identifiable intangible assets | $ | 28,746 |  |  | $ | (6,444) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Approximate Percent Change in Estimated Fair Value\n | +25 bps Discount Rate |  | -25 bps Growth Rates |  | -50 bps Royalty Rate\nGillette indefinite-lived intangible asset | (5) | % |  | (5) | % |  | (4) | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCONSOLIDATED AMOUNTS | Three Months Ended December 31 |  | Six Months Ended December 31\n | 2023 |  | 2022 |  | 2023 |  | 2022\nNet earnings | $ | 3,493 |  |  | $ | 3,959 |  |  | $ | 8,049 |  |  | $ | 7,922 | \nLess: Net earnings attributable to noncontrolling interests | 25 |  |  | 26 |  |  | 60 |  |  | 50 | \nNet earnings attributable to P&G (Diluted) | 3,468 |  |  | 3,933 |  |  | 7,988 |  |  | 7,872 | \nLess: Preferred dividends | 70 |  |  | 70 |  |  | 140 |  |  | 141 | \nNet earnings attributable to P&G available to common shareholders (Basic) | $ | 3,398 |  |  | $ | 3,863 |  |  | $ | 7,849 |  |  | $ | 7,731 | \n |  |  |  |  |  |  | \nSHARES IN MILLIONS |  |  |  |  |  |  | \nBasic weighted average common shares outstanding | 2,358.0 |  |  | 2,365.9 |  |  | 2,359.0 |  |  | 2,375.7 | \nAdd: Effect of dilutive securities |  |  |  |  |  |  | \nConvertible preferred shares(1) | 73.9 |  |  | 76.7 |  |  | 74.3 |  |  | 77.0 | \nStock options and other unvested equity awards(2) | 36.4 |  |  | 38.6 |  |  | 38.5 |  |  | 39.7 | \nDiluted weighted average common shares outstanding | 2,468.4 |  |  | 2,481.2 |  |  | 2,471.8 |  |  | 2,492.4 | \n |  |  |  |  |  |  | \nNET EARNINGS PER COMMON SHARE(3) |  |  |  |  |  |  | \nBasic | $ | 1.44 |  |  | $ | 1.63 |  |  | $ | 3.33 |  |  | $ | 3.25 | \nDiluted | $ | 1.40 |  |  | $ | 1.59 |  |  | $ | 3.23 |  |  | $ | 3.16 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31 |  | Six Months Ended December 31\n | 2023 |  | 2022 |  | 2023 |  | 2022\nShare-based compensation expense | $ | 150 |  |  | $ | 145 |  |  | $ | 275 |  |  | $ | 250 | \nNet periodic benefit cost for pension benefits | 52 |  |  | 44 |  |  | 109 |  |  | 87 | \nNet periodic benefit credit for other retiree benefits | (156) |  |  | (132) |  |  | (311) |  |  | (264) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Notional Amount |  | Fair\u00a0Value\u00a0Asset |  | Fair Value (Liability)\n | December 31, 2023 |  | June 30, 2023 |  | December 31, 2023 |  | June 30, 2023 |  | December 31, 2023 |  | June 30, 2023\nDERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS\nInterest rate contracts | $ | 3,098 |  |  | $ | 4,044 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | (317) |  |  | $ | (445) | \nDERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS\nForeign currency interest rate contracts | $ | 12,267 |  |  | $ | 11,005 |  |  | $ | 5 |  |  | $ | 26 |  |  | $ | (347) |  |  | $ | (631) | \nTOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | $ | 15,365 |  |  | $ | 15,049 |  |  | $ | 5 |  |  | $ | 26 |  |  | $ | (664) |  |  | $ | (1,076) | \n |  |  |  |  |  |  |  |  |  |  | \nDERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS\nForeign currency contracts | $ | 4,321 |  |  | $ | 3,489 |  |  | $ | 37 |  |  | $ | 7 |  |  | $ | (7) |  |  | $ | (42) | \n |  |  |  |  |  |  |  |  |  |  | \nTOTAL DERIVATIVES AT FAIR VALUE | $ | 19,686 |  |  | $ | 18,538 |  |  | $ | 42 |  |  | $ | 33 |  |  | $ | (671) |  |  | $ | (1,118) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Amount of Loss Recognized in OCI on Derivatives\n | Three Months Ended December 31 |  | Six Months Ended December 31\n | 2023 |  | 2022 |  | 2023 |  | 2022\nDERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS(1) (2) |  |  |  | \nForeign exchange contracts | $ | (487) |  |  | $ | (1,013) |  |  | $ | (202) |  |  | $ | (305) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Amount of Gain/(Loss) Recognized in Earnings\n | Three Months Ended December 31 |  | Six Months Ended December 31\n | 2023 |  | 2022 |  | 2023 |  | 2022\nDERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS |  |  |  | \nInterest rate contracts | $ | 117 |  |  | $ | (49) |  |  | $ | 128 |  |  | $ | (180) | \nDERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS |  |  |  | \nForeign currency contracts | $ | 128 |  |  | $ | 95 |  |  | $ | 57 |  |  | $ | (51) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Investment Securities |  | Postretirement Benefit Plans |  | Foreign Currency Translation |  | Total AOCI\nBalance at June 30, 2023 | $ | 13 |  |  | $ | 67 |  |  | $ | (12,300) |  |  | $ | (12,220) | \nOCI before reclassifications(1) | (2) |  |  | (19) |  |  | 83 |  |  | 62 | \nAmounts reclassified to the Consolidated Statement of Earnings(2) | \u2014 |  |  | (11) |  |  | \u2014 |  |  | (11) | \nNet current period OCI | (2) |  |  | (30) |  |  | 83 |  |  | 51 | \nLess: OCI attributable to noncontrolling interests | \u2014 |  |  | \u2014 |  |  | (2) |  |  | (2) | \nBalance at December 31, 2023 | $ | 11 |  |  | $ | 37 |  |  | $ | (12,214) |  |  | $ | (12,167) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Separation Costs |  | Asset-Related Costs |  | Other Costs |  | Total\nRESERVE JUNE 30, 2023 | $ | 155 |  |  | $ | \u2014 |  |  | $ | 19 |  |  | $ | 174 | \nCosts incurred for the three months ended September 30, 2023 | 69 |  |  | 12 |  |  | 11 |  |  | 92 | \nCosts incurred for the three months ended December 31, 2023 | 40 |  |  | 30 |  |  | 19 |  |  | 89 | \nCosts incurred for the six months ended December 31, 2023 | 109 |  |  | 42 |  |  | 30 |  |  | 181 | \n |  |  |  |  |  |  | \nCosts paid/settled for the six months ended December 31, 2023 | (91) |  |  | (42) |  |  | (27) |  |  | (160) | \nRESERVE DECEMBER 31, 2023 | $ | 173 |  |  | $ | \u2014 |  |  | $ | 22 |  |  | $ | 195 |   |  |  |  |  | \nItem 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations  |  |  |  |  |  |  |  | \nReportable\u00a0Segments | Product Categories (Sub-Categories) | Major Brands\nBeauty | Hair Care (Conditioners, Shampoos, Styling Aids, Treatments) | Head & Shoulders, Herbal Essences, Pantene, Rejoice\nSkin and Personal Care (Antiperspirants and Deodorants, Personal Cleansing, Skin Care) | Olay, Old Spice, Safeguard, Secret, SK-II\nGrooming | Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming) | Braun, Gillette, Venus\nHealth Care | Oral Care (Toothbrushes, Toothpastes, Other Oral Care) | Crest, Oral-B\nPersonal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care) | Metamucil, Neurobion, Pepto-Bismol, Vicks\nFabric & Home Care | Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents) | Ariel, Downy, Gain, Tide\nHome Care (Air Care, Dish Care, P&G Professional, Surface Care) | Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer\nBaby, Feminine & Family Care | Baby Care (Baby Wipes, Taped Diapers and Pants) | Luvs, Pampers\nFeminine Care (Adult Incontinence, Feminine Care) | Always, Always Discreet, Tampax\nFamily Care (Paper Towels, Tissues, Toilet Paper) | Bounty, Charmin, Puffs  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31, 2023 |  | Six Months Ended December 31, 2023\n | Net Sales |  | Net Earnings |  | Net Sales |  | Net Earnings\nBeauty | 18 | % |  | 19 | % |  | 18 | % |  | 20 | %\nGrooming | 8 | % |  | 9 | % |  | 8 | % |  | 9 | %\nHealth Care | 15 | % |  | 15 | % |  | 15 | % |  | 15 | %\nFabric & Home Care | 35 | % |  | 34 | % |  | 35 | % |  | 33 | %\nBaby, Feminine & Family Care | 24 | % |  | 23 | % |  | 24 | % |  | 23 | %\nTotal Company | 100 | % |  | 100 | % |  | 100 | % |  | 100 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31\nAmounts in millions, except per share amounts | 2023 |  | 2022 |  | % Chg\nNet sales | $ | 21,441 |  | $ | 20,773 |  | 3%\nOperating income | 4,433 |  | 4,785 |  | (7)%\nEarnings before income taxes | 4,496 |  | 4,835 |  | (7)%\nNet earnings | 3,493 |  | 3,959 |  | (12)%\nNet earnings attributable to Procter & Gamble | 3,468 |  | 3,933 |  | (12)%\nDiluted net earnings per common share | 1.40 |  | 1.59 |  | (12)%\nCore net earnings per common share | 1.84 |  | 1.59 |  | 16%\n\n | Three Months Ended December 31\nCOMPARISONS AS A PERCENTAGE OF NET SALES | 2023 |  | 2022 |  | Basis Pt Chg\nGross margin | 52.7 | % |  | 47.5 | % |  | 520 | \nSelling, general & administrative expense | 25.8 | % |  | 24.5 | % |  | 130 | \nOperating income | 20.7 | % |  | 23.0 | % |  | (230) | \nEarnings before income taxes | 21.0 | % |  | 23.3 | % |  | (230) | \nNet earnings | 16.3 | % |  | 19.1 | % |  | (280) | \nNet earnings attributable to Procter & Gamble | 16.2 | % |  | 18.9 | % |  | (270) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Net Sales Change Drivers 2023 vs. 2022 (Three Months Ended December 31)(1)\n | Volume with Acquisitions & Divestitures |  | Volume Excluding Acquisitions & Divestitures |  | Foreign Exchange |  | Price |  | Mix |  | Other(2) |  | Net Sales Growth\nBeauty | \u2014 | % |  | (1) | % |  | (1) | % |  | 4 | % |  | (3) | % |  | 1 | % |  | 1 | %\nGrooming | 1 | % |  | 1 | % |  | (3) | % |  | 7 | % |  | 1 | % |  | \u2014 | % |  | 6 | %\nHealth Care | (3) | % |  | (4) | % |  | 2 | % |  | 5 | % |  | 1 | % |  | (1) | % |  | 4 | %\nFabric & Home Care | \u2014 | % |  | 1 | % |  | \u2014 | % |  | 4 | % |  | 1 | % |  | \u2014 | % |  | 5 | %\nBaby, Feminine & Family Care | (2) | % |  | (2) | % |  | (1) | % |  | 4 | % |  | 1 | % |  | \u2014 | % |  | 2 | %\nTotal Company | \u2014 | % |  | (1) | % |  | (1) | % |  | 4 | % |  | \u2014 | % |  | \u2014 | % |  | 3 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended December 31\nAmounts in millions, except per share amounts | 2023 |  | 2022 |  | % Chg\nNet sales | $ | 43,312 |  | $ | 41,385 |  | 5%\nOperating income | 10,200 |  | 9,724 |  | 5%\nEarnings before income taxes | 10,299 |  | 9,832 |  | 5%\nNet earnings | 8,049 |  | 7,922 |  | 2%\nNet earnings attributable to Procter & Gamble | 7,988 |  | 7,872 |  | 1%\nDiluted net earnings per common share | 3.23 |  | 3.16 |  | 2%\nCore net earnings per common share | 3.66 |  | 3.16 |  | 16%\n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended December 31\nCOMPARISONS AS A PERCENTAGE OF NET SALES | 2023 |  | 2022 |  | Basis Pt Chg\nGross margin | 52.3 | % |  | 47.5 | % |  | 480 | \nSelling, general & administrative expense | 25.7 | % |  | 24.0 | % |  | 170 | \nOperating income | 23.6 | % |  | 23.5 | % |  | 10 | \nEarnings before income taxes | 23.8 | % |  | 23.8 | % |  | \u2014 | \nNet earnings | 18.6 | % |  | 19.1 | % |  | (50) | \nNet earnings attributable to Procter & Gamble | 18.4 | % |  | 19.0 | % |  | (60) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Net Sales Change Drivers 2023 vs. 2022 (Six Months Ended December 31)(1)\n | Volume with Acquisitions & Divestitures |  | Volume Excluding Acquisitions & Divestitures |  | Foreign Exchange |  | Price |  | Mix |  | Other(2) |  | Net Sales Growth\nBeauty | \u2014 | % |  | \u2014 | % |  | (2) | % |  | 5 | % |  | (2) | % |  | 1 | % |  | 2 | %\nGrooming | (1) | % |  | (1) | % |  | (3) | % |  | 8 | % |  | 1 | % |  | 1 | % |  | 6 | %\nHealth Care | (1) | % |  | (1) | % |  | 2 | % |  | 5 | % |  | 2 | % |  | \u2014 | % |  | 8 | %\nFabric & Home Care | \u2014 | % |  | \u2014 | % |  | (1) | % |  | 6 | % |  | 1 | % |  | 1 | % |  | 7 | %\nBaby, Feminine & Family Care | (2) | % |  | (3) | % |  | (1) | % |  | 6 | % |  | 1 | % |  | (1) | % |  | 3 | %\nTotal Company | (1) | % |  | (1) | % |  | (1) | % |  | 6 | % |  | \u2014 | % |  | 1 | % |  | 5 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended December 31, 2023\n | Net Sales |  | % Change Versus Year Ago |  | Earnings/(Loss) Before Income Taxes |  | % Change Versus Year Ago |  | Net Earnings/(Loss) |  | % Change Versus Year Ago\nBeauty | $ | 3,849 |  |  | 1 | % |  | $ | 1,112 |  |  | (3) | % |  | $ | 868 |  |  | (5) | %\nGrooming | 1,734 |  |  | 6 | % |  | 538 |  |  | 8 | % |  | 440 |  |  | 9 | %\nHealth Care | 3,172 |  |  | 4 | % |  | 932 |  |  | 5 | % |  | 719 |  |  | 5 | %\nFabric & Home Care | 7,415 |  |  | 5 | % |  | 2,018 |  |  | 31 | % |  | 1,577 |  |  | 35 | %\nBaby, Feminine & Family Care | 5,146 |  |  | 2 | % |  | 1,437 |  |  | 29 | % |  | 1,102 |  |  | 30 | %\nCorporate | 126 |  |  | N/A |  | (1,541) |  |  | N/A |  | (1,214) |  |  | N/A\nTotal Company | $ | 21,441 |  |  | 3 | % |  | $ | 4,496 |  |  | (7) | % |  | $ | 3,493 |  |  | (12) | %\n |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended December 31, 2023\n | Net Sales |  | % Change Versus Year Ago |  | Earnings/(Loss) Before Income Taxes |  | % Change Versus Year Ago |  | Net Earnings/(Loss) |  | % Change Versus Year Ago\nBeauty | $ | 7,946 |  |  | 2 | % |  | $ | 2,361 |  |  | (2) | % |  | $ | 1,839 |  |  | (4) | %\nGrooming | 3,458 |  |  | 6 | % |  | 1,071 |  |  | 7 | % |  | 862 |  |  | 7 | %\nHealth Care | 6,245 |  |  | 8 | % |  | 1,821 |  |  | 8 | % |  | 1,408 |  |  | 8 | %\nFabric & Home Care | 15,061 |  |  | 7 | % |  | 4,049 |  |  | 31 | % |  | 3,146 |  |  | 34 | %\nBaby, Feminine & Family Care | 10,332 |  |  | 3 | % |  | 2,845 |  |  | 31 | % |  | 2,177 |  |  | 32 | %\nCorporate | 270 |  |  | N/A |  | (1,849) |  |  | N/A |  | (1,383) |  |  | N/A\nTotal Company | $ | 43,312 |  |  | 5 | % |  | $ | 10,299 |  |  | 5 | % |  | $ | 8,049 |  |  | 2 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months Ended December 31, 2023 | Net Sales Growth |  | Foreign Exchange Impact |  | Acquisition & Divestiture Impact/Other(1) |  | Organic Sales Growth\nBeauty | 1 | % |  | 1 | % |  | (1) | % |  | 1 | %\nGrooming | 6 | % |  | 3 | % |  | \u2014 | % |  | 9 | %\nHealth Care | 4 | % |  | (2) | % |  | \u2014 | % |  | 2 | %\nFabric & Home Care | 5 | % |  | \u2014 | % |  | 1 | % |  | 6 | %\nBaby, Feminine & Family Care | 2 | % |  | 1 | % |  | \u2014 | % |  | 3 | %\nTotal Company | 3 | % |  | 1 | % |  | \u2014 | % |  | 4 | %\n(1)Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.\nSix Months Ended December 31, 2023 | Net Sales Growth |  | Foreign Exchange Impact |  | Acquisition & Divestiture Impact/Other(1) |  | Organic Sales Growth\nBeauty | 2 | % |  | 2 | % |  | (1) | % |  | 3 | %\nGrooming | 6 | % |  | 3 | % |  | \u2014 | % |  | 9 | %\nHealth Care | 8 | % |  | (2) | % |  | \u2014 | % |  | 6 | %\nFabric & Home Care | 7 | % |  | 1 | % |  | \u2014 | % |  | 8 | %\nBaby, Feminine & Family Care | 3 | % |  | 1 | % |  | 1 | % |  | 5 | %\nTotal Company | 5 | % |  | 1 | % |  | (1) | % |  | 5 | %\n(1)Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSix Months Ended December 31, 2023\nOperating Cash Flow |  | Capital Spending |  | U.S. Tax Act Payments |  | Adjusted Free Cash Flow\n$ | 10,004 |  |  | $ | (1,742) |  |  | $ | 422 |  |  | $ | 8,684 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSix Months Ended December 31, 2023\nAdjusted Free Cash Flow |  | Net Earnings |  | Adjustments toNet Earnings(1) |  | Net Earningsas Adjusted |  | Adjusted Free CashFlow Productivity\n$ | 8,684 |  |  | $ | 8,049 |  |  | $ | 1,026 |  |  | $ | 9,075 |  |  | 96 | %\n(1)Adjustments to Net Earnings relate to the Gillette intangible asset impairment charge announced in December 2023.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTHE PROCTER & GAMBLE COMPANY AND SUBSIDIARIESReconciliation of Non-GAAP Measures\n | Three Months Ended December 31, 2023 |  | Three Months Ended December 31, 2022\nAmounts in millions except per share amounts | As Reported (GAAP) |  | Incremental Restructuring |  | Intangible Impairment |  | Core(Non-GAAP) |  | As Reported(GAAP)(1)\nCost of products sold | $ | 10,144 |  |  | $ | (12) |  |  | $ | \u2014 |  |  | $ | 10,132 |  |  | $ | 10,897 | \nSelling, general and administrative expense | 5,522 |  |  | (8) |  |  | \u2014 |  |  | 5,515 |  |  | 5,091 | \nOperating income | 4,433 |  |  | 19 |  |  | 1,341 |  |  | 5,793 |  |  | 4,785 | \nIncome taxes | 1,003 |  |  | (20) |  |  | 315 |  |  | 1,299 |  |  | 876 | \nNet earnings attributable to P&G | 3,468 |  |  | 39 |  |  | 1,026 |  |  | 4,533 |  |  | 3,933 | \n |  |  |  |  |  |  | Core EPS |  | \nDiluted net earnings per common share(2) | $ | 1.40 |  |  | $ | 0.02 |  |  | $ | 0.42 |  |  | $ | 1.84 |  |  | $ | 1.59 | \n(1)For the three months ended December 31, 2022, there were no adjustments to or reconciling items for Core EPS.(2)Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.\n |  |  |  |  |  |  |  |  | \nCHANGE VERSUS YEAR AGO |  |  |  |  |  |  |  |  | \nNet earnings attributable to P&G | (12) | % |  |  |  |  |  |  |  | \nCore net earnings attributable to P&G | 15 | % |  |  |  |  |  |  |  | \nDiluted net earnings per common share | (12) | % |  |  |  |  |  |  |  | \nCore EPS | 16 | % |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTHE PROCTER & GAMBLE COMPANY AND SUBSIDIARIESReconciliation of Non-GAAP Measures\n | Six Months Ended December 31, 2023 |  | Six Months Ended December 31, 2022\nAmounts in millions except per share amounts | As Reported (GAAP) |  | Incremental Restructuring |  | Intangible Impairment |  | Core(Non-GAAP) |  | As Reported(GAAP)(1)\nCost of products sold | $ | 20,645 |  |  | $ | (12) |  |  | $ | \u2014 |  |  | $ | 20,633 |  |  | $ | 21,743 | \nSelling, general and administrative expense | 11,127 |  |  | (8) |  |  | \u2014 |  |  | 11,119 |  |  | 9,918 | \nOperating income | 10,200 |  |  | 19 |  |  | 1,341 |  |  | 11,560 |  |  | 9,724 | \nIncome taxes | 2,250 |  |  | (20) |  |  | 315 |  |  | 2,545 |  |  | 1,910 | \nNet earnings attributable to P&G | 7,988 |  |  | 39 |  |  | 1,026 |  |  | 9,054 |  |  | 7,872 | \n |  |  |  |  |  |  | Core EPS |  | \nDiluted net earnings per common share(2) | $ | 3.23 |  |  | $ | 0.02 |  |  | $ | 0.42 |  |  | $ | 3.66 |  |  | $ | 3.16 | \n(1)For the six months ended December 31, 2022, there were no adjustments to or reconciling items for Core EPS.(2)Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.\n |  |  |  |  |  |  |  |  | \nCHANGE VERSUS YEAR AGO |  |  |  |  |  |  |  |  | \nNet earnings attributable to P&G | 1 | % |  |  |  |  |  |  |  | \nCore net earnings attributable to P&G | 15 | % |  |  |  |  |  |  |  | \nDiluted net earnings per common share | 2 | % |  |  |  |  |  |  |  | \nCore EPS | 16 | % |  |  |  |  |  |  |  |   |  |  |  |  | \nItem 3. | Quantitative and Qualitative Disclosures About Market Risk  |  |  |  |  | \nItem\u00a04. | Controls and Procedures  |  |  |  |  | \nItem\u00a01. | Legal Proceedings  |  |  |  |  | \nItem\u00a01A. | Risk Factors  |  |  |  |  | \nItem\u00a02. | Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number of Shares Purchased(1) |  | Average Price Paid per Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(3) |  | Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program\n10/01/2023 - 10/31/2023 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (3)\n11/01/2023 - 11/30/2023 | 3,311,725 |  |  | $150.98 |  | 3,311,725 |  |  | (3)\n12/01/2023 - 12/31/2023 | 3,411,865 |  |  | 146.55 |  |  | 3,411,865 |  |  | (3)\nTotal | 6,723,590 |  |  | $148.73 |  | 6,723,590 |  |  |   |  |  |  |  | \nItem\u00a05. | Other Information  |  |  |  |  | \nItem\u00a06. | Exhibits  |  |  |  |  |  |  |  | \n3-1 |  | Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October\u00a011, 2011 and consolidated by the Board of Directors on April 8, 2016) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-K for the year ended June 30, 2016)\n |  | \n3-2 |  | Regulations (as approved by the Board of Directors on December 13, 2022, pursuant to authority granted by shareholders at the annual meeting on October 13, 2009) (Incorporated by reference to Exhibit (3-2) of the Company\u2019s Current Report on Form 8-K filed December 13, 2022)\n |  | \n4-1 |  | Indenture, dated as of September 3, 2009, between the Company and Deutsche Bank Trust Company Americas, as Trustee (Incorporated by reference to Exhibit (4-1) of the Company's Annual Report on Form 10-K for the year ended June 30, 2015)\n |  | \n31.1 |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Executive Officer+\n |  | \n31.2 |  | Rule 13a-14(a)/15d-14(a) Certification \u2013 Chief Financial Officer+\n |  | \n32.1 |  | Section 1350 Certifications \u2013 Chief Executive Officer+\n |  | \n32.2 |  | Section 1350 Certifications \u2013 Chief Financial Officer+\n |  | \n101.SCH(1) |  | Inline XBRL Taxonomy Extension Schema Document\n |  | \n101.CAL(1) |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n |  | \n101.DEF(1) |  | Inline XBRL Taxonomy Definition Linkbase Document\n |  | \n101.LAB(1) |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n |  | \n101.PRE(1) |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n |  | \n104 |  |  | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)  |  |  |  |  | \n* | Compensatory plan or arrangement\n | \n+ | Filed herewith\n | \n(1) | Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | \n |  |  |  | THE PROCTER & GAMBLE COMPANY\n |  |  |  | \nJanuary 23, 2024 |  |  |  | /s/ MATTHEW W. JANZARUK\nDate |  |  |  | (Matthew W. Janzaruk)\n |  |  |  | Senior Vice President - Chief Accounting Officer(Principal Accounting Officer)"}]}
